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Abstract 
Colorectal cancer is the second most common cancer in the Western world and is thought to 
arise mainly from colorectal adenomas. Red meat and alcohol intake and (long-term) cigarette 
smoking probably increase colorectal tumor risk. Although risk increase was found to be weak, 
certain subgroups might be more susceptible to these carcinogens because of inherited 
polymorphisms resulting in increased activation of potential carcinogens. In this thesis, we 
investigated whether meat consumption, cigarette smoking, and alcohol intake, in combination 
with such genetic polymorphisms, increase the risk of colorectal adenomas and colorectal cancer. 
For this purpose, we used two different study populations. One was an adenoma case-control 
study with 440 adenoma cases and 447 polyp-free controls recruited among those undergoing 
endoscopy at eight Dutch outpatient clinics between June 1997 and June 2000. The other was a 
Dutch prospective cohort enrolled between January 1987 and December 1991. Follow-up for 8.5 
years resulted in 102 colorectal cancer cases. We compared these cases with a random sample of 
537 controls frequency-matched on age, sex and town. Information on dietary and lifestyle habits 
was collected through self-administered questionnaires. DNA was isolated from whole blood 
and genetic polymorphisms were subsequently determined by use of standardized methods. 
We found that colorectal adenoma risk was not increased with high meat consumption (OR 
1.2, 95% CI 0.8-1.9) or unfavorable meat preparation methods. These null-associations were not 
modified by genetic polymorphisms affecting metabolism of heterocyclic amines that may be 
formed during preparation of meat at high temperatures (N-acetyltransferases (NAT) 1 and 2, 
sulfotransferase (SULT) 1A1, and glutathione S-transferases (GST) Ml and Tl). Long-term 
cigarette smoking increased adenoma risk (OR 2.4, 95% CI 1.4-4.1 for smoking for more than 25 
years compared to never smokers). Although most pronounced in those with fast SULT1A1 (OR 
4.3, 95% CI 1.6-11.8) and slow NAT2 variants (OR 3.5, 95% CI 1.9-6.4), there was no 
statistically significant effect modification by genetic polymorphisms involved in metabolism of 
arylamines and polycyclic aromatic hydrocarbons from cigarette smoke (NAT1, NAT2, 
SULT1A1, GSTM1, GSTT1, and epoxide hydrolase). Alcohol consumption increased colorectal 
adenoma risk especially among women (OR 1.8, 95% CI 1.0-3.2 for 10 or more drinks weekly 
versus less than one drink per week). Among men, adenoma risk increased only with 
consumption of more than 21 drinks per week (OR 1.8, 95% CI 0.9-3.8). Alcohol is metabolized 
to carcinogenic acetaldehyde by alcohol dehydrogenase (ADH3). The association between 
alcohol and adenomas was weakly - but not statistically significantly - stronger among those with 
the fast ADH3 variant compared to those with imputed slow phenotypes. 
Colorectal cancer risk increased slightly with frequent red meat consumption (OR 1.6, 95% CI 
0.9-2.9, highest vs. lowest intake). Genetic polymorphisms in NAT1, NAT2, and GSTM1 did not 
importantly modify this association. Risk of colorectal cancer was increased with smoking 
duration, but only among former smokers having smoked for more than 15 years (OR 2.7, 95% 
CI 1.0-7.4) compared to former smokers having smoked for shorter time. NAT1, NAT2, and 
GSTM1 polymorphisms did not influence this association. 
In summary, the results of our studies do not point toward strong modifying effects of genetic 
polymorphisms of enzymes involved in carcinogen metabolism, which is in accordance with 
results of similar studies on colorectal tumors. Such effects may however be present, but 
possibly, we were not able to demonstrate them. To elucidate the potential role of genetic 
susceptibility in colorectal carcinogenesis, alternative epidemiologic study designs and statistical 
methods should be considered. These observational studies should be conducted 
simoultaneously with experimental studies aiming to generate more biological knowledge on the 
diverse processes leading to colorectal tumorigenesis in humans. 
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CHAPTER 1 
All over the world, cancer is a major cause of death and in most Western societies, it is 
only exceeded by cardiovascular diseases. In 1996, 10 million new cases and more than 7 
million deaths from cancer were estimated globally '. The prevalence rates of specific 
cancers, among which colorectal cancer, vary highly over the world 2. This variation is to 
a large extent caused by variation in environmental exposure to dietary and lifestyle 
factors '. 
Colorectal cancer is after prostate cancer in men and breast cancer in women the second 
most common cancer in developed countries 2 and is thought to arise almost uniquely 
from colorectal adenomas 3. It is estimated that less than 10% of all colorectal cancers can 
be attributed to inheritance of rare and highly penetrant genetic mutations causing 
cancer in about 90% of affected offspring at a relatively young age 4. In the majority of 
colorectal cancers, however, genetic factors probably only determine the impact of the 
exposure to carcinogenic and protective environmental substances on cancer risk5. 
E n v i r o n m e n t a l e x p o s u r e 
The colorectal epithelium is exposed to many substances from the environment, of 
which most originate from the diet. Some of these substances may increase colorectal 
cancer risk, whereas others might be protective. So far, it is largely unknown which 
factors of this complex mix of factors influencing carcinogenesis at different stages, are 
important 6'7. 
Thus, dietary factors are thought to be important in the etiology of colorectal cancer, 
although only weak associations were found for all factors that possibly influence 
colorectal cancer risk '. In this respect, there is most evidence that vegetables decrease 
the risk of colorectal neoplasm, possibly through their high content of potential anti-
carcinogenic substances such as dietary fiber, folate and other vitamins, or their 
association with a healthy lifestyle '. Other factors probably decreasing colorectal cancer 
risk are a high level of physical activity and intake of non-steroidal anti-inflammatory 
drugs 7. In this thesis, however, we focus on risk factors of colorectal cancer rather than 
on protective factors. 
Factors that probably increase the risk of colorectal cancer are the consumption of red 
meat and of alcohol '. Further, evidence is accumulating that (long-term) cigarette 
smoking may be a risk factor of colorectal cancer 8. 
To date, it is not known which substances in meat may cause an increase in colorectal 
neoplasm risk. Animal fat9 and heme 10 are candidate substances. Potential carcinogens 
formed during meat processing and preparation may also be responsible, as both 
processed and well-done meats were found to increase colorectal neoplasm risk in 
epidemiological studies ""'''. The preparation of meat at temperatures of above 150°C 
leads to formation of heterocyclic aromatic amines (HCAs) by pyrolysis of proteins 1819. 
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HCAs were found to be potent animal carcinogens and are possibly carcinogenic to 
humans even at low doses 20. 
Cigarette smoke contains many potential carcinogens, among which polycyclic aromatic 
hydrocarbons (PAHs) and arylamines 21. The colon and rectum can become exposed 
when smoke is ingested, or more indirectly, through transport of potential carcinogens 
by blood or bile via the liver or otherwise, to the colon22'23. 
Alcohol may stimulate tumor promotion and/or progression via co-carcinogenesis, and 
may also induce DNA hypomethylation 24. The main evidence for ethanol as risk factor 
of colorectal carcinogenesis points to its main metabolite, acetaldehyde, a probable 
carcinogen found to cause various types of D N A damage in metabolic and in animal 
experiments 25. 
Although these factors have been identified as probable risk factors of colorectal cancer, 
estimated relative risks generally vary between one and two 1'812. This indicates that if 
(red) meat consumption, cigarette smoking and alcohol intake increase cancer risk, their 
effect is expected to be small. However, the risk of colorectal cancer resulting from 
exposure to these substances may be higher within certain subgroups being more 
susceptible to specific carcinogens than the general population. 
Metabolism of carcinogens 
Most carcinogens need metabolic activation in the human body before they can cause 
DNA damage, and thus, possibly increase cancer risk. This implicates that the 
metabolism of these potential carcinogens is crucial with respect to cancer risk. The 
metabolism of many carcinogens involves a primary modification step catalyzed by so-
called phase I enzymes. This first step results in metabolites with functional chemical 
groups, determining the further pathway of the metabolite. Some of these intermediate 
metabolites can form D N A and protein adducts. After the phase I reaction, conjugation 
reactions catalyzed by phase II enzymes take place, in which the metabolite is 
inactivated, or alternatively, is further activated. 
The extent to which potential carcinogens become activated or detoxified depends on 
the (genetically determined) properties of metabolic enzymes and determines the 
individuals' susceptibility to environmentally induced cancer. This concept is illustrated 
in figure 1.1. 
HCA metabolism starts with activation by cytochrome P450 enzymes (mainly by 
CYP1A2), after which HCA metabolites are further activated or are inactivated through 
phase II reactions. Both activation and detoxification can be catalyzed by N-
acetyltransferases (NATs) and sulfotransferases (SULTs) 26. Glutathione S-transferases 
(GSTs) may directly inactivate HCA metabolites 27 but may also play a more indirect 
role in HCA metabolism, via the induction of the CYP1A2 28. 
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Figure 1,1. Simplified metabolism of environmental carcinogens in relation to genetic 
susceptibility by polymorphisms genes encoding metabolic enzymes. Gray arrow.-, 
indicate events that potentially increase risk of neoplasm. 
Arylamines from cigarette smoke are metabolized via similar pathways as HCAs, 
although the metabolites produced from arylamines may differ from those formed from 
HCAs 29. The metabolism of arylamines and HCAs is, in simplified form, depicted in 
figure 1.2. PAH metabolism occurs in a similar way as HCA and arylamine metabolism 
and involves a first activation step catalyzed by CYP enzymes, after which further 
activation or detoxification is catalyzed by several phase II enzymes such as GSTs and 
SULTs. Microsomal epoxide hydrolase (encoded by the EPHX gene) catalyzes phase I 
and phase II reactions and may activate or inactivate PAH metabolites 30,31. 
Acetaldehyde is formed through dehydrogenation of ethanol by alcohol dehydrogenase 
enzymes, of which ADH-y is encoded by ADH3. Acetaldehyde can subsequently be 
detoxified by aldehyde dehydrogenase. 
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Figure 1.2. Metabolism of arykmines. Simplified from Grant et al. (199/) :". UGT: 
UDI'-iilucuronosyltrarisfcrasc. 
Genetic susceptibility 
In the context of this thesis, the term 'genetic susceptibility' is used for an underlying 
genetic polymorphism causing carcinogens from the environment to be metabolized at 
reduced or increased rate, thereby altering exposure and thus formation of D N A damage 
and risk of neoplasm. Genetic polymorphisms result in altered gene expression or in 
protein variants with different activity, stability or substrate affinity. Polymorphisms 
occur at high frequency in populations and are associated with a low absolute cancer 
risk, but because they are highly prevalent, they could involve a high population 
attributable risk5. 
Many of the enzymes involved in the metabolism of HCAs, arylamines, PAHs, and 
ethanol are encoded by polymorphic genes. For most of these genes, tight correlations 
between the specific genotypes and their corresponding phenotypes were found. 
N-acetyltransferase enzymes are encoded by NAT1 and NAT2 genes. For NAT2, the 
correlation between genotype and phenotype is well established 32. In comparison with 
NAT2*4 and NAT2*12 alleles, in vitro studies showed that several other allelic variants 
code for enzymes with reduced stability or affinity, or do not result in a protein at 
13 
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all 26,32,33. Most of these so-called 'slow' alleles occur at relatively high frequencies 26'34, so 
that slow acetylation occurs in more than 50% of Caucasians 35. 
In contrast to NAT2, there has been debate about the correlation between NAT1 
genotype and the corresponding phenotype 33. Compared to NAT1*4 encoded enzymes, 
it was initially thought that the NAT1*10 allele was associated with increased acetylation 
activity 36. However, more recent studies indicate that the activity of the NAT1*10 
encoded enzyme is similar to 'normal' NAT1 acetylation, whereas NAT1*11 is related 
to decreased enzyme activity 37. The frequency of the NAT1*11 allele - which occurs 
most frequently of all slow acetylation alleles, is, however, lower (5%) than that of the 
*10 allele (20%)38,38, and this has consequences for the sample size required to be able to 
detect effects o£NATl polymorphism. 
Sulfotransferases are encoded by various genes, of which SULT1A1 is highly expressed 
in the liver. This gene was found to harbor a polymorphism leading to variation in 
enzyme activity 39. The S17LTM7*2 allele leads to substantially decreased enzyme 
activity and thermostability and occurs with a frequency of about 35% in Caucasian 
populations 40. 
The GSTM1 polymorphism is determined by a gene deletion, and the GST-fi. enzyme 
is not expressed in subjects who are homozygous for the null allele 41. The GSTM1 null 
genotype occurs in about half of Caucasians 42. 
As GSTM1, a polymorphism in the GSTT1 gene also leads to absence of the encoded 
enzyme. GSTT1 gene deletion occurs at lower frequencies of about 15-20% in 
Caucasian populations 42. 
Lifestyle and colorectal neoplasm: possible role of genetic 
susceptibility 
There are three main reasons why information about metabolic polymorphisms should 
be incorporated into cancer epidemiology 43. First, the identification of subpopulations 
susceptible to a certain environmental factor known to increase cancer risk would 
increase the power of epidemiological studies. Second, incorporation of polymorphisms 
in genes involved in the metabolism of a certain agent thought to increase cancer risk 
may strenghten the evidence for that agent, if these polymorphisms indeed modify the 
association between the agent and cancer. Third, the study of metabolic polymorphisms 
may help in setting tolerance limits for theoretically risky low-level exposures, for which 
individual susceptibility should be considered. 
The impact of genetic susceptibility on the association between environmental exposure 
and cancer can only be studied if there is some evidence that 1) the genetic 
polymorphism is related to altered enzyme expression or function; 2) the gene codes for 
an enzyme that is relevant in activation or deactivation pathways; 3) the enzyme 
14 
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catalyzes biotransformation of (a component of) the studied exposure factor; and 4) the 
studied exposure factor is associated with increased risk of neoplasm 43. 
The interplay between genetic susceptibility and environmental exposure is often 
referred to as gene-environment interaction. However, we prefer not to use this term 
since this might incorrectly suggest presence of statistical interaction, whereas the term 
refers to biological co-action. 
As can be concluded from the above, genetic polymorphisms influencing the 
metabolism of potential carcinogens from the diet or from cigarette smoke may be 
important factors in environmentally determined colorectal neoplasm. Table 1.1 
summarizes published studies in which the impact of genetic susceptibility to HCAs, 
arylamines, PAHs and ethanol on the association of meat consumption, smoking and 
alcohol intake with colorectal neoplasm were investigated. 
Only few studies incorporating metabolic polymorphisms had been published by 1995 
(table 1.1), when the studies described in this thesis were initiated. Most of those studies 
included only small populations, but were nevertheless indicative for a role of 
polymorphisms in metabolic genes in environmentally induced colorectal neoplasm 44'45, 
thereby warranting the initiation of larger studies. In later years, both study size and the 
number of metabolic polymorphisms that was included increased. 
However, we conclude from table 1.1 that the studies incorporating metabolic 
polymorphisms have yielded inconsistent results so far. Results from studies on meat 
consumption and preparation did not give evidence for a role of GSTM1 genotype. The 
effect of NAT2 polymorphism, if any, was only small, indicating that high meat 
consumption and/or high-risk meat preparation in combination with fast NAT2 
acetylation might modestly increase colorectal neoplasm risk. Only one study 
incorporated NAT1 and the two studies incorporating EPHX polymorphisms yielded 
opposite results. Indications for GSTM1 genotype to weakly influence smoking-
associated colorectal neoplasm risk were found in three out of six studies. GSTT1 
genotype was not found to be important. NAT2 polymorphism might modestly 
influence the association between smoking and colorectal neoplasm, but the studies 
conducted so far provide no consistence about which of the imputed phenotypes 
increases colorectal neoplasm risk. Again, results on EPHX polymorphisms as presented 
from two studies, were contradictory (table 1.1). The only study investigating the 
potential role o£ADH3 in the association of alcohol consumption with colorectal cancer 
found a weak indication that those with the ADH3 slow imputed phenotype might be at 
increased risk of colorectal cancer 46. 
15 
CHAPTER 1 
a 
H 
o a 
5 z 
5 z 
o 
» O r H 
f> c<S r-^  
00 ^O 00 
^H ^ - CN 
« « as 
« 2 « 
E-. 
h < 
z 
u> 
.« 
* 
ja 
c 
<u 
a 
I 
C 
E o u 
J = 
o 
s^ 
i-
<u 
oT" 
^ 
1 -o 
rt 
E 
•o 
h-
^ < 
£ 
* 
fi 
1 
•o 
h. 
T 
< 
i 2 
* J2 
c 
1 
+ 
h-c 
^ < 
vi2 
a 
H 
c 
I 
< 
z 
« 
<i3 
Ji 
t-.t-.F-. 
^ ^ ^ 
2 2 2 i2 i2 >a 
°<s »d og 
E £ E 
u u u 
.M) M _W) « 
s s 
I £ 
g 
1^ 1 
u 
* 
fc 
00 
o 
* 
S e c 
CM T - " 
i-( <N 
, - H ^ O ^ H T-H 
o 
e 
^ 
^ 
* 
^ i 
^ 
0 
1 
£ 
# M 
u 
ta <u 
o 
G 
fs 1-
l>3 
(T» 
T f 
oo 
oo 
tf 0 
F-
r^ £ t+H 
O 
fcS 
o 
c 
<N 
t-i 
§ 
, , 
^o 
,_ 
o 
CN 
05 
o 
,_^  
r-
C> 
OS 
0 
si 
< * - l 
o 
u 
is 
0 
c 
"4 OJ 
<N 
^o 
n\ 
m 
rg 
cd 
0 
'5 2 
• - ^ T3 ^ 
C D W flJ 
l> X <" £ 
00 . 2 !fi . 2 
S S o S 
E g a I 
be g 00 c 
3 u u 
3 g <fc 
- 3 r~ 1> ^H 00 
'E 
s J £ £ £ 
oo oo 
g s _ 
1 
s 
§3 
H 
n 
.S 
rt 
E 
C 
0 
o 
[>. 
0 
+ 
* 
_o 
<1> E 
^ 
5= 
C 
1 
S 
<u 
S 
a> 
C 
s 
§ 
* 1 
_o 
y 
'a V, 
e 
6 
-n 
OH 
1 
^ i -
+ C I 
<+3 
^ u 
rt 
rt 
E 
T3 
03 
6 ^ 
* 0 
*i 
rt 
s 
-d 
*4> 
O 
B lU 
* 
X 
+ 
C 
n 
0 g 
s s 
u o 
-4 (N 
S + a + 
c 
o 
U 
16 
INTRODUCTION 
0 0 
CO 
^ 1 
^—' 
C\j 
PU 
o 
~ 
in 
© 
"— 
<N 
tf 
i n 
in 
ON 
CO 
© 
tf 0 0 
£ 
^ 
ta o 
c 
I D 
co 
o 
• • 
« 0 
^ £ 
e S t 
<•*- . 2 <*• *+H 
° rt -^  ° 
sja -P fl & 
cO S3 
-^" g 
bP 
12 
S 2 
< * 
e6 bfi 
60 .£ 
a 
<D 
gfc 
co co 
> > 
i> OJ 
a 
o 
a 
o t-, 
1? 
CO 
~5D "So •§ 
« £ 
OS 
0 
tS 
PS 
o 
os 
0 o 
a a s 
E £ 2 S 
g P 
fa " 5 
3 O 
2 2 
bO 00 
B- P-
£ £ 
g 
CO 
U 
f~M 
hi 
o 
is bo 
d 
a 0 
£ 
l-i 
<D 
> h 
^ 
h^  1 
| 
1 &c 
a 3 :
 o £ 
,_ tU 
> <L>
J3 
* 
bo 
a J2 
o E 
l_ 
<D 
> 1) 
<U 
Q-
1 
CO U 
*S 
bo 
a 3 
o £ 
i-H (U 
> I t 
ft tq 
I 
0 p 
~*t 
bo 
a 3 
o £ 
*"• -*• 
i> T 
> + a co 
4J 
^ 
1 
<-2 
* 
be 
a 3 
o £ 
j _ , 
OJ 
> 1>
— — >. 
3 3 3 =3 
E £ £ „ c 
fc <" p 3 3 U .2> a 
£ — J2 
*J 
OJ 
O 
J3 bC 
IS 
"So 
c J2 =5 
II g g 
1- CO 3 U 
CJ 
CO 
u i8 
a> 
o 
- C 
bC 
~SD 
a 
J2 
o 
E 
a 
k> a 
a a 
u 
« 
'3 
cr 
^ 
aj 
0 
T3 
•a 
bo 
a 2 
0 
£ 
a 
3 
W 
! 
rt 
i> 
c 
5 
OJ 
>. 
T1-
m 
u 
0 
E 
' 3 
a-
c 
£ 
1 
£ 
! 
c2 
"S 
£ 
fi 
s § 
a bD 
a 2 
0 
£ 
:
 y 
J 
1) 
£ 
<u 
_fl 
"*" r^  "3 
H f r-i 
§§ s 
S i n 
<£ ^ u 08 ^5 otj W D OJ 
0 0 o 
-a T3 -a 
J3 JS J ! bO &C tJD 
S^ S^ IS 
g CO (J 
eg 
^ CO 
2 U 
gfc 
CO CO 
U O 
PS 
s 2 
Sfc 
CO CO 
O U 
Rg 
S CO 
2: u 
R 
s 2 
RS 
S 2? 2 2 
3 12 
o o £ E £ « ^ S in r^  6 o 3 E E a 
E E 
*-H ON 
Er 
O J5 
Si 
_o 
3 hO 
fl j j 
E 
S 
o 
T t 
+ 
t 
o 
U 
0 
— o 
s c 
< U 
17 
CHAPTER 1 
Rationale and aim of thesis 
Our studies are focused on exposure to potential carcinogens, especially from meat and 
cigarette smoke, but also from alcohol. Of these potential carcinogens, relatively much is 
known about metabolic pathways, polymorphisms in genes coding for important 
metabolizing enzymes, and phenotype-genotype correlations. As the exposure to HCAs, 
arylamines, and PAHs is largely determined by cigarette smoking and possibly, the 
consumption of heavily browned meat, we developed questionnaires to assess cigarette 
smoking and meat consumption and preparation in detail. To estimate exposure to the 
main metabolite of ethanol, acetaldehyde, alcohol consumption was also assessed. 
Genetic susceptibility factors discussed are major genetically polymorphic 
biotransformation enzymes such as glutathione S-transferases, N-acetyltransferases, and 
sulfotransferase. Environmental exposure and genetic susceptibility might both be 
important during tumor initiation, promotion and progression. Therefore, this thesis 
discusses the interplay between genetic susceptibility and environmental exposure in 
several types and stages of neoplasm, i.e. colorectal adenomas and colorectal carcinomas. 
The main purpose of the studies described in this thesis was to evaluate whether there is 
interplay between common genetic polymorphisms encoding metabolic enzymes, and 
exposure to environmental carcinogens in the etiology of colorectal neoplasm. 
Specific questions were: 
- Are HCAs present in meat prepared according to Dutch habits, and if so, do 
metabolic polymorphisms of genes encoding enzymes that may be important in the 
metabolism of HCAs (i.e., NAT1, NAT2, SULT1A1, GSTM1, GSTT1) influence 
the associations of high meat consumption and/or assumed high-risk meat 
preparation methods with colorectal adenomas (Chapter 4) and/or cancer (Chapter 
7)? 
- Do polymorphisms in genes that encode enzymes important in the metabolism of 
carcinogens from cigarette smoke further increase the risk of smoking-associated 
adenomas (chapter 5) and/or smoking-associated colorectal cancer (Chapter 7)? 
- Is there evidence for modification of the association between alcohol consumption 
and colorectal adenomas by the ADH3 gene polymorphism (Chapter 6)? 
O u t l i n e o f t h e s i s 
Chapter 2 describes the recruitment of cases and controls for the studies on colorectal 
adenomas. Because the recruitment of such a study population is prone to selection and 
information bias, methodological and practical issues are discussed. 
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£il'iPI£Lj> illustrates how genetic polymorphisms can be studied efficiently in large 
epidemiological studies, taking detection of N-acetyltransferase 1 and 2 polymorphism 
as an example. 
Li! !lrl££i 4 throijglL.O. describe the impact of several metabolic polymorphisms on 
associations of meat consumption and preparation (chapter 4), cigarette smoking 
(chapter 5), and alcohol intake (chapter 6), with colorectal adenomas (see also the 
appendix to this thesis for additional analyses). The interplay between genetic 
polymorphisms and meat consumption and cigarette smoking in association with 
colorectal carcinomas is discussed in Chyilfer Z-
Finally, in Chapter 8, the results of the research described in this thesis are critically 
reviewed and integrated into the current knowledge from epidemiological studies 
investigating the potential interplay between environmental exposure and metabolic 
polymorphisms in cancer. Further, the potential for these types of studies in the future, 
and other possibilities for future research are discussed. 
References 
1. World Cancer Research Fund / American Institute for Cancer Research (1997). Food, nutrition and the 
prevention of cancer: a global perspective, Washington DC: American Institute for Cancer Research. 
2. Pisani, P., Bray, F., and Parkin, D.M. (2002). Estimates of the world-wide prevalence of cancer for 
25 sites in the adult population. IntJ Cancer 97: 72-81. 
3. Fearon, E.R. and Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-
767. 
4. Lev, R. (1990). Adenomatous polyps oj the colon, New York: Springer-Verlag. 
5. Sinha, R. and Caporaso, N. (1999). Diet, genetic susceptibility and human cancer etiology./ Nutr 
129: 556S-559S. 
6. Potter, J.D. (1995). Risk factors for colon neoplasia-epidemiology and biology. Eur J Cancer 31A: 
1033-1038. 
7. Potter, J.D. (1999). Colorectal cancer: molecules and populations./ Nat Cancer Inst 91: 916-932. 
8. Giovannucci, E. (2001). An updated review of the epidemiological evidence that cigarette smoking 
increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 10: 725-731. 
9. Potter, J.D., Slattery, MX., Bostick, R.M., and Gapstur, S.M. (1993). Colon cancer: a review of the 
epidemiology. Epidemiol Rev 15: 499-545. 
10. Sesink, A.L.A., Termont, D.S.M.L., Kleibeuker, J.H., and Van der Meer, R. (2000). Red meat and 
colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic 
epithelium. Carcinogenesis 21: 1909-1915. 
11. Norat, T., Lukanova, A., Ferrari, P., and Riboli, E. (2001). Meat consumption and colorectal cancer 
risk: a dose-response meta-analysis of epidemiological studies. IntJ Cancer, in press. 
12. Sandhu, M.S., White, I.R., and McPherson, K. (2001). Systematic review of the prospective cohort 
studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol 
Biomarkers Prev 10: 439-446. 
13. Goldbohm, R.A., Van den Brandt, P.A., Van 't Veer, P., Brants, H.A., Dorant, E., Sturmans, F., and 
Hermus, R.J. (1994). A prospective cohort study on the relation between meat consumption and the 
risk of colon cancer. Cancer Res 54: 718-723. 
CHAPTER 1 
14. Knekt, P., Steineck, G., Jarvinen, R., Hakulinen, T., and Aromaa, A. (1994). Intake of fried meat and 
risk of cancer: a follow-up study in Finland. IntJ Canter 59: 756-760. 
15. Probst-Hensch, N.M., Sinha, R., Longnecker, M.P., Witte, J.S., Ingles, S.A., Frankl, H.D., Lee, E.R., 
and Haile, R.W. (1997). Meat preparation and colorectal adenomas in a large sigmoidoscopy-based 
case-control study in California (United States). Cancer Causes Control 8: 175-183. 
16. Gerhardsson de Verdier, M., Hagman, U., Peters, R.K., Steineck, G., and Overvik, E. (1991). Meat, 
cooking methods and colorectal cancer: a case-referent study in Stockholm. IntJ Cancer 49: 520-525. 
17. Sinha, R., Chow, W.H., Kulldorff, M., Denobile, J., Butler, J., Garcia, CM., Weil, R., Hoover, R.N., 
and Rothman, N. (1999). Well-done, grilled red meat increases the risk of colorectal adenomas. 
Cancer Res 59: 4320-4324. 
18. Overvik, E. and Gustafsson, J.A. (1990). Cooked-food mutagens: current knowledge of formation 
and biological significance. Mutagenesis 5: 437-446. 
19. Skog, K., Steineck, G., Augustsson, K., and Jagerstad, M. (1995). Effect of cooking temperature on 
the formation of heterocyclic amines in fried meat products and pan residues. Carcinogenesis 16: 861-
867. 
20. Wakabayashi, K., Nagao, M., Esumi, H., and Sugimura, T. (1992). Food-derived mutagens and 
carcinogens. Cancer Res 52: 2092s-2098s. 
21. Hoffmann, D., Djordjevic, M.V., and Hoffmann, I. (1997). The changing cigarette. Prev Med 26: 
427-434. 
22. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A., Kearney, J., and Willett, 
W.C. (1994). A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal 
cancer in U.S. men. J Natl Cancer Inst 86: 183-191. 
23. Hirvonen, A., Nylund, L., Kociba, P., Husgafvel, P.K., and Vainio, H. (1994). Modulation of urinary 
mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15: 813-
815. 
24. Seitz, H.K., Poschl, G., and Simanowski, U.A. (1998). Alcohol and cancer. Recent Dev Alcohol 14: 67-
95. 
25. International programme on chemical safety (1995). Acetaldehyde. Environmental health criteria, Vol. 
167, Geneva, Switzerland: World Health Organization. 
26. Grant, DM., Hughes, N.C., Janezic, S.A., Goodfellow, G.H., Chen, H.J., Gaedigk, A., Yu, V.L., and 
Grewal, R. (1997). Human acetyltransferase polymorphisms. Mutat Res 376: 61-70. 
27. MacLeod, S., Sinha, R., Kadlubar, F.F., and Lang, N.P. (1997). Polymorphisms of CYP1A1 and 
GSTM1 influence the in vivo function of CYP1A2. Mutat Res 376: 135-142. 
28. DeMarini, D.M., Hastings, S.B., Brooks, L.R., Eischen, B.T., Bell, D.A., Watson, M.A., Felton, J.S., 
Sandler, R., and Kohlmeier, L. (1997). Pilot study of free and conjugated urinary mutagenicity 
during consumption of pan-fried meats: possible modulation by cruciferous vegetables, glutathione 
S-transferase Ml , and N-acetyltransferase 2. Mutat Res 381: 83-96. 
29. Hein, D.W., Doll, M.A., Rustan, T.D., and Ferguson, R.J. (1995). Metabolic activation of N-
hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 
7 specific NAT2 nucleic acid substitutions. Cancer Res 55: 3531-3536. 
30. Bentley, P., Oesch, F., and Glatt, H. (1977). Dual role of epoxide hydratase in both activation and 
inactivation of benzo(a)pyrene.^4rcfe Toxicol 39: 65-75. 
31. Seidegard, J. and DePierre, J.W. (1983). Microsomal epoxide hydrolase. Properties, regulation and 
function. Biochim BiophysActa 695: 251-270. 
32. Cascorbi, I., Drakoulis, N., Brockmoller, J., Maurer, A., Sperling, K., and Roots, I. (1995). 
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian 
individuals: correlation with phenotypic activity. Am J Hum Genet 57: 581-592. 
33. Sim, E., Payton, M., Noble, M., and Minchin, R. (2000). An update on genetic, structural and 
functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mot Genet 9: 
2435-2441. 
20 
INTRODUCTION 
34. Lin, H.J., Han, C.Y., Lin, B.K., and Hardy, S. (1994). Ethnic distribution of slow acetylator 
mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4: 125-134. 
35. Hirvonen, A. (1999). Polymorphic NATs and cancer predisposition. In: Metabolic polymorphisms 
and susceptibility to cancer. Vineis, P., Malats, N., Lang, M., d'Errico, A., Caporaso, N., Cuzick, J., 
and Boffetta, P. (eds.). IARC Scientific Publications No. 148, Lyon, France: International Agency for 
Research on Cancer. 
36. Bell, D.A., Badawi, A.F., Lang, N.P., Ilett, K.F., Kadlubar, F.F., and Hirvonen, A. (1995). 
Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*\0 
allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226-5229. 
37. Bruhn, C , Brockmoller, J., Cascorbi, I., Roots, I., and Borchert, H.H. (1999). Correlation between 
genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem 
Pharmacol 58: 1759-1764. 
38. Bunschoten, A., Tiemersma, E., Schouls, L., and Kampman, E. (2000). Simultaneous determination 
of polymorphism in N-acetyltransferase 1 and 2 genes by reverse line blot hybridization. Anal 
Biochem 285: 156-162. 
39. Raftogianis, R.B., Wood, T.C., and Weinshilboum, R.M. (1999). Human phenol sulfotransferases 
SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-
phenotype correlations. Biochem Pharmacol 58: 605-616. 
40. Carlini, E.J., Raftogianis, R.B., Wood, T.C., Jin, F., Zheng, W., Rebbeck, T.R., and Weinshilboum, 
R.M. (2001). Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, 
Chinese and African-American subjects. Pharmacogenetics 11: 57-68. 
41. Seidegard, J., Vorachek, W.R., Pero, R.W., and Pearson, W.R. (1988). Hereditary differences in the 
expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene 
deletion. Proc Natl Acad Sci USA 85: 7293-7297. 
42. Cotton, S.C., Sharp, L., Little, J., and Brockton, N. (2000). Glutathione S-transferase 
polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151: 7-32. 
43. Vineis, P., Malats, N., Lang, M., d'Errico, A., Caporaso, N., Cuzick, J., and Boffetta, P. (eds.) (1999). 
Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications No. 148, Lyon, 
France: International Agency for Research on Cancer. 
44. Lang, N.P., Butler, M.A., Massengill, J., Lawson, M., Stotts, R.C., Hauer, J.M., and Kadlubar, F.F. 
(1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative 
exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer 
Epidemiol Biomarkers Prev 3: 675-682. 
45. Wohlleb, J.C., Hunter, C.F., Blass, B., Kadlubar, F.F., Chu, D.Z.J., and Lang, N.P. (1990). Aromatic 
amine acetyltransferase as a marker for colorectal cancer: environmental and demographic 
associations. IntJ Cancer 46: 22-30. 
46. Chen, J., Ma, J., Stampfer, M.J., Hines, L.M., Selhub, J., and Hunter, D. (2001). Alcohol 
dehydrogenase 3 genotype is not predictive for risk of colorectal cancer. Cancer Epidemiol Biomarkers 
Prev 10: 1303-1304. 
47. Roberts-Thomson, I.C., Ryan, P., Khoo, K.K., Hart, W.J., McMichael, A.J., and Butler, R.N. (1996). 
Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 2>A1: 1372-1374. 
48. Welfare, M.R., Cooper, J., Bassendine, M.F., and Daly, A.K. (1997). Relationship between acetylator 
status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 18: 
1351-1354. 
49. Chen, J., Stampfer, M.J., Hough, H.L., Garcia-Closas, M., Willett, W.C., Hennekens, C.H., Kelsey, 
K.T., and Hunter, D.J. (1998). A prospective study of N-acetyltransferase genotype, red meat intake, 
and risk of colorectal cancer. Cancer Res 58: 3307-3311. 
50. Gertig, D.M., Stampfer, M., Haiman, C , Hennekens, C.H., Kelsey, K., and Hunter, D.J. (1998). 
Glutathione S-transferase GSTM1 and GSl'll polymorphisms and colorectal cancer risk: a 
prospective study. Cancer Epidemiol Biomarkers Prev 7: 1001-1005. 
21 
CHAPTER 1 
51. Kampman, E., Slattery, MX., Bigler, J., Leppert, M., Samowitz, W., Caan, B.J., and Potter, J.D. 
(1999). Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter 
case-control study. Cancer Epidemiol Biomarkers Prev 8: 15-24. 
52. Le Marchand, L., Hankin, J.H., Wilkens, L.R., Pierce, L.M., Franke, A., Kolonel, L.N., Seifried, A., 
Custer, L.J., Chang, W., Lum-Jones, A., and Donlon, T. (2001). Combined effects of well-done red 
meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal 
cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1259-1266. 
53. Ulrich, CM., Bigler, J., Whitton, J.A., Bostick, R., Fosdick, L., and Potter, J.D. (2001). Epoxide 
hydrolase Tyrll3His polymorphism is associated with elevated risk of colorectal polyps in the 
presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10: 875-882. 
54. Cortessis, V., Siegmund, K., Chen, Q., Zhou, N., Diep, A., Frankl, H., Lee, E., Zhu, Q.S., Haile, R., 
and Levy, D. (2001). A case-control study of microsomal epoxide hydrolase, smoking, meat 
consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 61: 2381-
2385. 
55. Lin, H.J., Probst-Hensch, N.M., Ingles, S.A., Han, C.Y., Lin, B.K., Lee, D.B., Frankl, H.D., Lee, 
E.R., Longnecker, M.P., and Haile, R.W. (1995). Glutathione transferase (GSTM1) null genotype, 
smoking, and prevalence of colorectal adenomas. Cancer Res 55: 1224-1226. 
56. Probst-Hensch, N.M., Haile, R.W., Ingles, S.A., Longnecker, M.P., Han, C.Y., Lin, B.K., Lee, D.B., 
Sakamoto, G.T., Frankl, H.D., Lee, E.R. (1995). Acetylation polymorphism and prevalence of 
colorectal adenomas. Cancer Res 55: 2017-2020. 
57. Katoh, T., Nagata, N., Kuroda, Y., Itoh, H., Kawahara, A., Kuroki, N., Ookuma, R., and Bell, D.A. 
(1996). Glutathione S-transferase Ml (GSTM1) and Tl (GSTT1) genetic polymorphism and 
susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17: 1855-1859. 
58. Slattery, MX., Potter, J.D., Samowitz, W., Bigler, J., Caan, B., and Leppert, M. (1998). NAT2, 
GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 7: 1079-1084. 
59. Potter, J.D., Bigler, J., Fosdick, L., Bostick, R.M., Kampman, E., Chen, C , Louis, T.A., and 
Grambsch, P. (1999). Colorectal adenomatous and hyperplastic polyps: smoking and N-
acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 8: 69-75. 
60. Katoh, T., Boissy, R., Nagata, N., Kitagawa, K., Kuroda, Y., Itoh, H., Kawamoto, T., and Bell, D.A. 
(2000). Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and 
susceptibility to gastric and colorectal adenocarcinoma. IntJ Cancer 85: 46-49. 
61. Inoue, H., Kiyohara, C , Shinomiya, S., Marugame, T., Tsuji, E., Handa, K., Hayabuchi, H., Eguchi, 
H., Fukushima, Y, and Kono, S. (2001). Glutathione 5-transferase polymorphisms and risk of 
colorectal adenomas. Cancer Lett 163: 201-206. 
ratf W 
••"wajs- .-:*.•—ras."!!-'1 
• « . . ' » •• 
*!*«*•?• P".": 
V - *J •-. 
&H. , --j .. . . . . . . 
! ! • :-\TWM^•:.-,.../ ,i 
• • ^ i t a p ^ - . : ; ! • • • • . • 
• •
:£'1W#W- • - * 
- J i • 
fci •/V--!!Jjgl!!:l''fe. 
^.W^^-i-- \ 
•tff-.'-Jfli-:., 
'JfifeU: 
""Jar" 
• i - t t t t * 
- • • - • ' • - L l M M l MlMlLll 
.-^a! 
^f^P^: - •-• •:•*:.: 
MKTJIHP-- • :A •. •.. .-••'! '£*. 
i "V'TWfte'i 
N'*j^[;-a*i: V-'- i 
'*'•&?&£ 
***" "n^ 
" ' - • " , , - ' " 
! 
, j 
••:[1.r 
-.&*=?•• • 
a 
• i S i ' 
i l i ! ^ : ^ . l r
 ;iSiiv l^ 
CHAPTER 2 
Colorectal adenomas are benign tumors of glandular colorectal epithelium ' and are 
generally regarded as precursors of colorectal cancer2. Adenomas are highly prevalent in 
the general population. In European populations, prevalences of around 30% have been 
reported from the general population, increasing to 50% in populations older than 70 3. 
The main study described in this thesis is a case-control study including colorectal 
adenoma cases and polyp-free controls (see chapters 3-6). In this chapter, we discuss the 
advantages and disadvantages of this case-control study. 
S A M P L E SIZE 
The main aim of this study was to investigate the joint effect of commonly occurring 
genetic polymorphisms and environmental exposures on the risk of adenomas. Required 
sample sizes were calculated using the expected frequencies of the co-occurrence of 
combinations of genetic susceptibility and environmental exposure (in tertiles, Table 
2.1). 
Table 2.1. Examples of the required number of cases and equal numbers of controls to 
detect specific odds ratio with a power (l-[3) of 90% (two-sided a=0.05). 
Expected Detectable odds ratio 
Determinant frequency/ 
prevalence 1.5 2.0 2.5 
Genetic polymorphism 
0.40 520 178 104 
Environmental 
exposure (tertiles) 0.33 570 190 108 
Genetic polymorphism and 
environmental exposure 0.12 1048 329 177 
With a sample size of about 435 cases and an equal number of controls, we were able to 
detect an odds ratio of 1.84 with a power of 90% 4 for risk of colorectal adenomas among 
exposed subjects with high genetic susceptibility (see Figure 2.1). 
Recruitment of the study population. 
Our adenoma case-control study was conducted at outpatient clinics of eight Dutch 
hospitals in the central region of the Netherlands. In the analyses described in this 
thesis, cases and controls recruited between June 1997 and June 2000 are included. New 
cases and controls are currently enrolled for additional analyses. The study logo (Figure 
2.2) includes the main components of the study: adenomas, genetic susceptibility 
(incorporated in the polyp's 'hair' as DNA strands), and environmental exposure (i.e. 
preparation of meat and cigarette smoking). 
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Figure 2.1. Required number of cases (assuming equal numbers of controls) to detect, 
specific odds ratios with a power (1-fJ) of 90% and a two-sided a of 0.05 at different 
frequencies (f) of combinations of exposure and genetic susceptibility. Concrete lines 
depict frequencies of 0.20 and 0.10: dotted lines illustrate frequencies of 0.25, 0,15. and 
0.05, respectively. The bold line illustrates required numbers of cases at a combined 
frequency of 0.12 occurring when exposure is divided in tertilcs and a genetic factor is 
prevalent at a frequency of 0.4. 
DEFINITION OF CASES AND CONTROLS 
We defined cases as those diagnosed with at least 
one histologically confirmed colorectal adenoma-
tous polyp ever in their life. Controls had no 
history of any type of polyps, including 
hyperplastic and metaplastic polyps. Cases and 
controls were Dutch speaking, of European origin, 
aged 18 to 75 years at time of endoscopy, were not 
suspected to have hereditary colorectal cancer 
syndromes (such as hereditary non-polyposis 
colorectal cancer, familial adenomatous polyposis 
coli, Gardners syndrome), did not suffer from chronic inflammatory bowel diseases, and 
did not have a history of colorectal cancer or (partial) bowel resection. 
Figure 2.2. Logt 
case-control stuc 
s of the adenoma 
Iv (Dutch name: 
7>OL7EP-studie) 
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previous index
 caSe-control definition % of study 
endoscopies endoscopy population 
„ I 
T "w" "U new case: first adenoma at index 32.9 
A -iV -> 
-i old case, no adenomas at index, „ _ 
only one adenoma before index 
recurrent case, one or more previous 59 
endoscopies with adenomas 
> control
 5 1 4 
t 
time 0 10° 
Endoscopy findings 
; adenoma 
: hyperplastic polyp 
; no polyp 
Figure 2.3. Schematic overview of examples oi typical cases and controls included in 
the adenoma study, based on 823 subjects (see text for explanation). 
In Figure 2.3, several typical examples of cases and controls included in the study are 
depicted. The endoscopy leading to invitation is referred to as the index endoscopy, 
indicated with black vertical arrows in Figure 2.3. Note that results of endoscopies 
conducted in the year previous to the index endoscopy were considered as if these were 
the result of the index endoscopy. Thus, if an adenoma was found at one of these 
occasions the index endoscopy was considered positive and the subject was classified as 
new a case. This one-year interval between the index endoscopy and possible previous 
endoscopies was taken because endoscopies conducted within one year mainly serve to 
check for adequate removal of the initial adenoma(s) rather than to check for recurrent 
adenomas, for which a control colonoscopy is indicated only after three to six years 5. 
Events that happened in the past, thus before the index endoscopy, are depicted left of 
the index endoscopy. Because negative endoscopies conducted in the past were not 
recorded, we could not differentiate between 'incident' and 'prevalent' cases, but rather 
refer to 'new', 'old' and 'recurrent' cases as a summary definition of several subtypes of 
cases and controls (see Figure 2.3). The definitions shown in Figure 2.3 specify all cases 
and controls enrolled in our study population. So-called 'new' cases were diagnosed 
with a first adenoma at most one year before the index endoscopy. 'Old' cases were 
diagnosed with adenomas more than one year before the index endoscopy and were 
adenoma-negative at index endoscopy. Recurrent cases, diagnosed with adenomas at 
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least twice, were also included. Controls could have had polyp-negative endoscopies 
before, but we did not include subjects who were diagnosed with hyperplastic polyps 
only. In contrast, cases could have had hyperplastic polyps if they had been diagnosed at 
least once with an adenoma (Figure 2.3). 
RECRUITMENT PROCEDURES 
Cases and controls were enrolled at the outpatient clinics of eight hospitals (henceforth 
numbered 1-8). Recruitment started in June 1997 in two hospitals, and was 
subsequently extended to the other hospitals. The last hospital entering the study was 
hospital 8 in December 1998. Cases and controls for our study were recruited among 
those undergoing endoscopy. The recruitment was conducted in close cooperation with 
staff of the outpatient endoscopy units of the eight hospitals participating in our study. 
Therefore, the recruitment procedures slightly differed between hospitals, depending on 
the preference of the endoscopy staff. The used procedures can roughly be divided into 
two different methods: a direct method, involving recruitment by endoscopy staff, and an 
indirect method, according to which recruitment was carried out by a research nurse 
reviewing endoscopy reports at three-month intervals. Details of the recruitment 
procedures in each of the eight hospitals are given in the appendix to this Chapter. 
In general, according to the direct method, eligible subjects were informed about the 
study and were invited by endoscopy staff upon endoscopy. If potential participants 
agreed to participate, they received an information package containing an information 
brochure, an informed consent form, a short questionnaire (hereafter referred to as the 
short questionnaire), and a stamped addressed envelope. Blood for DNA analyses was 
subsequently drawn by endoscopy staff or at the hospitals' laboratory. Depending on the 
hospital-specific procedure (see appendix to this Chapter) the participants either directly 
were given three detailed self-administered questionnaires, or these were sent to them 
by mail once the informed consent was received at the research center. The 
questionnaires were a semi-quantitative food frequency questionnaire, a meat 
consumption and preparation questionnaire, and a general questionnaire on medical 
history, family history of colorectal cancer, and several lifestyle factors such as smoking 
and drug use. Participants were requested to complete the self-administered 
questionnaires at home and to return these by mail in stamped addressed envelopes. 
For the indirect method, at three-month intervals, a research nurse reviewed the reports 
of all endoscopies performed during the previous period. Eligible subjects were invited 
by a letter from the endoscopist who had conducted the examination. With this letter, 
they also received the information package (see direct method). After receiving the 
participants' informed consent and the short questionnaire, an appointment was made 
for the collection of blood. At this appointment, dietary and lifestyle questionnaires were 
provided to the participant. The questionnaires were completed at home and were 
returned to the investigators by mail. 
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In four hospitals, subjects were recruited according to the direct method, whereas the 
indirect method was applied in three hospitals. In one hospital, direct was changed to 
indirect recruitment after approximately a year and a half, when a research nurse took 
over the recruitment. Of a total of 1140 subjects included by 1. June 2000, 53% was 
recruited via the direct method. 
R E S P O N S E RATES 
After three years of recruitment, 1140 subjects who had undergone endoscopy agreed to 
participate. The average response for the direct procedure was 83%, whereas it was 44% 
for the indirect method (Table 2.4). The overall response was 54%. After exclusion of 
those who did not complete the questionnaires (n=68), who participated twice (n=4; 
first record was used), for whom medical files were not available (n=37), whom, by 
retrospection, proved not to meet the inclusion criteria (n=69), and those who were 
diagnosed with non-adenomatous (n=46) or unknown type of polyps (n=55) only, our 
study population counted 861 subjects. The study population used for the analyses 
described in this thesis additionally included 64 subjects meeting our criteria from a 
preceding study, for which sporadic adenoma cases and polyp-free controls were 
enrolled in one of the eight hospitals 6 (hospital 1, see appendix to this Chapter for 
details), so that our final population counted 925 subjects. For the analyses, 38 subjects 
of whom dietary information was judged insufficient (because of too many blanks or 
serious inconsistencies in answers) were excluded, reducing the study population to 887 
subjects, 440 cases and 447 controls, as well subjects of whom specific information 
(genotypes, meat preparation methods, etc.) was not available, depending on the specific 
analyses (see chapters 4-6). 
C H A R A C T E R I S T I C S OF T H E S T U D Y P O P U L A T I O N 
As shown in Table 2.2, cases and controls differed in several respects. The case group 
consisted of significantly more men than the control group, and cases were older than 
controls. Consequently, the mean body mass index was higher for cases than for 
controls. Moreover, the main reasons for endoscopy differed between cases and 
controls; bowel complaints were more common among controls than among cases, 
whereas cases more often suffered from rectal bleeding. Rectal bleeding is regarded as an 
indication for colorectal adenomas as is a history of adenomas (which was the major 
reason (>90%) for screening among cases). Apart from these two indications, all other 
indications (i.e., bowel complaints, defecation problems, iron deficiency anemia, and 
other/unknown) are not considered to be indicative for adenomas 7'8. By subtraction of 
the proportion of cases undergoing endoscopy for reasons indicative of adenomas (i.e., 
rectal bleeding (27%) and screening (39%)) from the total case population, we estimated 
that for about 44% of the cases, adenomas should be regarded as an incidental finding. 
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More controls than cases indicated that they had changed their diet because of bowel 
complaints. Self-reported constipation occurred more frequent among controls than 
among cases (Table 2.2). 
Tab le 2.2. Background characteristics and medical history of die study population. 
Characteristic 
Background 
Female, n (%) 
Age (years), mean ± SD 
Low education level, n (%)b 
Body mass index (kg/m2), mean ± 
Medical history, n (%) 
Endoscopy indication 
Rectal bleeding 
bowel complaints 
defecation problems 
screeningc 
iron deficiency anemia 
other or unknown 
SD 
Dietary changes for bowel complaints 
Frequent constipation (> once/month) 
Family history of colorectal cancer 
Previous diagnosis of polyp d 
Cases 
(N=440) 
199 (45) 
58.9 ± 10.6 
148 (33.6) 
26.1 ± 3.9 
120 (27.3) 
64 (14.6) 
44 (10.0) 
173 (39.3) 
21 (4.8) 
18 (4.1) 
80 (18.2) 
43 (9.8) 
102 (23.2) 
135 (30.7) 
Controls 
(N=447) 
282 (63) 
50.4 ± 14.1 
131 (29.3) 
25.4± 4.1 
77 (17.2) 
170 (38.0) 
95 (21.3) 
32 (7.2) 
42 (9.4) 
31 (6.9) 
127 (28.4) 
83 (18.6) 
85 (19.0) 
0 
p-value a 
< 0.001 
< 0.001 
0.17 
0.02 
< 0.001 
< 0.001 
< 0.001 
0.13 
< 0.001 
" p-valucs arc calculated by t-tcst tor continuous variables and by cln-square test tor categorical 
variables;1' primary school and lower vocational training; '' screening for recurrent adenomas and 
family history (less than 10% of those screened among cases); d including old eases, recurrent 
cases, non-adenomatous polyps, and 'recurrence" within one year. 
Methodological considerations 
R A T I O N A L E OF A D E N O M A C A S E - C O N T R O L S T U D Y 
We studied colorectal adenomas because colorectal adenoma studies have several 
advantages above those on colorectal cancer. First, as adenomas are considered 
precursors of colorectal cancer, epidemiological studies on adenomas might indicate the 
risk factors important in the early stages of carcinogenesis 3. Second, in view of the 
relatively high prevalence of adenomas in the general population 3, the recruitment 
period of case-control studies can be shorter than for studies considering cancer. Third, 
dietary and lifestyle habits may be more adequately recalled by adenoma cases than by 
cancer cases, as these are inquired relatively shortly after the initiation of the disease. 
Moreover, in contrast to colorectal cancer 9, colorectal adenomas do probably not 
directly affect dietary and other lifestyle habits. This reduces the chance of recall bias 3. 
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However, studying adenomas instead of cancer also involves disadvantages. First, not all 
adenomas will develop into cancerous lesions 10,n. It is possible that some specific risk 
factors are determinants only of adenomas that do not develop into carcinomas, as has in 
the past been proposed for smoking 12,13. However, colorectal adenoma risk factors are 
very similar to risk factors of colorectal cancer 1415. Second, the choice of an appropriate 
control group may be debated. Controls can be sampled randomly from the general 
population, but adenomas are highly prevalent in the general population and often 
remain asymptomatic 3. Thus, a population-based control group would include subjects 
with undetected adenomas. If one wants to exclude those with polyps from the control 
group, it is required that all controls undergo colonoscopy, resulting in an 'endoscopy-
based' control population. Some case-control studies including both a population-based 
control group and a control group recruited at endoscopy showed no major differences 
between these two groups 16'17, but another study showed that alcohol consumption and 
smoking were risk factors for adenomas when cases were compared with endoscopy 
controls, but not when compared with population-controls 18. Controls should be 
sampled from the same population in which the cases arise ". This population is called 
the 'source' or 'base' population 19'20. In some studies, an endoscopy control group might 
better reflect this source population than the general population 21,22, provided that the 
controls seek medical care for similar reasons as the cases and that these reasons are 
unrelated to the exposures under study3. We observed that in the hospitals participating 
in our study, patients mainly undergo endoscopy because of gastrointestinal complaints, 
defecation problems, anal bleeding, screening because of adenoma history or a family 
history of colorectal cancer, or iron deficiency anemia. This means that cases and 
controls are comparable in the sense that both groups have a history of complaints, and 
in the sense that their theoretical possibility to be diagnosed with adenomas is equal, 
which does not apply for the general population. 
P R E C I S I O N 
Based on the results of power calculations given in Table 2.1, with a study size of 435 
cases and an equal number of controls, the power of this study was large enough (i.e., 
> 90%) to detect potential effects of combinations of genetic polymorphisms and 
environmental factors. To detect statistical interactions between exposure and genetic 
susceptibility, however, no main effect of the genetic and the environmental factor is 
assumed. This assumption was valid for almost all of the genetic polymorphisms, but 
not for the exposure factors under study, for which risk estimates ranged between 1.2 
for daily meat consumption and 2.4 for smoking during more than 25 years (see chapter 
4-6). Thus, the power to detect statistically significant interactions between exposure 
and genetic susceptibility may have been overestimated 23. 
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Table 2,3, Retrospectively calcuLitcd power for the detection of the multiplicative 
interactions observed between exposure and genetic susceptibility. 
Determinant 
Long-term smoking 
and SULT1A1 fast 
and NAT2 slow 
High alcohol intake 
and ADH3 fast 
High meat intake 
and NAT2 slow 
Exposure 
frequency/ 
prevalence 
0.33 
0.33*0.74=0.24 
0.33*0.59=0.19 
0.33 
0.33*0.36=0.12 
0.33 
0.33*0.59=0.19 
OR for 
high-risk 
combination 
4.32 
3.43 
1.76 
1.57 
OR 
(int)» 
1.25 
1.80 
1.53 
1.41 
Power for 
detection of 
OR(int)b 
0.14 
0.52 
0.34 
0.27 
Detectable 
OR(int)c 
2.89 
2.43 
2.38 
2.34 
" OR(irit). odds ratio for interaction: b the truly achieved power within our stuo 
the detection of ,i statistically significant interaction term of the same maritime 
our study, one-sided test with a = 0.05; * given an achieved sample size of • 
number of controls), detectable OR(int) are calculated at C<=0,05 (one-sided) 
80%. 
v pop 
e: as < 
140 c. 
with 
ulauon tor 
•bserved in 
tses (equal 
x power of 
Consequently, the study power was large enough to evaluate the effect of 'high-risk 
combinations'. However, as shown in Table 2.3, to study gene-environment 
interactions, larger populations are needed 24,25. The power was sufficient (i.e., > 80%) 
for the detection of relatively strong interactions (i.e., OR for interaction of 3 or 4). 
However, the strength of the interaction is probably small and decreases in the presence 
of (non-)differential misclassification26. 
S E L E C T I O N IMAS 
Selection bias refers to situations in which the relation between exposure and disease is 
different for participants in comparison with those who are in theory eligible, and may 
be introduced by differential selection procedures or by differential participation 
rates 19,27. Here, we discuss these possibilities. 
Our study population was recruited via two different methods, as has been explained 
(see also the appendix to this Chapter). To decrease the possibility of differential 
selection, the study protocol required cases and controls to be enrolled according to 
preset criteria both via the direct and the indirect method. It is not likely that exposure-
related invitation occurred, since the level of the exposure under study was not known at 
time of endoscopy. An important advantage of the direct method was that the obtained 
response rates were relatively high (Table 2.4). However, the investigators could not 
closely monitor recruitment so that exact calculation of response rates was hampered 
and the possibility of selection bias was increased. In contrast, the indirect recruitment 
procedure enabled the investigators to select the eligibles according to the preset criteria, 
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1 
2 
3 
4 
5 
6 
7 
8 
direct + indirect 
direct 
direct 
direct 
indirect 
direct 
indirect 
indirect 
and to monitor response. However, response rates were considerably lower than those 
obtained via the direct method (see Table 2.4). 
T a b l e 2.4. Response rates per hospital. 
• i T» i i x, • i • „/ „ Number of participants in 
Hospital Recruitment method Estimated response in % ' 
study (%) 
35 168 (18.9) 
77 124 (14.0) 
91 141 (15.9) 
69 39 (4.4) 
48 178 (20.1) 
87 22 (2.5) 
38 56 (6.3) 
52 159 (17.9) 
Total 54 887 (100) 
" Response rates were not exactly known since endoscopy stall" did not report non-responders 
(direct method), and of the invited subjects, some might have responded after the clewing dale of 
the recruitment period, 1 June 2000 (both methods). 
Inclusion of cases with r ecur ren t adenomas 
We included cases with recurrent adenomas in our study (see Figure 2.3), which 
possibly resulted in overrepresentation of cases with a history of adenomas in our study 
population since these had a higher probability of being invited. This might have 
introduced bias. Subjects suffering from recurrent adenomas may be at higher risk of 
adenomas 8'28, and hereditary factors may play a more important role in these subjects 
than in persons being diagnosed with adenomas once in their lives. However, 57% of 
the recurrent cases in our study were found to have adenomas only once before the 
index endoscopy, and in 28% of the recurrent cases, an adenoma had been detected 
twice before the index endoscopy, indicating that genetic factors might not be of major 
importance. Besides, risk factors for those cases previously diagnosed with adenomas 
were similar to the risk factors found for those diagnosed with primary adenomas (see 
also Table 2.7). The results did not change after exclusion of recurrent cases from the 
analyses for all of the potential risk factors under study (see Chapters 4-6). We could 
probably adequately control for this higher chance for recurrent cases to be invited by 
conducting analyses adjusted for indication of endoscopy (classified as complaints, 
screening, and other/unknown). More important in this respect is the potential role of 
lifestyle changes, which will be discussed below. 
Differences be tween hospitals 
There were large differences in case-control ratios between hospitals, as is shown in 
Figure 2.4. When considering the hospital-specific populations, the percentage of cases 
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ranged from 16% to 100% (Figure 2.4). This variation can be due to differences in 
recruitment procedures as applied by endoscopy staff (hospital 4), to the relatively short 
recruitment period in the hospital (hospital 7), or to small sample sizes (hospital 6). 
Alternatively, these differences might reflect differences between hospitals with respect 
to endoscopy guidelines determining which patients get an endoscopy, or with respect 
to differences between the populations served. 
In spite of the large differences between hospitals, we did not include 'hospital of 
endoscopy' as a covariate in the multivariate analyses presented in this thesis, because of 
the small cell numbers obtained for some hospitals (Table 2.4). With the proportion of 
cases, indication of endoscopy tended to differ over hospitals. Indication of endoscopy 
was included in the multivariate models described in chapters 4-6 to control for 
differences between cases and controls. However, our results might suffer from residual 
confounding by uncontrolled differences between hospitals. As recruitment proceeds, 
with increasing hospital-specific sample sizes, this issue can be more adequately 
addressed in future studies. 
indirect recruitment 
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Figure 2.4. Recruitment of the study population per hospital. Total bats give the 
contribution of hospital-specific samples to the study population; the percentage of cases 
per hospital-specific sample is given by the gray bars and indicated by the figures above 
the bars (see also text). 
Response bias 
The observed differences in the proportion of cases between hospitals did apparently not 
depend on response rates, although these also varied over hospitals (Table 2.4). The 
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direct method resulted in a high response rate probably because all potential participants 
were personally approached by a member of the endoscopy staff. Comparison of 
responses to the short questionnaire as given by participants with the answers from 
those refusing participation but completing the short questionnaire (Table 2.5) revealed 
not much difference between participants and non-participants, although non-
participants were somewhat older and consumed less meat. However, the results of this 
non-response analysis are difficult to interpret. Only about one third of non-participants 
completed the short questionnaire and, similar to the participants, these could have been 
more health-conscious or healthier than the total of non-participants 29,3°. Moreover, for 
ethical reasons, we had no information on the disease status of the non-participants, 
which hinders investigation of exposure-disease relationships for non-participants. 
Tab le 2,5, Characteristics of participants of the adenoma case-control study in 
comparison with invited subjects who did not participate, but completed the short 
questionnaire. 
Characteristic 
Male, % 
Age (yr.), mean ± SD 
BMI (kg/m2), median (25th; 75,h percentile) 
High education level, %c 
Ever smoked, % 
Alcohol intake (drinks/wk), median (25,h ; 75th 
percentile) 
Meat consumption (frequency/week), mean ± SD 5.4 ± 1.5 5.1 ± 1.6b 
" Including all those who had agreed to participate and rilled out the short questionnaire at 
1 May 2000; bsipnticantlv different from participants (p< U.05); ''at least B.Se. decree. 
P O T E N T I A L BIAS BY AGE A N D SEX DIFFERENCES BETWEEN CASES A N D C O N T R O L S 
As shown in Table 2.2, the control group consisted of significantly more women, 
possibly because women were more likely than men to undergo endoscopy for major 
bowel complaints such as irritable bowel syndrome (IBS). IBS was found to be more 
prevalent in Dutch women than in men 31. Also, cases were older than controls. Such 
differences may introduce several types of bias, but not if gender and age are properly 
monitored and adjusted for ". Like others who were confronted with similar gender and 
age differences 22,32,33, we therefore adjusted all analyses presented in this thesis for sex 
and age. 
Participants to 
adenoma study 
N = 1114il 
46.5 
56 ± 12 
25 (23 ; 28) 
21.1 
69.9 
Non-participants 
N=238 
45.6 
60 ± 12b 
25 (22 ; 28)b 
21.4 
69.9 
4 (0 ; 12) 4 (0 ; 12) 
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I N F O R M A T I O N BIAS 
Information bias may occur when the exposure of interest is differentially reported by 
cases and controls, due to differential recall or to under- or over-reporting. In this 
respect, several potential sources of bias need to be discussed, such as the effect of prior 
diagnosis of adenomas on exposure, and of the inclusion of subjects with bowel 
complaints. Differential recall of dietary and smoking habits could have occurred, 
though controls had an equal 'recall stimulus' 19 because, like cases, they underwent 
endoscopy. However, indication of the endoscopy was different for cases and controls 
and might have influenced both recall and behavior. Here, we will discuss possible 
sources of bias, such as the effect of time interval between enrollment and endoscopy, 
prior diagnosis of adenomas, and the potential influence of bowel complaints. 
Influence of t ime interval be tween endoscopy and Invitation 
The chance of recall bias was possibly higher for subjects recruited via the indirect 
methods than for those recruited via the direct method, as the time-interval between 
endoscopy and invitation was longer (Table 2.6), increasing the probability for the 
invited subjects to be aware of their disease-status. If the factors under study would have 
been known as a risk factor for colorectal adenomas, cases might have reported lower or 
higher exposure than their true level of exposure. However, smoking and alcohol 
consumption are generally believed to increase risk of several cancers, but probably not 
of colorectal adenomas. As shown in Table 2.6, relatively more cases were recruited by 
the direct method than by the indirect method. Moreover, subjects recruited by the 
direct method were less likely to be female or to suffer from bowel complaints, and 
more likely to have ever smoked, but these latter two differences could also result from 
the observed sex differences. 
Table 2.6. Statistically sitrnii'icanr differences bv recruitment procedure. 
Characteristic 
Interval between blood collection and index 
endoscopy (months), mean ± SD 
Cases, % 
Colon complaints, % 
Females, % 
Ever smokers, % 
Direct recruitment 
N=326 (45.3 %) 
0.4 ± 1.8 
49.4 
23.9 
49.4 
58.6 
Indirect recruitment 
N=393(54.7%) 
3.7 ± 2.2 
45.0 
31.3 
58.8 
50.1 
Cases with recurrent adenomas 
We included recurrent adenoma cases. Those being diagnosed with colorectal adenomas 
may have been advised to change their diet or to increase their physical activity. 
However, none of those previously being diagnosed with adenomas indicated to have 
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changed alcohol consumption because of colorectal adenomas, whereas smoking rates 
did not differ between cases with primary and cases with recurrent adenomas. Meat 
consumption was not different for recurrent and non-recurrent cases. Except for 
differences in endoscopy indication, the only difference observed between the two types 
of cases was that recurrent cases were slightly older than non-recurrent cases (Table 
2.7). Therefore, adjustment for age, sex and indication of endoscopy seemed adequate. 
Indeed, adjustment for dietary changes did not markedly change observed associations 
between exposure factors and adenomas. Moreover, the results did not change after 
exclusion of recurrent cases from the analyses for all of the potential risk factors under 
study (see Chapters 4-6). 
Table 2.7. Statistically significant differences between recurrent cases and those 
diaenosed with adenomas onlv once. 
Characteristic Recurrent cases N=61 (13.9 %) 
4.9 
93.4 
1.6 
61.6 ± 9.4 
Non-recurrent cases 
N=379 (86.1 %) 
59.4 
30.6 
10.0 
58.4 ± 10.7 
Indication of endoscopy, % 
complaints 
screening 
other/unknown 
Age, mean ± SD 
Bowel complain ts 
Large bowel complaints seemed to be more common among controls than among cases. 
Inclusion of controls with bowel complaints might in theory lead to overestimation of 
the studied associations between e.g. alcohol and adenomas, as bowel complaints might 
cause patients to reduce their alcohol intake. However, habitual alcohol use did not 
differ between subjects suspected from irritable bowel syndrome (IBS) or diverticular 
disease and apparently healthy subjects in other studies 31'34. Underestimation of the 
studied associations is also possible, as excess alcohol intake might lead to bowel 
complaints 35. Under- or overestimation of the odds ratio did probably not occur, as 
those undergoing endoscopy because of large bowel complaints differed from other 
subjects with respect to fiber intake and coffee consumption, but not on any of the 
exposures under study (Table 2.8). Indeed, exclusion of those undergoing endoscopy for 
bowel complaints did not change any of the results described. In our study population, 
two controls reported to have stopped drinking alcohol because of bowel complaints, 
whereas none of the cases and controls changed their meat consumption. 
Non-different ial misclassification of exposure 
Except differential misclassification, non-differential misclassification may also have 
occurred and might in theory have lead to bias toward, but also to bias away from the 
null when categorizing subjects into tertiles of exposure 19. However, this topic is not so 
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much related to our study population as to the nature of the questionnaires, and will 
therefore not be discussed here. 
Table 2.8. Statistically significant differences between subjects undergoing endoscopy 
for bowel complaints and subjects undergoing endoscopy tor other reasons. 
Characteristic 
Cases, % 
History of polyps, % 
Family history of colorectal cancer, % 
Frequency of constipation, % 
Female, % 
Age (yr.), mean ± SD 
Fiber intake (g/d), mean ± SD 
Coffee (cups/d), mean ± SD 
Bowel complaints as 
indication 
N=234 (26.4%) 
27.4 
2.6 
16.2 
22.2 
61.5 
51.2 ± 14.5 
22.9 ± 6.4 
4.0 ± 2.7 
Other indications for 
endoscopy 
N=653(73.6%) 
57.6 
19.8 
22.8 
11.3 
51.6 
55.8 ± 12.5 
24.0 ± 6.7 
4.4 ± 2.7 
MlSCLASSIFICATION OF CASES AND CONTROLS 
Some of the controls might truly have been cases, as previous studies showed that at 
single colonoscopies, 10-15% of polyps may be missed, depending on polyp size 1036. 
Moreover, not all controls in our study underwent complete colonoscopy. The 
inclusion of controls with incomplete endoscopy (23% of controls) could in theory have 
resulted in misclassification leading to bias toward the null, since these controls could 
have undetected adenomas in the proximal colon. However, controls who did not 
undergo complete colonoscopy only differed with respect to the reason for endoscopy 
(mostly complaints) whereas those undergoing complete colonoscopy more often 
sought medical care for screening because of a positive family history (Table 2.9). 
Exclusion of controls with incomplete colonoscopy did not strengthen or attenuate our 
results. 
Tab le 2,9. Statistically significant differences between control subjects undergoing 
complete and incomplete endoscopy. 
Characteristic Complete endoscopy N=345 (77.1 %) 
Incomplete endoscopy 
N=102 (22.8%) 
Indication for endoscopy, % 
complaints 
screening 
other/unknown 
Family history of colorectal cancer, % 
73.6 
9.3 
17.1 
22.0 
86.3 
0 
13.7 
EXTERNAL VALIDITY OF RESULTS DESCRIBED IN THIS THESIS 
With respect to external validity, a limitation of our study might be the choice of the 
control group, as not all controls were asymptomatic, average-risk individuals. Most of 
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the controls had some bowel-related complaints or a family history of colorectal cancer. 
Moreover, our study population might have been more health-conscious than the 
general population, which might be reflected by the lower smoking rates observed in 
our study population (23.4%) in comparison with rates in the general Dutch population 
of the same age (30.6% +). This might affect the generalizability of our results. To be 
able to compare our case-control population with the general population on important 
determinants of colorectal adenomas, such as meat consumption (Chapter 4), smoking 
(Chapter 5), and alcohol consumption (Chapter 6), we conducted a separate study. 
In this study, 4000 subjects were randomly selected from three district council registries. 
These subjects inhabited three different districts in the central parts of the Netherlands 
(which was also the region where our case-control population originated from), and the 
sample had the same age and sex distribution as our case-control population. All selected 
subjects received an invitation from the district council and the same short questionnaire 
as was completed by our cases and controls (see before). After three months, 1987 
subjects had completed and returned the questionnaire (response rate 49%), of which 
1935 were included in preliminary analyses. Early interim analyses including 66 controls 
from the adenoma case-control study did not reveal differences between the two 
populations. However, later analyses showed some clear differences. As shown in Table 
2.10, compared to the endoscopy control group, the sample from the general population 
was somewhat younger, counted less men, more well-educated subjects, and less 
subjects with a family history of colorectal cancer. Alcohol consumption was lower in 
the population-based sample than in the case-control population, although this 
difference might be attributable to sex and age differences between the two populations 
(Table 2.10). 
Tab le 2.10. Comparison of the adenoma case-control study with a population-based 
sample as estimated from the short questionnaire. 
Characteristic 
Population-
based sample 
N = 1935 
Endoscopy 
control group 
N=423 
Adenoma 
cases 
N=400 
Male, % 32 37 a 55 a 
Age, mean ± SD 45.7 ± 12.5 50.6 ± 14.1a 59.3 ± 10.3a 
Body mass index, mean ± SD 24.8 ± 4.3 25.4 ± 4.1 26.1 ± 4.0 a 
High education levelb, % 42 25" 25 a 
Family history of colorectal cancer, % 5 19 a 24a 
Ever smoked cigarettes, % 62 51 a 64 
Alcoholic drinks per week, mean ± SD 5.4 ± 7.3 6.3 ± 8.9 8.6 ± 10.8 a 
Meat consumption in g/d, mean ± SD 98.4 ± 51.6 98.3 ± 51.0 97.9 ± 45.9 
>tb 
for statistically significant, differences between (lie population 
groups; " subject or partner of subject obtained at Last B.Se, dc 
sample and enc 
f
 see http://www.cbs.nl; Centraal Bureau voor de Statistiek, 2001. 
38 
ADENOMA STUDY POPULATION 
Conclusion and recommendations 
We conclude that our case-control population seems to have acceptable validity, 
although rather large differences between hospitals were observed. These differences 
possibly reflect differences in the populations served, but could also reflect hospital 
guidelines with respect to who should get an endoscopy, or problems with adequate 
recruitment of study subjects. We controlled for these differences by adjusting all 
analyses for indication of endoscopy, although some residual confounding due to these 
hospital-differences may have remained. Our findings may not be applicable to the 
general population as our control group mostly underwent endoscopy for complaints. 
Consequently, we should be prudent in generalizing our results. Although the results 
presented in chapter 4-6 may not apply to the general population, they are comparable to 
results reported from other adenoma case-control studies 314. 
To investigate the characteristics of our control group in relation to the general 
population in more detail, the information we collected from the population-based 
sample (see Table 2.10) should be more carefully compared with information from our 
case-control group, and more data from this population-based sample should preferably 
be collected. Also, the hospital-specific differences between case-control populations 
should be studied in more detail. This will be possible with the enlargement of the study 
population in the coming years. In the future, the case-population of our adenoma study 
could also be used to conduct case-only analyses to evaluate the potential joint effect of 
environmental exposures and genetic susceptibility37 (see Chapter 8). 
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CHAPTER 3 
Abstract 
Polymorphism in N-acetyltransferases NAT1 and NAT2 may contribute to differences in cancer 
susceptibility of subjects exposed to alkylating compounds. We developed a robust method for 
simultaneous determination of these NAT polymorphisms: Reverse Line Blot (RLB) 
hybridization, based on PCR followed by allele-specific oligo-hybridization. On a membrane, 
allele-specific oligonucleotide probes of the NAT genes {NAT1M, *3, *10, *U and NAT2M, *5, 
*6, *7 *12) were applied in lines. After separate amplification of the NAT genes, simultaneous 
hybridization of these products in lines perpendicular to the lines with oligonucleotide probes 
was performed, followed by non-radioactive detection. This resulted in hybridization patterns, 
representing the NAT genotype of an individual. RLB hybridizations were conducted on DNA 
from 240 Dutch Caucasian participants in an ongoing case-control study on colorectal adenoma 
(including 126 polyp-free control subject). Results were in complete agreement to those 
obtained by commonly used methods, i.e. allele-specific PCR and PCR-RFLP. Allele-
frequencies in the polyp-free control group were similar to those described in the literature. RLB 
hybridization is, however, considerably faster and cheaper than the common assays. Moreover, 
expansion with allelic variants of other genes is relatively easy, which makes RLB hybridization 
very useful for multiplex analysis of numerous polymorphisms in epidemiological studies. 
I n t r o d u c t i o n 
N-acetyltransferases 1 and 2 (NATi, NAT2) are important enzymes in the 
biotransformation of various xenobiotics with a primary aromatic amine or hydrazine 
structure, such as heterocyclic aromatic amines (HCAs), which may play an important role 
in the etiology of colorectal, breast and bladder cancer '. Genes coding for the NAT 
enzymes are observed to be polymorphic and specific variants may be related to increased 
risk of cancer in subjects exposed to HCAs \ 
Commonly used methods for determination of polymorphism in NATI and NAT2 genes 2" 
5
 are respectively based on allele specific PCR methods and PCR followed by restriction 
fragment length polymorphism analyses (PCR-RFLP), both of which are time consuming 
and relatively expensive. For epidemiological studies, efficient, less labor intensive and less 
contamination prone methods are preferable. Recently, new methods for NAT2 genotyping 
based on oligonucleotide ligation (OLA)6 or using allele specific oligo (ASO) hybridization 
with fluorescent probes and melting curve analysis 7 were developed. These approaches can 
easily be used in large epidemiological studies because of their simplicity and high sample 
throughput. So far, simultaneous detection of the allelic variants in both NATI and NAT2 
genes was thought to be impossible because of the high degree of similarity of the genes 8'9. 
Labuda et al. recently developed a method in which dot blotting of in multiplex amplified 
products of both NAT genes was followed by ASO hybridization 10. Although this method 
enabled simultaneous amplification of both NAT genes, detection was relatively labor 
intensive. 
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In this paper, we describe a rapid Reverse Line Blot (RLB) hybridization method, 
previously used for genotyping human bacterial pathogens 1112, enabling simultaneous 
determination ofNATl and NAT2 allelic variants potentially relevant to cancer risk. Results 
and performance of this method are compared with commonly used allele-specific PCR 
and PCR-RFLP methods. 
M a t e r i a l s a n d m e t h o d s 
SUBJECTS, B L O O D SAMPLING A N D DMA ISOLATION 
NAT1 and NAT2 genotyping was conducted on DNA samples isolated from blood of 
240 participants in an ongoing Dutch case-control study on the etiology of colorectal 
adenomatous polyps. All participants were from Caucasian decent. Controls (n=126) 
had no (history of) polyps and underwent endoscopy for gastrointestinal complaints 
such as anal bleeding, pain or defecation problems. Cases (n=114) were diagnosed with 
adenomatous polyps at least once and visited the outpatient clinic because of 
gastrointestinal complaints or for follow-up of colorectal polyps. 
D N A was isolated from 200 (i.1 frozen whole blood and purified using the QIAamp 
blood Kit (QIAGEN Inc. USA). The eluted DNA was diluted to a concentration of 
about 20 ng/|il and stored at 4°C in deep-well microtiterplates. 
G E N O T Y P I N G M E T H O D S 
Genotyping was performed by RLB hybridization and by the reference methods. To test 
the efficiency of the method, all laboratory analyses were done only once and in case of 
negative results (because of, for example, the quality of DNA or pipetting errors during 
the procedure), amplifications were not repeated. One well in every column of a 
microtiterplate did not contain a DNA sample but water as negative PCR control instead 
(n=36) to check for cross contamination. Twelve duplicate DNA samples were 
randomly distributed over the three microtiterplates. 
In order to evaluate the RLB method, we compared the outcome with the outcome of 
the commonly used methods. Moreover, genotype distributions and allele frequencies 
were calculated for the 126 polyp-free controls only, and compared with the frequencies 
of other population-based studies. 
REVERSE L I N E B L O T (RLB) H Y B R I D I Z A T I O N F O R SIMULTANEOUS NAT1 A N D 
NAT2 G E N O T Y P I N G 
The principle of RLB hybridization is based on non-radioactive hybridization of 43 
D N A samples with a maximum of 43 different oligonucleotide probes in one single 
assay and was first described by Kaufhold et at. u. In short, PCR products of both NAT 
genes are hybridized to a set of gene specific oligonucleotide probes which are bound to 
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a membrane, followed by chemiluminescent detection of the hybridization and exposure 
of the membrane to a light sensitive film. The principle of this method is depicted in 
Figure 3.1. 
biotin 
aminolinker|5 
free / \ 
C- group f •  I 
streptavidin 
enzyme conjugate (S) luminol and 
E light enhancer 
activation of covalent binding 
the membrane of the oligo 
hybridization with 
the PCR product 
enzymatic incubation addition of substrate and 
detection of light on a 
light sensitive film 
• • • • 
Figure 3.1. Principle of the Reverse Line Blot hybndizjtion method. 
Preceding the hybridization, amplification of NAT1 and NAT2 was performed using 
primer NAT1-1 in combination with primer NAT 1-2b, and primer NAT2-1 in 
combination with primer NAT2-2b respectively (Table 3.1). To the different PCR 
mixes (25 ul: 10 m M Tris-HCL pH 9.0, 2.5 mM MgCl2, 50 mM KC1, 0.01% gelatin, 
0.1% Triton XI00, 0.2 m M dNTPs, 0.5 unit Super TAQ polymerase (SphaeroQ), 
15pmol of both primers) 100 ng of DNA was added. After 4 min of denaturation at 
94°C, the mixture for NAT1 amplification was subjected to 35 cycles of 30 s at 94°C, 
30 s at 50°C and 1 min at 72°C, followed by a final elongation step of 5 min at 72°C. For 
amplification of NAT2 the same temperatures were used but the duration of 
denaturation, annealing and elongation were doubled. All PCR were performed in a 
Programmable Thermal Controller (PTC-100; MJ Research). Contamination was 
prevented using filter-tips and mineral oil covering the amplification mixtures. The 
amplified products were visualized under UV light after DNA electrophoresis on an 
ethidium bromide stained 2% agarose gel. The NAT1 fragment was 285 bp whereas the 
NAT2 fragment was 1093 bp in size. 
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Table 3. 
referenee 
1. Primers 
.methods'. 
Mid nltgoimckoiuk-ptobes used tor RLB hybridization and the 
Detection of Detection 
Primer/ probe polymorphic of allele/ Sequence (5' —» 3') 
position(s) gene 
Reference 
NAT1 RLB 
Amplification 
Hybridization 
NAT1-1 
NATl-2b 
NAT1-RLB1 
NAT1-RLB2 
NAT1-RLB3 
NAT1-RLB4 
1088T/1095C 
1088T/1095A 
1088A/1095A 
1095A + 9bp 
deletion 
TAAAACAATCTTGTCTATTTG 
biotin-CAATAAACCAACATTAAAAG 
NAT1*4 amino-
AATAATAAIAAATGTCTTTTAAAGATGGC 
NAT1*3 amino-TAATAAIAAATGTATTTTAAAGAT 
GGCCT 
NAT1*10 amino-ATAATAAAAAATGTATTTTAAAGA 
TGGCC 
NAT1*11 amino-CCTTTTCAAATAATAATAATAATA 
AATGTATTTT 
this study 
this study 
this study 
this study 
this study 
NAT2 RLB 
Amplification NAT2-1 
NAT2-2b 
GGAACAAATTGGACTTGG 
biotin-TCTAGCATGAATCACTCTGC 
Hybridization NAT2-RLB1 341T amino-GACCATTGACGGCAGGAA this study 
NAT2-RLB2 341C NAT2*5A amino-ACCACTGACGGCAGGAAT this study 
or *5BC 
NAT2-RLB3 590G amino-GCTTGAACCTCGAACAATTGA this study 
NAT2-RLB4 590A NAT2*6 amino-CTTGAACCTCAAACAATTGAAGA this study 
NAT2-RLB5 803A amino-GGTTGAAGAAGTGCTGAAAAATA this study 
NAT2-RLB6 803G NAT2*5B amino-GTTGAAGAAGTGCTGAGAAATAT this study 
C or *12 
NAT2-RLB7 857G amino-CCTGGTGATGGATCCCTT this study 
NAT2-RLB8 857A NAT2*7 amino-AACCTGGTGATGAATCCCTTA this study 
NAT! Reference method 
NAT1-3 
NAT1-4 
NAT1-5 
NAT1-6 
NAT1-7 
Hisl 
His2 
His3 
His4 
1088T NAT1*4 GCCATCTTTAAAAGACATTTA 
1088A NAT1*W GCCATCTTTAAAAGACATTTT 
TATTTGTCATCCAGCTCACC 
1095A NAT1*3 CCACAGGCCATCTTTAAAAT 
or*4 
1095C NAT1*4 CCACAGGCCATCTTTAAAAG 
Histone TGGAAATGAACGACTTTCGG 
Histone TGACGAAGGAGTTCATGATG 
Histone AATCTCCI I I I IACAAATGAG 
Histone CTGTTAATTTCATTCATTGAG 
NAT2 Reference method 
NAT2-3 
NAT2-4 
NAT2-5 
NAT2-6 
NAT2-7 
341 
341 
590 
590, 803, 857 
803, 857 
NAT2*5 
NAT2*5 
NAT2*6 
NAT2*6 
or *7 or 
*12 
NAT2*7 
or *12 
CACCTTCTCCTGCAGGTGACCG 
TGTCAAGCAGAAAATGCAAGGC 
GGCTGTTCCCTTTGAGAACC 
ACACAAGGGTTTATTTTGTTCC 
GTGGGCTTCATCCTCACCTA 
!
 U n d e r l i n e d bases d i n o t e d ie posit ior 
(/.. ni . i i insci ipt in jM"ep;ir,iti()ii: '' Biider < 
of the bases, wh ich vary 
(//., nnpuhlish.ed d a t e 
,:t.\vei.:i) tin.: .ii 
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For the hybridization experiments we designed the NAT1 oligonucleotide probes 
derived from alleles *4, *3, *10 and *11 to detect polymorphism at position 1088 and 
1095 and the 9-bp poly-A deletion in that region (Table 3.1, oligonucleotide probes 
NAT1-RLB1 to NAT1-RLB4). Probe NAT1-RLB4 (allele NAT1*11) also detects allele 
NAT1*3 (the probe derived from allele NAT1*3 is on the other hand not detecting 
NAT1*11). For NAT2, we designed oligonucleotide probes to establish allelic variants 
NAT2*5, *6, *7, *12 (NAT2-RLB2, 4, 6, 8) as well as to detect the wild-type allele 
represented by hybridization with probe NAT2-RLB1, 3, 5, 7 (Table 3.1). Allele 
NAT2*5A is represented by hybridization with probe NAT2-RLB2 alone, while in 
combination with a hybridization signal with probe NAT2-RLB6 the NAT2*5BC allele 
is determined. Oligonucleotide probes were synthesized with a 5'-terminal amino group, 
which was used to covalently link the probes to the activated membrane. The membrane 
containing the oligonucleotide probes used for hybridization with the PCR fragments 
was made as described by Kaufhold et al. in 1994 12. In short, a Biodyne C membrane 
(Pall, Pall BioSupport) was activated with 16% (wt/v) EDAC (l-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (Sigma) and placed in a miniblotter MN45 
(Immunetics). After 150 (i.1 of the probes was applied in a concentration which varied 
between 40 and 5400 pmol/u,l, the membrane was inactivated with 0.1 N N a O H and 
washed with 2x SSPE/0.1% SDS (SSPE; Gibco BRL, SDS, BDH). The concentrations 
of the probes on the membrane were established by first applying the probes in three 
different concentrations on the membrane (e.g. 167, 333 and 667 pmol/nl,) followed by 
hybridization with PCR samples of known genotype. Depending on the result, the 
concentrations were increased or decreased. Eventual concentrations were 42, 42, 83 and 
667 pmol/u.1 for probes NAT1-RLB1 to NAT1-RLB4, respectively, and 5333, 5333, 167, 
333, 167, 167, 167, and 667 pmol/u.1 for probes NAT2-RLB1 to NAT2-RLB8, 
respectively. Note that in practice the optimal probe concentrations may differ from the 
ones described here, due to different laboratory and manufacturing conditions. 
After binding of the probes, the membrane was taken from the miniblotter, washed and 
placed into the miniblotter again in a 90° rotated position. In a microtube containing 
150 nl of 2x SSPE/0.1% SDS, 10 juil of the PCR products of both NAT1 and NAT2 were 
added and heat-denatured. As positive hybridization controls, a set of 4 PCR samples of 
known genotype was used. After rapid cooling on ice, the PCR products were applied 
into the slots of the miniblotter and hybridized for 60 min at 45°C. The membrane was 
removed from the miniblotter and washed twice for 10 minutes at 64°C in 2x 
SSPE/0.5% SDS solution followed by 1-h incubation at 42°C with streptavidin-
peroxidase (Boehringer Mannheim GmbH) diluted 1:4000 in 2x SSPE/0.5% SDS. After 
washing twice at the same temperature for 10 min with 2x SSPE/0.5% SDS and twice 
with 2x SSPE at room temperature for 5 min, visualization of the hybridization was 
carried out with the ECL nucleic acid detection reagent (Amersham Pharmacia Biotech) 
followed by exposure of the membrane to a light-sensitive film (hyperfilm ECL; 
Amersham Pharmacia Biotech) for about 30 min. After successful hybridization, the 
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PCR products were stripped from the membrane by incubating the membrane twice for 
30 min in 1% SDS solution at 80°C and then the membrane was stored moist at 4°C for 
a further reuse. 
R E F E R E N C E M E T H O D S touNATt A N D NAT2 GF.NOTYPING 
NAT1 genotyping was performed by allele specific amplification as used by Bell 2 and 
Potter (Potter et al., manuscript in preparation). The PCR to detect the allele specific 
nucleotide at position 1088 was carried out using primer NAT1-1 together with either 
primer NAT 1-3 or primer NAT 1-4. Both reactions were co-amplified with primers 
Hisl and His2 derived from the human histone gene (Table 3.1). The PCR to detect the 
allele specific nucleotide at position 1095 was carried out using primer NAT1-5 with 
either primer NAT 1-6 or primer NAT 1-7 whereas the histone gene was co-amplified 
using primers His3 and His4 (Table 3.1). In contrast with RLB hybridization, we did 
not differentiate between allele NAT1*3 and allele NAT1*11, both amplified with 
primer NAT 1-5 and primer NAT 1-6. Fragments of these alleles differ only 9 bp in size 
which makes differences between these infrequent alleles hardly observable. 
Polymorphism in the NAT2 gene was determined by a primary PCR performed with 
primer NAT2-1 and NAT2-2 3 (Table 3.1) followed by three nested PCRs and RFLP 
analyses (4,s, Bigler et al., unpublished data). The region encompassing position 341 (for 
detection of allele NAT2*5) was amplified using primer NAT2-3 and NAT2-4 and the 
resulting fragments were digested with Acil. The region covering position 590 (for 
detection of allele NAT2*6) was amplified by primers NAT2-5 and NAT2-6 and the 
PCR fragments were digested with Taql. To determine the mutations at positions 803 
(for discrimination between allele NAT2*5A and NAT2*5B, or detection of allele 
NAT2*12) and 857 (for detection of allele NAT2*7) we used primer NAT2-6 and 
NAT2-7 (Table 3.1) and the PCR was followed by RFLP analyses with respectively Ddel 
and BamHl. PCR fragments as well as restriction fragments were separated with DNA 
electrophoresis on agarose gels stained with ethidium bromide and visualized under UV 
light. 
R e s u l t s 
All samples were subjected to genotyping by RLB hybridization and the reference methods. 
We were able to perform all genotyping by RLB hybridization in three days (96 samples can 
be genotyped in one single day). The allele specific amplification and PCR-RFLP methods 
genotyping took approximately fifteen days (96 samples can be determined in 5 days) 
because of the number of separate steps in these methods. 
We were able to determine the NAT1 genotype of 239 out of 240 samples by RLB 
hybridization and 235 out of 240 samples by allele specific PCR. In addition, NAT2 
genotyping resulted in 238 positive determinations by RLB hybridization compared to 224 
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obtained by PCR-RFLP analysis (data not shown). The 12 duplicate DNA samples gave 
identical outcomes and we did not see any genotyping discrepancies in outcome between 
RLB hybridization and the reference methods (data not shown). All of the 36 negative PCR 
controls remained negative by RLB hybridization whereas by PCR-RFLP analysis of 
NAT2, 10 out of 36 negative PCR controls were positive (data not shown). For data 
analysis, positive hybridization results were scored in a spreadsheet as plus, while we scored 
minus if no hybridization signal appeared. 
Figure 3.2 shows an example of an RLB result of the four positive controls (row 1-4), a 
negative PCR control (row 5) and seven samples from the study population (row 6-12). 
Deduction of the genotype on the basis of the hybridization pattern was simple. As an 
example, the PCR sample from a subject participating in the study, depicted in row 6, 
shows hybridization with NAT1 oligonucleotide probes 1 and 3, indicating the presence of 
allele NAT1*4 and NAT1*10. For NAT2, hybridization with oligonucleotide probe 1, 3, 4, 
5 and 7 is observed resulting in the NAT2*4/*6 genotype (Figure 3.2, Table 3.1 and 3.2). 
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Figure 3.2. Reverse line blot 
hybridization patterns of amplified 
NATS and NAT2 genes. Columns 1 
through 4 and columns 5 through 12 
depict the olie;ormcle< Hide-probes 
specific tor the various SA1 I and 
NA'1'2 alleles, respectively. Row 1 
through 4 show hybridization patterns 
oh a set of 4 PCR samples of known 
genotype, as a control to the 
hybridization. Rows 0 through 12 
show genotyping patterns of samples 
from individuals from the study 
population. Row 5 carries a negative 
PCR control. 
Table 3.2 shows an overview of all different RLB hybridization patterns of the 126 polyp-
free individuals in this study and the corresponding frequencies of the NAT1 and NAT2 
genotypes. 
Allele frequencies as determined by RLB hybridization of these subjects were 
comparable with those obtained from previous studies, as shown in Table 3.3. 
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Tabic 3.2, SAIi and SA'1'2 genotype of 126 polyp-free 
descent: results from the RLB method. 
Hybridization result per RLB 
oligonucleotide probe 
Genotype 
dividuals of Caucasian 
Number of individuals 
(%) 
NAT1 
1 
• • • 
*4/*4 
*4/*3 
*4/*10 
Mini 
*3/*10 
no/no 
*10/*11 
70 (55.6) 
3 (2.4) 
38 (30.2) 
4 (3.2) 
3 (2.4) 
6 (4.8) 
2(1.6) 
Discussion. 
RLB hybridization is a rapid, robust and reliable method for genotyping human NAT1 
and NAT2 alleles simultaneously. Within three days, 240 individuals were successfully 
genotyped for the NAT1*4, NAT1*3, NAT1*10, NAT1*U, NAT2M, NAT2*5A, 
NAT2+5BC, NAT2*6, NAT2*7 and NAT2+12 alleles. The results of the assay were in 
complete agreement with the results of allele specific PCRs and PCR-RFLP methods. 
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Allele frequencies obtained by RLB hybridization of polyp-free subjects were 
comparable to those in the literature. 
The commonly used methods for NAT genotyping have several disadvantages. The 
main drawback of allele specific methods used for NAT1 genotyping is the requirement 
of four independent multiplex amplifications, which are difficult to optimize and often 
result in false positive bands. A disadvantage o£NAT2 genotyping by PCR-RFLP is that 
nested amplifications are conducted on the primary PCR product, which is a 
contamination prone procedure in large studies. Indeed, in our study ten out of 36 
negative PCR controls gave a positive signal, probably due to well-to-well contamination 
with NAT2 PCR products while preparing the primary PCR products for the nested 
PCR. 
Table 3.3. NAT'I and NA'T'2 allele frequencies of the polyp-free population in this 
study; a comparison to other studies. 
Study 
This 
paper 
13 
2 
3 
14 
15 
NAT1 allele 
alleles . , 
*4 
tested (n) 
252 
344 
224 
0.73 
0.71 
0.77 
frequencies 
*3 no 
0.02 0.22 
0.02 0.26a 
0.03 0.16 
*11 
0.05 
0.01 
0.08 
alleles 
tested (n) 
252 
344 
744 
556 
200 
NAT2 allele frequencies 
*4 
0.24 
0.26 
0.25 
0.23 
*5A 
0.02 
\ 
0.03 
*5BC 
0.46 
0.40" 
0.45b 
0.41c 
*6 
0.27 
0.32 
0.28 
0.31 
0.26 
*7 
0.01 
0.02 
0.02 
0.01 
0.04 
*12 
0.01 
a
 Iii paper diflerciicuced in SAT MO and NATM4; '" allele ;\V'1T*5. \BC and .\/172*/2; 'allele 
A'ei72*5BC,\sml SAT2*L\ 
In addition, the restriction enzymes used by RFLP analyses are relatively expensive. 
Both methods are time consuming because of the necessity of many amplifications and 
- for the RFLP analyses- the obligatory incubation and electrophoresis steps. 
Furthermore, interpretation of the gels after electrophoresis requires experience. 
Although it is far less time consuming and less contamination prone, the RLB method 
has some drawbacks. Misclassification could occur by partial cross-hybridization of 
samples from subjects who possess a NAT1*11 allele. These samples hybridize with the 
oligonucleotide probe derived from allele NAT1*11 (NAT1-RLB4) as well as with the 
one derived from allele NAT1*3 (NAT1-RLB2) because probe NAT1-RLB2 is 100% 
identical to a part of probe NAT1-RLB4. Therefore, we were unable to discriminate 
NAT1*11 homozygous subjects from heterozygous NAT1*3/*11 subjects. However, 
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none of the 240 samples were determined as NAT1*3 /*11 since hybridization occurred 
only in combination with hybridization with probes derived from allele NAT1*4 or 
NAT1*10, confirming that the homozygous NAT1*11 genotype is very uncommon 2 ' 3 
and misinterpretation is hardly expected. For NAT2, misclassification between 
NAT2*4/*5BC and NAT2*5A/*12 could occur because hybridization patterns 
belonging to these genotypes are identical: both genotypes include mutations at position 
341 and 803. However, for NAT2*4/*5BC both mutations are on the same allele 
(*5BC), whereas for NAT2*5A/*12 the mutation at position 341 is positioned on allele 
*5A and the other changed nucleotide is located at allele *12. Nevertheless, NAT2*12 is 
a very uncommon allele (Table 3.3) so only minor misinterpretation is expected. 
RLB has important advantages over the usually applied methods. As mentioned earlier 
RLB hybridization results can easily be read and scored into a spreadsheet, which 
reduces the number of mistakes. The method is also less contamination prone, 
illustrated by the fact that all negative PCR controls remained negative by RLB analysis, 
whereas a substantial number of negative controls gave positive results by PCR-RFLP. 
The RLB hybridization method is faster than the described reference methods and one 
can expand the number of probes with oligonucleotide probes specific for other genes 
and allelic variants of interest up to 43. Moreover, it does not require expensive 
equipment or reagents and can easy be implemented in any laboratory that can perform 
PCR and hybridizations. 
In conclusion, because of high throughput of samples, the ease of the procedure and the 
ability to enlarge the method with other allelic variants of different genes, the RLB 
hybridization method can easily be applied in large epidemiological studies and this will 
ultimately contribute to a better understanding of individual genetic susceptibility to 
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CHAPTER 4 
Abstract 
Heterocyclic aromatic amines (HCAs), formed during preparation of meat at high temperatures, 
may increase the risk of colorectal adenomas. Genetic susceptibility to HCAs possibly modifies 
this association. To study associations of meat consumption, meat preparation habits, and 
genetic susceptibility with risk of colorectal adenomas, we conducted a case-control study 
including 431 adenoma cases and 433 polyp-free controls, recruited among patients undergoing 
endoscopy. Participants completed a meat consumption and preparation questionnaire and 
provided blood samples for DNA isolation. Polymorphisms of N-actyltransferases (NAT) 1 
and 2, sulfotransferase (SULT) 1A1, and glutathione-S-transferases (GST) Ml and Tl were 
determined. Although we detected HCAs in habitually prepared meat samples, high meat 
consumption did not importantly increase risk of colorectal adenomas (odds ratio (OR) 1.2, 95% 
confidence interval (CI) 0.8-1.9). Also, presumed unfavorable preparation habits such as the use 
of a lid and preference for darkly browned meat, did not increase adenoma risk (ORs and 95% 
CIs 0.8, 0.6-1.2 and 1.0, 0.6-1.5, respectively). There was no evidence for effect modification by 
NATi, SULT1A1, GSTM1, and GSTT1 polymorphisms. Only the NAT2 slow phenotype 
slightly increased risk of adenomas in combination with high meat consumption (OR 1.6, 95% 
CI 1.1-2.3). Thus, in this Dutch population, unfavorable meat consumption and preparation 
habits did not increase colorectal adenoma risk, and these associations were not influenced by 
polymorphisms in genes involved in HCA biotransformation. 
Introduction. 
Colorectal cancer is thought to arise from colorectal adenomas and is highly prevalent in 
the Western world u . Meat consumption probably increases the risk of colorectal cancer 
and adenomas 14. This increased risk is possibly due to the exposure to heterocyclic 
aromatic amines (HCAs) predominantly formed during cooking of meat at high 
temperatures 5'6. 
HCAs are potent mutagens in vitro and animal carcinogens 7"9 which are metabolized via 
various biotransformation pathways 10U. Many of the enzymes involved in activation and 
detoxification are encoded by polymorphic genes, for which several allelic variants exist 
that may increase or decrease enzyme expression, stability or activity. Such polymorphic 
genes are N-acetyltransferases (NATI and NAT2) and sulfotransferase (SULT1A1). 
Glutathione-S-transferases (GSTM1 and GSTT1) might inactivate some reactive HCA 
metabolites or may act more indirectly through induction of the cytochrome P450 1A2 
enzyme 12'13. Polymorphisms in all these genes are highly prevalent in Caucasian 
populations 14~16 and have been found to influence the association between meat 
preparation and colorectal neoplasm in several, but not all studies 17"19. 
Besides differences in genotype frequencies over populations, these inconsistencies can 
be the result of differences in study and/or questionnaire design or meat consumption or 
preparation. In European countries, daily exposure to HCAs might be lower than in the 
US due to a lower meat intake and differences in meat preparation. However, the actual 
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exposure of the general population to these substances is unknown. In most previous 
studies, exposure has been estimated from HCA measurements in meat prepared under 
laboratory conditions 5,2°"23 that do not necessarily reflect the habitual preparation 
methods of the general population. To investigate whether HCA exposure occurs in the 
Netherlands, we measured concentrations of six HCAs in beef patties prepared by 
volunteers according to their own preparation habits (henceforth referred to as the 
'Meat preparation study'). 
To evaluate whether these preparation methods are associated with colorectal adenoma 
risk, we explored meat preparation methods as well as genetic polymorphisms in a case-
control study on colorectal adenomas (henceforward referred to as the 'Case-control 
study'). 
Materials and Methods 
M E A T P R E P A R A T I O N STUDY 
Study design 
We recruited 63 volunteers out of a random sample of the general population with the 
same gender and age distribution as the control group of our case-control study (i.e., 
66% women, mean age ± SD, 48.3±10.2 years). To maximize the variation in meat 
preparation methods, we selected 40 volunteers preferring meat with a darkly browned 
surface, and 23 subjects preferring a lightly browned surface. All volunteers prepared 
three beef patties (100 g per patty) at home in the way they habitually do this. After 
preparation, at least one patty was stored in the volunteers' fridge. If prepared from pan 
residues, the volunteers added a spoon of gravy. Samples were collected within 24 hr 
and stored at -20°C until further analyses. In addition, the volunteers completed a self-
administered questionnaire on the preparation of beef patties several weeks before and 
during or shortly after preparation. At least 77% of volunteers answered questions on 
meat preparation similarly before and after baking indicating that most of them indeed 
prepared the meat as usual. In spite of our effort to maximize the variation in meat 
preparation, some preparation habits were quite uniform: only one volunteer prepared 
the meat at low temperature, and 10 volunteers added water during browning. 
De te rmina t ion of HCAs in beef pat t ies 
Beef patties were analyzed by a method based on the work described by Toribio and 
colleagues 24. After homogenization, N a O H was added to 6-g aliquots. Samples were 
subsequently extracted with sonication. By three-step solid phase extraction, the analytes 
were transferred to dichloromethane and subsequently isolated using a cation exchange 
SPE cartridge. Further clean up of the samples was achieved using a C18 SPE cartridge. 
After elution of HCAs from the cartridge and evaporation, they were resolved in 
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methanol-water. Concentrations of six HCAs were assessed using HPLC: 2-amino-3-
methylimidazo[4,5^/]quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5^/]quinoxaline 
(MelQx), 2-amino-3,4,8-trimethylimi-dazo[4,5:/]quinoxaline (DiMelQx), 2-amino-
3,4,7,8-tetramethyl-3H-imida-zo[4,5^/]quinoxaline (TriMelQx), 2-amino-l-methyl-6-
phenylimidazo[4,5-fo]pyridine (PhIP), and 2-amino-9H-pyrido[2,2-b]indoline (AaC). 
Part of the samples was analyzed in duplicate (10%) or in triplicate (8%). External 
calibration was applied using standard solutions of analytes. Recovery rates ranged 
between 36 and 57%. Detection limits, as calculated with Calwer 2.2 software using 
weighted regression models 25, were 1.0 ng/g for IQ, 3.7 ng/g for MelQx, 3.9 ng/g for 
DiMelQx and TriMelQx, and 1.8 ng/g for PhIP and A a C . 
C A S E - C O N T R O L S T U D Y 
Popula t ion 
Cases and controls were recruited among patients undergoing endoscopy at the 
outpatient clinics of eight hospitals in the Netherlands between June 1997 and June 
2000. Medical ethical committees of all participating hospitals and of Wageningen 
University approved the study protocol. 
Potential participants were recruited at time of endoscopy by trained staff (47%), or were 
selected at regular intervals using endoscopy reports of all patients who had undergone 
endoscopy in the previous three months and invited by mail (53%). Eligible subjects 
were Dutch speaking, of European origin, aged 18 to 75 years at time of endoscopy, did 
not belong to families with hereditary colorectal cancer syndromes, did not suffer from 
chronic inflammatory bowel disease, and did not have a history of colorectal cancer or 
(partial) bowel resection. Overall response was 54%. After obtaining informed consent, 
blood samples were drawn for D N A analysis and questionnaires were administered. 
Cases had at least one histologically confirmed colorectal adenomatous polyp ever in 
their life. Controls had no history of any type of polyps. Complete visualization of the 
colon (i.e., full colonoscopy or sigmoidoscopy combined with X-ray) was achieved for 
78% of controls and 89% of cases. Information on polyp recurrence, size, localization, 
and histology and the number of excised polyps was collected through medical files. 
The study population counted 925 subjects, including 64 subjects who also met our 
criteria, but were recruited between December 1995 and June 1997 for a preceding 
study on somatic mutations in colorectal adenomas conducted in one of the eight 
hospitals 26. 
Meat consumpt ion and prepara t ion assessment 
Participants were requested to fill out self-administered dietary and lifestyle 
questionnaires according to habits in the year previous to their last endoscopy or bowel 
complaints. 
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To study meat consumption and preparation habits, a questionnaire inquiring habitual 
consumption of 16 meat types (frequency and portion sizes) and gravy was developed. 
The questionnaire also contained detailed questions on the preparation of several types 
of meat (e.g., height of heat source, addition of water, use of a lid) categorized into six 
groups according to similarities in preparation methods. These methods had been found 
to be determinants of the meat surface temperature in a pilot study (unpublished data). 
The color of the meat surface was assessed from color photographs ranging from very 
dark to very light (prepared at 225, 200, 175, and 150°C respectively) of four meat types 
(beef patties, pork chops, steak and bacon) that originate from a Swedish 
questionnaire . 
The dietary questionnaire was a standardized and validated semi-quantitative food 
frequency questionnaire described in detail elsewhere 27 and was, in this study, used for 
estimation of total energy intake and intake of macro- and micronutrients, and of 
portion size of gravy. 
De te rmina t ion of genet ic po lymorphisms 
DNA was isolated from 200 u.1 frozen whole blood using the QIAamp blood kit (Qiagen 
Inc., U.S.A.), diluted to a concentration of approximately 20 ng/u.1, and stored at 4°C 
until analyzed. PCR was performed with internal negative and, where needed, positive 
controls. Laboratory personnel was blinded to case-control status. 
NAT1 and NAT2. Allelic variants of NAT1 and NAT2 were determined by an allele 
specific oligo hybridization assay developed in our laboratory by Bunschoten and 
colleagues 28. Using this method, we could identify NAT1 alleles *4, *3, *10 and *li, 
and NAT2 alleles *4, *5, *6, *7, *12. Validity and reproducibility of the method were 
extensively tested and proved to be 100%. 
SULT1A1. The SULT1A1 polymorphism (*1 and *2 alleles) was determined using a 
PCR-RFLP method described in detail by Engelke and colleagues 16. The polymorphism 
was not determined in the 64 samples from the preceding study on somatic mutations 
(see under Population). 
GSTM1 and GSTT1. GSTM1 and GSTT1 genotypes were simultaneously determined 
using a multiplex PCR procedure similar to the method of Arand and co-workers 29 with 
the inclusion of primers derived from (3-globin instead of albumin as a positive PCR 
control 30. To test reproducibility, approximately 10% of the samples were genotyped in 
duplicate; no differences were observed. 
Data analysis 
All beef patties (n=63) were analyzed for presence of HCA. Total HCA concentration 
was calculated by summation of the concentrations of all six HCAs. To study the 
probability of presence of at least one HCA in relation to preparation methods, logistic 
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regression was applied. Spearman rank correlations were calculated and, to study if 
specific preparation methods affect HCA concentrations, single classification ANOVA 
was applied. 
From our case-control study, we excluded 61 subjects of whom dietary data was not 
complete, resulting in a final study population of 864 subjects: 431 cases and 433 
controls. Variables describing the frequency of consumption of several meat types were 
divided in quartiles based on the distribution in the control group. Frequencies of red 
and white meat consumption were calculated by summing the frequencies of 
appropriate meat types, adjusted for the frequency of total meat consumption. Similarly, 
preparation characteristics were summarized per characteristic over the six meat 
categories and divided by the number of questions answered. 
To study the associations of meat consumption and preparation characteristics with 
colorectal adenomas, odds ratios (ORs) and 95% confidence intervals (95% CIs) were 
calculated using unconditional logistic regression. Of potential confounders (i.e., 
anthropometry factors, physical activity, smoking status, history of large bowel 
complaints, family history of colorectal cancer, total energy intake, and intake of macro-
and micronutrients and foods known to be possibly related to meat consumption), only 
age changed the ORs markedly. Therefore, we calculated ORs adjusted for age only, and 
adjusted for age, gender and indication of endoscopy to control for residual confounding 
by selection methods. We also considered the following variables for potential effect 
modification: gender, age, use of non-steroidal anti-inflammatory drugs (NSAIDs) and 
oral contraceptives, and family history, but none of these significantly modified the 
effect. When studying the association between specific types of meat or specific 
preparation methods and colorectal adenomas, we additionally considered inclusion of 
covariates describing other meat types or preparation methods in our multivariate 
models. 
Case-case analyses were conducted to study the risk associated with adenoma recurrence 
(primary vs. recurrent), size (< 1 cm vs. > 1 cm), localization (proximal vs. distal) and 
number (multiple vs. single) of adenomas. Furthermore, analyses were repeated after 
exclusion of cases who had been diagnosed with adenomas in the past (i.e., more than 
one year before the index endoscopy, n=132) and of controls without complete 
visualization of the colon (n=102). Also, the analyses were repeated without cases and 
controls who underwent endoscopy because of bowel complaints. 
All analyses were conducted using Statistical Analysis Software (SAS version 6.12, SAS 
Institute, Cary, NC) . 
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Results 
M E A T P R E P A R A T I O N S T U D Y 
In Table 4.1, HCA concentrations in the 63 beef patty samples are linked to preparation 
methods. In 35% of beef patties one or more HCAs were determined, which was mostly 
MelQx. Of the inquired preparation methods, use of a lid increased the probability of 
presence of MelQx. Presence of IQ did not depend on preparation methods. The 
concentration of IQ and MelQx seemed to be inversely related with preferred darkness 
of the meat surface, although not with statistical significance (r=-0.3, data not shown). 
The effect of cooking methods on the presence of other HCAs could not be studied due 
to the low number of samples in which these were observed. 
Table 4.1. Results of the meat preparation study: concentration of heterocyclic amines in 
63 beef parties, and correlation with preparation methods. 
Heterocyclic aminea 
All six IQ MelQx Di^ TrT- PhIP 
combined MelQx MelQx 
22(35) 7(11) 17(27) 1(2) 4(6) 1(2) N (%) of samples 
with >1 HCA 
Median cone.b in 
positive samples 5.59 1.31 5.41 5.76 6.22 4.38 
(ng/g meat) 
Range of cone, in 
positive samples 1.25-27.4 1.17-2.09 3.89-12.0 n.a.c 3.92-8.93 n.a.c 
(ng/g meat) 
Probability of HCAs in meat in relation to preparation, methods, RR (95% CI)d 
Preferred color of 
meat surface (very) 0.5(0.2-1.4) -c 0.5(0.1-1.5) 
dark 
Heat source high 1.1(0.4-3.3) - 0.7(0.2-2.3) 
Addition of water
 y _ 0.5 (0.1-2.1) 
during browning 
Use of a lid 3.2(0.9-11.6) - 5.5(1.4-20.9) 
" IQ, 2-amino-3-methylimidazo[4,5-/]quinoline; MelQx. 2-amino-3.8-dimc'tliylimida^of4,5-/') 
qiiinoxaline; Di.VIe.IQx, 2-amim>-3.4,8-trimethylimidazo[4,5-fj quinoxaline: TnMelQx, 2-
amirio-3,4,7,M-toti"amcthyl-31I-iniidazo[ 4,5-/) quinoxaline: Phil'. 2-amino-l-methyl-6-phcnyl-
iimd,)/o[-J,5-6]pyridine: 2-amino-9H-pyrido[2,2-7>]iridoline (AaC) was not detected in any of 
the samples and is therefore not included; '* cone, concentration: '' n.a.. not applicable: 
J
 calculated from logistic regression analyses; c not enough data in subclasses. 
CASK-CONTROL S T U D Y 
Table 4.2 summarizes the characteristics of the case-control population. Cases were 
older than controls and the proportion of men was higher in the case than in the control 
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group. Moreover, cases had a higher body mass index, more frequently had a low 
educational level, more frequently (had) smoked, and less frequently underwent 
endoscopy because of complaints (i.e., pain, defecation problems, or rectal bleeding) 
than controls. Cases more frequently consumed gravy, including gravy from pan 
residues. Cases and controls did not differ in the way they used to prepare meat. There 
were no differences between cases and controls with respect to total daily energy intake 
(8776±2415 kj among cases, 8677±2588 kj among controls), or the intake of meat-
related nutrients such as fat and animal proteins. However, cases consumed more 
alcohol and potatoes, and less grain (products) (i.e., cereals, rice, pasta) than controls 
(data not shown). 
Table 4.2. Characteristics of the case-control study population. 
Characteristic Cases Controls (n=431) (n=433) 
General characteristics 
Age, mean ± SD 
Gender, % male 
Body mass index, mean ± SD 
Education level, % low 
Smoking, % ever smokers 
Low physical activity 
Weekly use of NSAIDs 
Endoscopy because of intestinal complaints 
Family history of colorectal cancer 
Meat consumption, frequency/week, mean ± SD 
Total meat 
Red meat 
Poultry 
Gravy 
Gravy from pan residues 
Meat preparation preference, % 
Never adds water during browning 
Heat source always high during browning 
Always uses lid 
58.9±10.5 
54.1 
26.1 ±3.9 
36.2 
61.1 
34.8 
10.0 
52.0 
23.4 
5.5±1.5 
4.6±1.5 
0.9±0.8 
4.2±2.2 
3.8±2.4 
27.5 
17.9 
35.5 
50.3±14.1a 
37.0a 
25.4+4.1" 
29.8b 
49.0" 
31.9 
13.4 
76.9a 
19.2 
5.4±1.6 
4.5+1.5 
0.9+0.7 
3.6+2.3a 
3.3+2.5b 
26.5 
23.9 
38.4 
" p <f\fb (chi-sqiure test for categorical variables, t-iest for continuous variables); '"' p < 0.001 
(clii-square ti.;*t for categorical variables, t-tcst for continuous variables). 
In Table 4.3, the associations of meat and gravy consumption and of different 
preparation characteristics with colorectal adenomas are shown. As is concluded from 
this Table, frequent consumption of total meat was not markedly associated with 
colorectal adenomas. Although crude analysis suggested that gravy might be a risk factor 
for colorectal adenomas (OR 1.7, 95% CI 1.2-2.5), the association disappeared after 
adjustment for age. Risk of colorectal adenomas was not associated with frequent 
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consumption of red meat (Table 4.3) or white meat (multivariate OR and 95% CI 1.1, 
0.7-1.6, highest vs. lowest quartile). None of the 16 meat types was associated with 
increased risk of colorectal adenomas, neither when included separately, nor when 
included all at once in the age adjusted or the multivariate model (data not shown). 
Table 4.3. Risk of colorectal adenomas associated 
consumption and meat preparation methods'1. 
with habitual frequency of meat 
Total meat intake, times/week 
< 5 
5 
6 
7 
Red meat, times/week 
<3.7 
3.7-4.8 
4.8 - 5.6 
5.6+ 
Intake of gravy from pan residues, times/week 
0 - 0.24 
0.25 - 4 
5 
6+ 
Temperature of heat source during browning 
Low - medium with every meat type 
Depends on meat type 
High with every meat type 
Use of a lid 
Not with any meat type 
Depends on meat type 
With every meat type 
Addition of water during browning 
With every meat type 
Depends on meat type 
Not with any meat type 
Preferred color of meat surface 
< 1 of four meat types (very) dark 
Two or three of four meat types (very) dark 
All meat types (very) dark 
N cases/ 
controls 
76/85 
97/105 
138/127 
120/116 
88/104 
106/105 
115/105 
115/105 
93/113 
109/136 
95/82 
130/94 
227/205 
122/116 
76/101 
152/152 
122/108 
151/162 
139/138 
169/173 
117/112 
229/183 
130/172 
72/78 
Age adjusted 
OR 
1 (REF) 
1.10(0.71-1.71) 
1.30 (0.86-1.97) 
1.23 (0.81-1.88) 
1 (REF) 
1.20 (0.79-1.81) 
1.38 (0.92-2.08) 
1.22 (0.81-1.84) 
1 (REF) 
0.98 (0.66-1.45) 
1.21 (0.79-1.86) 
1.28(0.85-1.93) 
1 (REF) 
1.12(0.80-1.57) 
0.89 (0.61-1.29) 
l(REF) 
1.16 (0.80-1.66) 
0.78 (0.56-1.10) 
1 (REF) 
1.02 (0.73-1.43) 
0.99 (0.68-1.44) 
1 (REF) 
0.81 (0.59-1.12) 
0.94 (0.63-1.39) 
Multivariate 
ORb 
l(REF) 
1.17 (0.72-1.89) 
1.22 (0.77-1.94) 
1.22 (0.76-1.94) 
1 (REF) 
1.15 (0.73-1.81) 
1.32(0.84-2.06) 
1.11 (0.71-1.74) 
l(REF) 
0.98 (0.63-1.51) 
1.22 (0.76-1.95) 
1.24 (0.79-1.95) 
1 (REF) 
1.17(0.81-1.68) 
0.83 (0.55-1.26) 
1 (REF) 
1.19(0.81-1.77) 
0.81 (0.56-1.17) 
1 (REF) 
1.09 (0.76-1.57) 
0.95 (0.63-1.43) 
l(REF) 
0.83 (0.59-1.18) 
0.96 (0.62-1.48) 
* Number-- do run alw,)y- add rip to 431 (cases) or 433 i 
sonic \ limbics; '' adjusted tor aire, itciider, and indication iv 
controls) because 
t* endoscopy. 
>f missing data on 
When the amount of meat was taken into account, total meat increased the risk of 
colorectal adenomas (age adjusted OR per 100 g of meat per day 1.5, 95% CI 1.0-2.2, 
multivariate OR 1.4, 95% CI 0.9-2.1). The amount of gravy, as estimated from 
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photographs in the food frequency questionnaire, was positively - but not statistically 
significantly - associated with colorectal adenomas; the age adjusted OR per 100 g of 
gravy was 2.4 (95% CI, 0.94-6.4), and the multivariate OR 2.8 (95% CI, 0.96-7.9). If 
gravy not made from pan residues was excluded, the association weakened (multivariate 
OR 2.0, 95% CI 0.8-4.8). None of the meat preparation variables was associated with 
increased risk of adenomas (Table 4.3). The color of the meat surface as estimated from 
the photographs was not associated with adenomas (Table 4.3). None of the adenoma 
characteristics (i.e., histological type, size, location or number) was specifically associated 
with meat consumption and preparation (data not shown). Exclusion of recurrent cases 
yielded similar results as presented in Table 4.3 (data not shown). 
Tab le 4.4. Genetic polymorphisms of NATL NAT2, SULT1AL GSTM1, and CS7T7 
and risk of colorectal adenomas ". 
NATlh 
Slow (at least one *i J 
Normal' (no *10 or * 
Fast (at least one *10, 
NAT2 
allele) 
if allele) 
no *ff allele) 
Slow (no *4 or *12 alleles) 
Intermediate (one *4 or *12 allele) 
Fast (*4/*4, *12/*12 or *4/*12) 
SULT1A1 
Slow (*2/*2) 
Intermediate (*i/*2) 
Fast (*i/*f) 
GSTM1 
Present 
Null 
GSTT1 
Present 
Null 
Cases 
N (%) 
11 (2.6) 
248 (58.1) 
168 (39.3) 
259 (60.7) 
144 (33.7) 
24 (5.6) 
40(11.5) 
159 (45.7) 
149 (42.8) 
198 (46.3) 
230 (53.7) 
367 (85.8) 
61 (14.3) 
Controls 
N (%) 
23 (5.3) 
259 (60.1) 
149 (34.6) 
253 (58.6) 
146 (33.8) 
33 (7.6) 
58 (15.6) 
148 (39.7) 
167 (44.8) 
207 (47.9) 
225 (52.1) 
365 (84.5) 
67 (15.5) 
OR (95% CI) 
l(REF) 
2.00 (0.96-4.19) 
2.36(1.11-5.00) 
l(REF) 
0.96(0.72-1.29) 
0.71 (0.41-1.24) 
1 (REF) 
1.56 (0.98-2.47) 
1.29 (0.82-2.05) 
1 (REF) 
1.07 (0.82-1.40) 
1 (REF) 
0.91 (0.62-1.32) 
" Numbers do not always add up to 431 (cases) or 433 (controls) because of missing data on 
some polymorphisms; l' some older studies suggest that the NA1'1*10 allele is associated with 
increased NAT! activity ',*jl whereas no differences in activity were observed between *4f*4, 
*4/* 10 and *10;*1Q genotypes in a recent study 5". 
Table 4.4 gives the frequencies of imputed phenotypes of the genes under study, and of 
the associations of these genes with adenomatous polyps. As can be concluded from this 
Table, NAT1 fast and 'normal' acetylator (i.e., no *10 or *11 allele) genotypes were 
positively associated with colorectal adenoma risk. NAT2 imputed phenotypes were not 
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markedly associated with colorectal adenomas. Those with the SULTlAi*l/*2 
genotype had a borderline significantly increased risk of colorectal adenomas. GSTM1 
and GSTT1 polymorphisms were not associated with adenomas (Table 4.4). 
In Table 4.5, colorectal adenoma risk is shown for meat consumption and preparation in 
combination with imputed phenotypes of the genes that are considered most relevant 
for HCA detoxification and of which the phenotypic variants occur at sufficiently high 
frequencies, i.e., NAT2 and SULT1A1. Multivariate ORs are not shown but are similar 
to the age-adjusted ORs. N o specific combination clearly increased risk of adenomatous 
polyps. Interestingly, slow instead of fast NAT2 acetylators had an increased risk of 
adenomas when consuming meat and gravy relatively often. Similarly, there was a 
suggestion for a positive association of the combination of NAT2 slow acetylation and 
preference for heavily browned meat with colorectal adenomas, whereas fast acetylation 
appeared to decrease risk. Though subjects with intermediate/fast SULT1A1 imputed 
phenotypes had a slightly higher risk of colorectal adenomas when consuming meat or 
gravy relatively frequently, the SULT1A1 polymorphism did not modify the associations 
significantly (Table 4.5). Results for NAT1 are not shown in Table 4.5 because of low 
counts in the subcategories, as stated above. Although the ORs for combinations of high 
meat and gravy consumption with NATi fast acetylation were highest, there was no 
indication for an interaction between these factors (data not shown). There were no 
differences in risk of colorectal adenomas between combinations of GSTM1 variants 
and meat or gravy consumption (data not shown). For those with the GSTT1 null 
genotype, gravy consumption was not a risk factor, whereas those with other GSTT1 
genotypes had a borderline significantly increased risk of adenomas (OR 1.3, 95% CI 
0.9-1.7). 
Discussion 
We found no strong indications for meat consumption to increase risk of colorectal 
adenomas. Also, risk of adenomas was not associated with specific meat preparation 
methods, including the preferred color of the meat surface. Only the NAT2 slow 
phenotype slightly increased risk of adenomas in combination with high meat 
consumption. Polymorphisms of other genes (NATI, SULT1A1, GSTM1, and GSTT1) 
did not markedly influence the associations of meat consumption and preparation with 
adenomas. 
Participants in our case-control study underwent endoscopy because of bowel 
complaints (e.g. rectal bleeding, abdominal pain, defecation irregularities), or for 
screening because of previous adenomas or family history of colorectal cancer. This 
implies that we should be prudent in extrapolation of our results to the general 
population. However, our population was comparable with respect to risk factors such 
as meat consumption to a sample we randomly selected of the general population 
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(unpublished data). We do not expect selection bias to have occurred because cases and 
controls were selected using identical procedures and there were no differences between 
cases and controls with respect to energy intake and intake of macronutrients. 
Information bias is not likely to have occurred although most of the retrospectively 
recruited participants were aware of their case-control status at the time of completion 
of the questionnaires. As dietary advice, if provided, was to increase vegetable and/or 
fiber consumption only, our study population was probably not aware that meat 
consumption might be a risk factor for colorectal adenomas. Allele frequencies of the 
studied polymorphisms were similar to those reported from other studies 1416J1. 
Meat consumption as assessed by the meat consumption and preparation questionnaire 
correlated well with meat consumption as assessed by a semi-quantitative food 
frequency questionnaire validated for intake of energy, macro- and micronutrients, and 
all important food groups, including meat27,32. Correlation coefficients for the estimated 
frequencies of meat consumption ranged from 0.69 for beef to 0.88 for gravy. Portion 
sizes of the meats consumed were also inquired but were considered to be less precise 
than the frequencies. Portion sizes as calculated from the meat consumption and 
preparation questionnaire correlated moderately with those estimated from the food 
frequency questionnaire by photographs (correlation coefficients ranged from 0.58 for 
white meat to 0.70 for gravy) 27. The questions on the preparation of meat referred to 
Dutch cooking methods determining the temperature at the meat surface, which is an 
important determinant of HCA concentration 33. Our questionnaire included photos 
from an extensive Swedish questionnaire used to study the association between HCA 
intake and risk of several cancers 20. Information on a limited number of meat dishes, 
comparable to the number and type of dishes in our Dutch questionnaire, estimated 
potential HCA exposure almost equally well as this extensive Swedish questionnaire, 
introducing only a very limited amount of misclassification 34. 
Although the results of our case-control study are not in accordance with those of some 
studies 17,3538) they correspond to those of others 19,39''w; and more importantly, to the 
observations in our meat preparation study. In the latter study, we found no associations 
of meat preparation methods (except use of a lid) and preferred color of the meat surface 
with HCA concentrations. There are several possible explanations for our results, 
concerning homogeneity of the study population, the method used for HCA 
determination, and the relation between the inquired meat preparation methods and 
HCA concentrations, as we explain below. 
First, the populations we studied might have been too homogeneous with respect to 
meat consumption and preparation methods to observe effects. Populations studied by 
Lang, Sinha, and Probst-Hensch 17 included subjects from multiple ethnic groups and 
were therefore probably more heterogeneous 37,38. Lack of variation in our meat 
preparation study could have been the result of the meat type used. We chose beef 
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patties because these are usually prepared at high temperature and were thus expected to 
contain at least low HCA concentrations. Moreover, beef patties are acceptable by most 
social, religious, and ethnic groups, ages and sexes, (i.e., no pork or white meat), their 
preparation is not time-consuming, and they are available at relatively low costs. 
Second, the detection limits in our meat preparation study were relatively high and this 
could explain why HCAs were detected in only 35% of samples. These high limits were 
caused by background signals for which we adjusted using weighted regression 25. 
Background signals were possibly high because whole meat samples including gravy 
were analyzed instead of meat crusts only. Recovery rates were comparable to those 
found in other studies 43. High detection limits could be an explanation why PhIP was 
detected in only one sample, but it is more probable that PhIP levels were indeed low 
and more comparable to those found in Swedish studies 5, than to those reported from 
US studies 22-42'44'45. Possibly, Dutch cooking methods are more similar to those applied 
by Swedish than by US populations. This is illustrated by results from a pilot study, in 
which Dutch volunteers judged the photographs developed by Sinha and colleagues (see 
e.g. 21'22) too dark whereas those used in Sweden 20 were considered to be applicable to 
the Dutch situation. 
Third, it is possible that the meat preparation methods we inquired are not the main 
determinants of HCA concentrations, although the color of the meat surface was found 
to be an important determinant of HCA concentrations in laboratory studies 521'22. 
Laboratory conditions do not necessarily reflect domestic cooking conditions and this 
could explain our results as well as those from the study by Augustsson and colleagues 39. 
According to Dutch cooking methods, meat is pan-fried, starting with a short frying 
phase to sear the meat, after which water is added (depending on the meat type) and the 
meat is then simmered until done. Meat prepared in this way can be well done without 
having a darkly browned surface and frying time might be an important determinant of 
HCA formation 41,44. However, we had no information on frying time and it will be 
difficult to estimate this in large populations. 
Even though preparation methods did not reflect HCA exposure in our study 
population, the consumption of meat might be an important determinant of colorectal 
adenoma risk, especially when genetic polymorphisms are taken into account. This was 
indeed found in several 17184647j but not in all studies 19. Unexpectedly, we found that 
slow NAT2 acetylators consuming meat and gravy relatively frequently were at highest 
risk of colorectal adenomas. Fast acetylators are generally considered to be the risk group 
because NAT-catalyzed activation of HCAs seems to be favored over detoxification 48. 
However, the balance between these two may be determined by many factors. Our 
findings could, however, well be due to chance since we studied potential effects of 
gene-environment interactions that are now being regarded as having, at most, modest 
effects 49. 
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In conclusion, HCA exposure occurs in the general Dutch population but is not clearly 
related to inquired meat preparation methods or preferred meat color. This might 
explain why we found no association between meat preparation methods and colorectal 
adenomas and no obvious influence of genetic susceptibility to HCAs. Possibly, other 
factors or other substances in meat may explain the observed associations in other 
studies. However, as HCAs are potent carcinogens, they should still be considered as 
potential risk factors for colorectal neoplasm. A detailed study of the determinants of 
HCA formation in different countries and a large study in a heterogeneous population 
may help to elucidate the importance of HCA exposure with respect to colorectal 
neoplasm in Europe. 
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CHAPTER 5 
A b s t r a c t 
Cigarette smoke contains polycyclic hydrocarbons and arylamines that may both be activated by 
sulfotransferase, encoded by SULT1A1. A genetic polymorphism leads to an Arg213His 
substitution thereby decreasing enzyme activity and stability, and might thus modify the 
association between smoking and colorectal adenomas. We investigated this in a Dutch case-
control study. Additionally, we evaluated potential roles of epoxide hydrolase (EPHX), N-
acetyltransferases (NAT1 and NAT2), and glutathione S-transferases (GSTM1 and GSTT1). 
The data analysis included 431 adenoma cases and 432 polyp-free controls (54 % women, mean 
age 54.6 y) enrolled at endoscopy in eight Dutch hospitals between 1997 and 2000. All 
participants provided data on smoking habits and blood for DNA isolation. Genotyping was 
performed using appropriate PCR(-RFLP) procedures. Multivariate models included age, sex, 
endoscopy indication, consumption of snacks and alcohol, and, if appropriate, daily smoking 
dose or smoking duration. Smoking increased colorectal adenoma risk, most importantly with 
smoking duration. Smoking for more than 25 years more than doubled adenoma risk (OR 2.4, 
95% CI 1.4-4.1) compared to never smokers. Combinations of SULT1A1 fast sulfation (*1/*1) 
and of NAT2 slow acetylation with smoking, resulted in a four times higher risk of adenomas 
compared to never smokers with other inherited gene variants. Although variation over variants 
of EPHX was observed, there was no clear pattern. The other polymorphisms studied did not 
influence the association of smoking with adenomas. We conclude that smoking increases risk of 
colorectal adenomas and that SULT1A1 and NAT2 may modify in this association. 
Introduction 
Cigarette smoking is consistently found to be associated with the occurrence of 
colorectal adenomas ', and long-term smoking might increase colorectal cancer risk (as 
recently reviewed by Giovannucci 2). Tobacco smoke contains many potential 
carcinogens, among which polycyclic aromatic hydrocarbons (PAHs) and arylamines 3. 
The metabolism of these substances is complex and involves activation and 
detoxification steps, catalyzed by many polymorphic enzymes, such as glutathione S-
transferases Mu and Theta (encoded by GSTM1 and GSTT1), N-acetyltransferases 
(encoded by NAT1 and NAT2), microsomal epoxide hydrolase (encoded by EPHX), 
and thermo-stable phenol sulfotransferases (encoded by SULT1A1). 
Although thermo-stable phenol sulfotransferase is a key-enzyme in the metabolism of 
arylamines and some PAHs 4"6, to our knowledge, genetic variants of SULT1A1 have not 
yet been studied in combination with smoking and colorectal adenomas. The gene 
contains several polymorphic sites, of which a G to A transition leading to an Arg213His 
substitution is highly prevalent7. The His variant (*2 allele, occurring at a frequency of 
0.3 7) was associated with decreased activity and thermal stability of the enzyme in 
platelets 8'9 as well as decreased bioactivation of various promutagens by cDNA-
expressed enzymes 10. From a study conducted on breast cancer, well-done meat 
consumption (which may contain heterocyclic aromatic amines and PAHs) was a risk 
factor only in women with the SULT1A1*1/*1 and *l/*2 genotypes n . Considering the 
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role of SULT1A1 in the activation of procarcinogens of cigarette smoke and similarities 
between determinants of breast and colorectal cancer, the SULT1A1 polymorphism 
might importantly modify the association between smoking and colorectal adenomas. 
EPHX polymorphisms were reported to be possibly important in the association of 
smoking with colorectal neoplasm. In line with previous research 12, Ulrich and 
colleagues found that subjects with slow or unstable EPHX variants were at higher risk 
of colorectal adenomas when exposed to cigarette smoke 13, whereas on the opposite, fast 
epoxide hydrolase increased the risk of smoking-associated adenomas in another study14. 
Several studies conducted on the role of GSTs and NATs in the association between 
smoking and colorectal neoplasm did not reveal consistent associations (reviewed by 
Cotton and co-workers 15 and Brockton and colleagues 16). 
Because GSTs may be involved in the inactivation of some reactive intermediates 
formed from arylamines and PAHs, GSTM1 or GSTT1 null genotypes might lead to 
higher risk of colorectal adenomas. The other enzymes play dual (activating and 
deactivating) roles in the metabolism of arylamines and PAHs 61718. We investigated the 
role of SULT1A1 and EPHX genotypes, as well as potential roles of NAT1, NAT2, 
GSTM1 and GSTT1, in smoking associated-colorectal adenomas in a Dutch case-
control study. 
M a t e r i a l s a n d M e t h o d s 
P O P U L A T I O N 
Cases and controls were recruited among subjects undergoing endoscopy at the 
outpatient clinics of eight hospitals in the Netherlands between June 1997 and June 
2000. Medical Ethical committees of all participating hospitals and of Wageningen 
University approved the study protocol. 
Potential participants were recruited at time of endoscopy by trained staff (47%), or were 
selected at three-month intervals - using endoscopy reports of all patients who had 
undergone endoscopy in the preceding months - and invited by mail (53%). Eligible 
subjects were Dutch speaking, of European origin, aged 18 to 75 years at time of 
endoscopy, had no hereditary colorectal cancer syndromes, chronic inflammatory bowel 
disease, or history of colorectal cancer or (partial) bowel resection. Overall response was 
54%. After obtaining informed consent, blood samples were drawn for DNA analysis 
and questionnaires were administered. Cases had at least one histologically confirmed 
colorectal adenomatous polyp ever in their life. Controls had no history of any type of 
polyps. Complete visualization of the colon (i.e., full colonoscopy or sigmoidoscopy 
combined with X-ray) was achieved for 78% of controls and 89% of cases. Information 
on history, size, localization, histology, and number of polyps was collected through 
medical files. 
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We included information from 64 participants to a preceding and similar study that was 
conducted between December 1995 and June 1997 in one of the eight hospitals 19, 
resulting in a study population of 925 subjects. 
Q U E S T I O N N A I R E S 
Participants were requested to fill out self-administered questionnaires according to 
habits in the year previous to their last endoscopy or complaints. 
Smoking habits were assessed inquiring current smoking status, smoking materials, 
amounts smoked per day (separately for cigarettes, cigars and pipe), total number of 
years smoked, and, if applicable, the age at which the participant stopped smoking. The 
questionnaire also included questions on potential confounders such as physical activity 
(assessed according to Baecke and colleagues 20), frequency of constipation in the last 
three years, the number of first- and second-degree family members with colorectal 
cancer, and the highest completed level of education. 
To assess dietary habits, we used a standardized semi-quantitative food frequency 
questionnaire, described by Ocke and co-workers 21. This questionnaire was validated by 
comparison with dietary intake assessed by twelve 24-h recalls. For the nutrients 
considered in the present study, Pearson coefficients of correlation between these recalls 
and the questionnaire ranged from 0.85 for alcohol to 0.61 for fat and dietary fiber 
among men and from 0.87 (alcohol) to 0.63 (fat) among women. Of the foods 
considered as potential confounders, relative validity was lowest for vegetables among 
men and women (Spearman rank correlation coefficients 0.38 and 0.31, respectively) 
and highest for fruit among men (r=0.68) and for meat among women (r=0.70). 
LABORATORY ANALYSES 
DNA was isolated from 200 (J,l frozen whole blood using the QIAamp blood kit (Qiagen 
Inc., U.S.A.), diluted to a concentration of approximately 20 ng/|i.l, and stored at 4°C 
until analyzed. 
SULT1A1. The SULT1A1 polymorphism (*f and *2 alleles) was determined by a 
PCR-RFLP method described in detail by Engelke and colleagues22. The polymorphism 
was not determined in the 64 samples from the preceding study on somatic mutations 
(see under Population). 
EPHX. EPHX exon 3 and exon 4 allelic variants (U3Y and M3H, and 139H and 139R 
alleles) were determined by RFLP analysis as described elsewhere a. Reproducibility was 
tested by genotype determination of approximately 10% of the samples twice. The 
reproducibility of exon 3 and 4 genotyping was respectively 98% and 100%. 
NAT1 and NAT2. Allelic variants of NAT1 and NAT2 were determined by an allele 
specific oligo hybridization assay developed in our laboratory 24 identifying NAT1 alleles 
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*4, *3, *10 and *11, and NAT2 alleles *4, *5, *6, *7, *12. Validity and reproducibility of 
the method were extensively tested and proved to be 100%. 
GSTM1 and GSTT1. We determined the genotypes of GSTM1 and GSTT1 
simultaneously using a multiplex PCR procedure adapted from Arand and co-
workers 25. To control PCR performance, primers derived from P-globin 26 were 
included. To test reproducibility, approximately 10% of the samples were genotyped in 
duplicate; no differences were observed. 
PCR was performed with internal negative controls. Laboratory personnel was blinded 
to case-control status. 
D A T A ANALYSIS 
We excluded 38 subjects with insufficient dietary data, ten subjects of whom cigarette 
smoking status was unknown, and 14 subjects of whom no information about any of the 
genotypes under study was available, resulting in a final study population of 863 
subjects: 431 cases and 432 controls. 
Since there were few cigar/pipe smokers in our study population and smoking of cigars 
and/or pipe was not a risk factor for colorectal adenomas, we only considered cigarette 
smoking habits, i.e., smoking status (never, former, and current smoking), total smoking 
duration (excluding intermediate periods without smoking), daily number of cigarettes 
smoked, and, if applicable, the time since giving up smoking. Categorical variables had a 
separate category for missing information. Non-categorical exposure variables were 
categorized so that each category contained approximately equal numbers of controls. 
The lowest exposure categories served as the reference. 
GSTM1 and GSTT1 homozygous deletion were considered as high-risk categories. 
NAT1 genotypes were categorized as slow (at least one NATl*il allele) and fast (all 
others) 27. NAT2 imputed phenotypes were fast (NAT2M/M, NAT2*4/*12, and 
NAT2*12/*12), intermediate (one NAT2M or NAT2+12 allele) and slow (all others). 
Phenotypes of EPHX were imputed for both exons separately and for the combination 
of exon 3 and exon 4 113H and 139H, and their combination were considered to result 
in low enzyme activity. To facilitate comparison of our results with those of other 
studies, we compared EPHX phenotypes as we previously imputed n with the 
classification according to Cortessis and colleagues 14 and the classification used by 
Ulrich and colleagues '3. SULT1A1 was categorized as follows: *2/*2 as slow, *l/*2 as 
intermediate, and *1/*1 as fast sulfation. 
Univariate analyses were conducted to test for potential confounders (i.e., gender, age, 
body mass index, physical activity, education level, indication of endoscopy, smoking of 
cigars or pipe (y/n), history of constipation (y/n), family history of colorectal cancer 
(y/n), consumption of vegetables, fruit, meat, alcohol, and snacks, and the intake of 
energy, fat, and fiber). These showed that gender, age, body mass index, indication of 
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endoscopy, dietary changes, and the consumption of total meat, alcohol and snacks were 
associated both with colorectal adenomas and with cigarette smoking. The multivariate 
models included the variables age, sex, and indication of endoscopy (three levels: 
gastrointestinal complaints, screening, or unknown/other). Additionally, we added 
consumption of snacks and alcohol (both in g/d) to the multivariate model, because 
these factors were found to influence univariate ORs for the association between 
smoking (both status and number of cigarettes per day) and colorectal cancer most 
importantly after age (>5% change in OR). ORs for smoking duration were additionally 
adjusted for the number of cigarette smoked per day, and vice versa. 
To test whether the combinations of imputed phenotypes and smoking deviated from 
multiplicativity, we calculated p-values for interaction by inclusion of a term for 
imputed phenotype (as high-risk=2, intermediate-risk=l, and low-risk imputed 
phenotype=0) multiplied by smoking duration as a continuous variable into our 
multivariate models. To test whether combinations of imputed phenotypes and smoking 
were more or less than additive, we applied bootstrapping to calculate a 95% confidence 
interval with the calculated RERI (excess risk due to interaction) 28 according to the 
following formula: 
RFRT = RR — RR 
^^-^ ('high-risk phenotype' and smoking) (high-risk phenotype alone, no smoking) 
\smoking, no 'high-risk phenotype') • 
A statistically significant confidence interval should not include the value 0. 
To exclude the influence of previous adenomas (i.e., more than one year before the 
index endoscopy, n=129) among cases, and of undetected proximal polyps among 
controls (n=97), we repeated our analyses without these groups. 
As smoking might be a risk factor in different stages of tumorigenesis 29~31, we studied 
primary vs. recurrent adenomas, adenomas smaller than 1 cm vs. those > 1 cm), proximal 
vs. distal adenomas and multiple vs. single adenomas. These subgroup analyses, except 
the analyses on recurrent adenomas, were conducted for primary adenomas only. 
All analyses were conducted using Statistical Analysis Software (SAS version 6.12, SAS 
Institute, Cary, NC) . 
Results 
In Table 5.1, the characteristics of the study population are given by cigarette smoking 
status. Smokers had a higher probability to have ever been diagnosed with colorectal 
adenomas, had a higher intake of energy, fat, meat, and coffee, but consumed less fruit 
than never smokers. The group of past smokers was older than the never and current 
smokers, and counted more men and more alcohol drinkers than the other two groups. 
Current smokers were younger and less well educated, had a lower intake of fiber, 
vegetables, and fruit, and consumed more coffee than past and never smokers (Table 
5.1). Strikingly, GST genotypes seemed to be associated with smoking status. The 
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frequency of the GSTM1 null genotype was highest in the group of current smokers, 
whereas the GSTT1 null genotype frequency was lowest in this group. Fast sulfation 
was present at highest frequency among never smokers (Table 5.1). 
T a b l e 5.1. Characteristics of the study populat ion by cigarette .-.nicking slams 
Characteristic 
Age, years, mean ± SD 
Men, n (%) 
Body mass index, kg/m2, mean ± SD 
Cases, n (%) 
Bowel complaints as indication, n (%) 
Family history of colorectal cancer, n (%) 
Low educational level, n (%)A 
Low physical activity, n (%)c 
Ever smoked pipe or cigars, n (%) 
Cigarette smoking duration, years, mean±SD 
Cigarettes per day, mean ± SD 
Alcohol drinkers, n (%) 
Energy intake, kj/day, mean ± SD 
Fiber, g/day, mean ± SD 
Fat, g/day, mean ± SD 
Vegetables, g/day, mean ± SD 
Fruit, pieces/day, mean ± SD 
Meat, g/day, mean ± SD 
Coffee, cups/day, mean ± SD 
Snacks, g/day, mean ± SD 
SULT1A1 fast, n (%)f 
EPHX exon 3 slow, n (%)f 
EPHX exon 4 slow, n (%)f 
M4Tifast,n(%) f 
NAT2 fast, n (%)f 
GSTM1 null, n (%) 
GSTT1 null, n (%) 
a
 Sicr int ' i r i n f l v rhl t '^r 'T ' i r h e m ; v f i n n \<r 'ArtA n o v c r 
Ci 
Never 
smoker 
N=387 
55.1 ± 13.5 
151 (39.0) 
25.9 ± 4.2 
166 (42.9) 
245 (63.3) 
81 (20.9) 
133 (34.4) 
128 (33.1) 
25 (6.5) 
0 ± 0 
0 ± 0 
302 (78.0) 
8406 ± 2344 
24.0 ± 6.6 
78.3 ± 27.3 
121.3 ± 43.4 
1.6 ± 1.1 
97.5 ± 49.0 
3.8 ± 2.3 
30.6 ± 27.3 
163 (49.1) 
48 (13.3) 
234 (65.2) 
368 (95.8) 
164 (42.6) 
203 (52.6) 
70(18.1) 
smof,-f-?x- -;Ht-ni 
garette smoking 
Past 
smoker 
N=274 
57.5 ± 11.5' 
167(61.0)" 
26.2 ± 3.6 
161 (58.9)" 
172 (62.8) 
57 (20.8) 
74(27.0)* 
103 (37.6) 
27 (9.9) 
23.6 ± 12.2* 
16.7 ± 11.4a 
243 (88.7)' 
8951 ±2407a 
24.1 ± 6.3 
84.7 ±27.5" 
121.2 ± 44.4 
1.4 ± 1.0" 
109.6 ± 53.4" 
4.5 ± 2.6a 
33.8 ± 29.6 
85(38.8)" 
34 (13.8) 
167 (67.3) 
265 (97.4) 
112(41.2) 
132 (48.5) 
41 (15.1) 
sr.mfiv flith-ronf 
status 
Current 
smoker 
N=202 
49.7 ± 13.5bc 
78 (38.6)c 
24.8 ± 4.0bc 
104 (51.5)b 
139 (68.8) 
45 (22.3) 
81 (40.1)bc 
61 (30.2) 
7 (3.5) c 
29.5 ± 12.4bc 
15.6 ± 8.3b 
169 (83.7) 
9106 ± 2932b 
22.7 ± 7.1 b'c 
88.2 ± 34.5b 
111.6 ± 45.0bc 
1.1 ± 1.0bc 
109.9 ±57.4b 
5.1 ±3.2b 'c 
36.9 ± 30.3 b 
70 (41.2) 
19(10.1) 
111 (58.7) 
190 (94.5) 
71 (35.3) 
119 (59.2)c 
19 (9.5)b 
hffvu,'\'-ri r n r r i M i f 
and never smokers; '' significantly 
or lower vocational framing only: 
Sl'L'l'IAl sulfation is defined , 
piicnotvpes are / / / / lor econ 3 and 
*11 alleles, fast .V.-17'_' acetylation 
and *I2/*J2. 
different between currt-nt and past smokers; d primary school 
'' scored according to Baecke 2" and divided in tertiles ' fast 
is presence of two */ alleles, die UI'IIX sk>\\ imputed 
lill for exon 4, fist NA'I'I acetylation is defined as absenct- of' 
includes the following combination oi alleles: *4/*4. *4/*!2, 
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Characteristic 
Cigarette smoking status 
Never 
Former 
Current 
Duration of smoking (years) 
0 
1-15 
16-25 
>25 
Cigarettes per dayb 
0 
1-9 
10-19 
>20 
Time since quitting (years)c 
Never smoked 
>18 
8.1-18 
1-8 
< l d 
adcm 
N cases/controls 
166/221 
161/113 
104/98 
166/221 
49/73 
63/55 
153/83 
166/221 
58/51 
91/77 
109/72 
166/221 
52/39 
38/35 
57/33 
113/104 
niws 
OR (95% CI)' 
1 (REF) 
1.62(1.12-2.33) 
2.10(1.38-3.18) 
1 (REF) 
1.28 (0.70-2.33) 
2.19(1.21-3.98) 
2.42(1.43-4.11) 
l(REF) 
1.09 (0.56-2.13) 
0.89 (0.44-1.79) 
1.17 (0.59-2.33) 
l(REF) 
1.23 (0.73-2.07) 
1.26 (0.70-2.27) 
2.06(1.18-3.59) 
2.13(1.42-3.21) 
p-trend 
0.0002 
0.0006 
0.78 
0.03 
Table 5.2 shows the associations of cigarette smoking characteristics with risk of 
adenomas. Current smokers were at highest risk of colorectal adenomas, and although 
lower, risk of adenomas was still significantly higher among former than among never 
smokers. The risk of adenomas increased with cigarette smoking duration, also after 
adjustment for smoking dose. However, after adjustment of the number of cigarettes 
smoked per day by smoking duration, the number of cigarettes smoked per day no 
longer increased colorectal adenoma risk (Table 5.2). After giving up smoking, the risk 
of adenomas decreased and smoking was not associated with risk of adenomas anymore 
eight years after quitting. Adenoma risk was not different for different types of cigarettes 
smoked (i.e., filter, non-filter, or both types, data not shown). Although it was a risk 
factor for both sexes, smoking was a stronger risk factor for adenomas among men than 
it was among women (risk estimates for current vs. never smoking, OR 3.1, 95% CI 1.6-
3.7, and OR 1.6, 95% CI 1.0-2.6, respectively). This was probably due to the longer 
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duration of cigarette smoking (mean ± SD, 18.6 ± 16.7) among men than among 
women (mean ± SD, 11.8 ± 14.7). The associations shown in Table 5.2 did not differ 
between former and current smokers. These associations did not change after restriction 
of the study population to cases with first adenoma diagnosed at the endoscopy at time 
of invitation and to controls whose colon was completely visualized, or to subjects 
undergoing an endoscopy for other reasons than gastrointestinal complaints or 
defecation problems. 
The association of smoking duration with specific colorectal adenoma characteristics is 
shown in Table 5.3. We found that cigarette smoking was a stronger risk factor for small 
adenomas (equal to or smaller than 1 cm) compared to larger adenomas, and for 
(tubulo-)villous adenomas compared to adenomas without villous characteristics. 
I i H r •> i 
Adenoma characteristic Duration of smoking (years) 
0 1-25 > 25 
Size of largest adenoma 
< 1 cm 
> 1cm 
Most 'severe' histology 
tubular 
(tubulo-)villous 
Number of adenomas 
single 
multiple 
Location of adenomas 
all adenomas distal 
at least one proximal 
N controls 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
O R (95% CI) 
N cases 
221 
1 (REF) 
43 
1 (REF) 
68 
1 (REF) 
61 
l (REF) 
52 
1 (REF) 
69 
l ( R E F ) 
44 
1 (REF) 
85 
l (REF) 
28 
128 
1.99(1.04-3.82) 
44 
1.14(0.58-2.23) 
33 
1.58 (0.86-2.91) 
49 
1.44 (0.70-2.87) 
29 
1.82 (1.02-3.24) 
53 
1.05 (0.47-2.34) 
25 
1.73 (1.00-3.00) 
68 
0.68 (0.23-1.96) 
10 
83 
2.48 (1.28-4.81) 
45 
2.10 (1.09-4.07) 
60 
2.40 (1.29-4.47) 
64 
2.00 (1.00-3.98) 
45 
2.04(1.11-3.75) 
55 
2.57(1.23-5.34) 
52 
2.21 (1.25-3.91) 
81 
2.37 (0.98-5.78) 
28 
.lucitonu cnar.'tcten 
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1 a b l e i 
duiMiioi 
Imputed ph( 
SULT1A1 
EPHX 
exon3 
EPHX 
exon 4 
EPHX 
exon 3 & 
exon 4 
GSTM1 
GSTT1 
NAT2 
" Risk cs 
alcohol { 
.4, Risk." or colorectal adenomas in association \ 
and inherited 
jnotype 
Slow 
Intermediate 
Fast 
Fast 
Intermediate 
Slow 
Fast 
Intermediate 
Slow 
Fast 
Slow 
Present 
Null 
Present 
Null 
Slow 
Intermediate 
Fast 
ciniaics arc jdji. 
in |//d), and ck> 
genetic susceptibility. 
O R (95% CI) 
N ca/co b 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
OR (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
O R (95% CI) 
N ca/co 
sled for age, sex 
ircctcs (n/'day). h 
viih combinat ions 
Duration of smoking (years) 
0 
1 (REF) 
13/27 
1.94 (0.80-4.72) 
59/70 
1.64 (0.69-3.90) 
66/97 
l ( R E F ) 
72/101 
0.93 (0.55-1.59) 
58/81 
0.89 (0.43-1.86) 
22/26 
1 (REF) 
8/16 
0.88 (0.31-2.56) 
38/63 
1.34 (0.50-3.62) 
105/129 
l ( R E F ) 
136/196 
1.51 (0.61-3.69) 
15/12 
1 (REF) 
81/102 
1.18 (0.74-1.88) 
85/118 
l ( R E F ) 
139/177 
0.73 (0.39-1.33) 
27/43 
l ( R E F ) 
89/132 
1.67 (1.01-2.76) 
66/67 
0.58 (0.24-1.43) 
10/21 
indication of entk 
N ca/co. number o 
1 -25 
1.51 (0.42-5.47) 
13/20 
3.07 (1.12-8.43) 
42/47 
4.66(1.66-13.11) 
32/28 
1.68 (0.84-3.34) 
42/57 
2.35 (1.15-4.81) 
44/45 
1.27 (0.88-8.52) 
11/15 
2.93 (0.48-17.80) 
5/4 
2.74 (0.88-8.52) 
34/39 
2.17 (0.73-6.44) 
58/75 
2.11 (1.22-3.65) 
88/108 
1.66 (0.50-5.45) 
9/9 
2.01 (1.05-3.84) 
53/62 
1.88 (1.00-3.84) 
56/66 
1.63 (0.95-2.78) 
93/111 
2.02 (0.80-5.09) 
16/17 
1.97 (1.08-3.60) 
61/72 
1.87 (0.93-3.76) 
39/48 
5.34 (1.45-19.65) 
9/8 
scopy, consumption 
t cases over mmibei 
of smoking 
> 2 5 
3.47 (0.97-12.40) 
13/9 
3.94(1.41-11.04) 
60/30 
4.32(1.59-11.77) 
51/34 
3.08(1.59-5.97) 
76/39 
1.39 (0.66-2.95) 
45/35 
3.63 (1.22-10.83) 
20/7 
1.75 (0.33-9.27) 
5/5 
2.06 (0.65-6.56) 
42/25 
3.85(1.29-11.50) 
94/51 
2.51 (1.44-4.36) 
128/78 
6.93 (1.64-29.34) 
13/3 
2.45 (1.24-4.81) 
66/41 
2.89 (1.51-5.50) 
87/42 
2.30 (1.33-3.98) 
135/74 
2.38 (0.86-6.60) 
18/9 
3.48 (1.88-6.41) 
108/49 
1.85 (0.88-3.90) 
40/29 
2.57 (0.49-13.44) 
5/5 
of snacks and 
of controls in 
spun tic ea txgory, 
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Genetic variants of EPHX, GSTM1, GSTT1, and NAT2 were not associated with 
colorectal adenoma risk per se (data not shown), though the presence of slow imputed 
variants at both exons of the EPHX gene was more prevalent among adenoma cases (OR 
1.67 95% CI 0.98-2.85). Our data indicate that the SULT1A1*1 allele, coding for fast 
variants of the SULT enzyme, might predispose to adenomas (OR 1.41, 95% CI 0.91-
2.18, homozygotes and heterozygotes included), whereas the NATi*il allele, leading to 
slow acetylation, might protect against these (OR 0.47, 95% CI 0.23-0.97). The 
SULT1A1 and EPHX polymorphisms were in Hardy-Weinberg equilibrium. 
Table 5.4 shows the effect of the studied genetic variants on the association between 
smoking and colorectal adenomas. The frequency of slow variants of NAT1 (>1 *11 
allele present) was too low to enable calculation of risk estimates and NAT1 is therefore 
not included in the table. Of the studied genetic polymorphisms, variants ofSULTlAl, 
EPHX, and NAT2 seemed to increase the smoking-associated risk of colorectal 
adenomas, though not always via a clear pattern (see Figure 5.1). P-values for interaction 
were 0.03, 0.04 and <0.0001, respectively. This indicates that the combination of 
assumed high-risk variants with long smoking duration were lower than expected under 
the assumption of multiplicativity. Application of bootstrapping to calculate the OR and 
95% CI for interaction under the assumption of additivity, as proposed by Assman et 
al. 28, revealed borderline significant ORs of 0.22 (95% CI -0.06-2.77) for fast SULT1A1 
in combination with smoking for more than 25 years, and of-0.35 (95% CI -1.83-0.14), 
for the combination of fast NAT2 with long smoking duration. As can be concluded 
from Table 5.4 and Figure 5.1, presence of the SULT1A1*1 allele increased the risk of 
smoking-associated colorectal adenomas. NAT2 slow acetylation seemed to increase risk 
with smoking duration, although we observed a high OR among fast acetylators with a 
smoking history of 1-25 years. This finding might in part be the result of small numbers 
of subjects with fast NAT2 genotypes (Table 5.4). Because of these low counts, we 
combined fast and intermediate NAT2 acetylators in Figure 5.1, which shows that risk 
of colorectal adenomas might be highest in slow acetylators. After combination of these 
two imputed phenotypes, the multivariately adjusted p-value for interaction remained 
highly statistically significant (p=0.003). For the variants of the EPHX polymorphic site 
in exon 3, the pattern was unclear. Highest risks were observed for those who had 
smoked for more than 25 years and had either the fast or slow variant, and for those who 
had smoked 1-25 years and had inherited the intermediate variant. The presence of slow 
variants at both exons seemed not to modify the association of smoking with adenomas. 
Use of the EPHX classifications described by Cortessis et al. M and Ulrich et al. 13 led to 
similar conclusions. The other genetic polymorphisms, i.e., GSTM1 and GSTT1, 
seemed not to modify the association between smoking duration and colorectal 
adenomas. 
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Discussion 
We found that cigarette smoking increased the risk of colorectal adenomas and that 
duration of cigarette smoking was the main determinant. Giving up smoking reduced 
the risk after a period of eight years. Smoking characteristics were most strongly 
associated with risk of small and non-villous adenomas. Smoking was a stronger risk 
factor for colorectal adenomas in those with SULT1A1 fast sulfation and possibly, in 
those with slow NAT2 acetylation than for those with other inherited variants of these 
genes. 
The study population was enrolled among subjects undergoing endoscopy at the 
outpatient clinics of eight hospitals. Frequently occurring indications (not related to 
smoking status) were routine check-up (37%) and anal bleeding (28%) among cases and 
large bowel complaints (38%) and defecation problems (22%) among controls. This 
might implicate that our study population is not comparable to the general population. 
Indeed, the proportion of current smokers is higher in the general Dutch population of 
the same age (30.6%) than it was in our study population (23.4%), whereas the number 
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of cigarettes smoked per day was similar t . On the other hand, rates of ever smoking in a 
sample (n=1935) we randomly selected from the general population inhabiting the 
same regions as our study population, were in between rates observed for cases and 
controls (62%, unpublished data). Although the response rate was relatively low in this 
study, bias by smoking status-specific response 32 did probably not occur, as smoke rates 
among participants were similar to the rates among invited subjects who decided not to 
participate in our study (unpublished data). It is unlikely that selection of subjects has 
introduced bias as smoking status of invited subjects was unknown at the time of 
recruitment. Moreover, smoking was not related to indication of colonoscopy or 
sigmoidoscopy in our study. Not surprisingly, therefore, our results did not change after 
exclusion of those undergoing endoscopy for bowel complaints or defecation problems. 
We do not think that recall bias occurred. In general, smoking is not a well-known risk 
factor of colorectal adenomas and it is probably not advised to patients diagnosed with 
adenomas to give up smoking. 
Like almost all other studies 2930-33-44; our study gives evidence for an increased risk of 
colorectal adenomas among smokers, especially among those who smoked for a long 
period. Also in line with other studies, we found that the association with smoking was 
most pronounced for small (< 1cm) and non-villous adenomas 29-30,41. 
Strikingly, we observed associations between smoking status and GSTMi, GSTT1, and 
SULT1A1 genotype. To our knowledge, such associations, if reported 45'46, were not 
present in previous studies. Our results might be due to chance. Certain genetic 
polymorphisms, however, are known to predispose for risk behavior, as in the case of 
ADH2 genotype and alcohol abuse 47. 
Only a few studies have been published to date with respect to SULT1A1 and EPHX 
variants and colorectal adenomas. This implies that more research is needed to verify 
our finding that SULT1A1 fast sulfation and EPHX slow epoxide hydrolysis (i.e., 
HH/HH) variants may increase adenoma risk irrespective of exposure. Fast sulfation was 
observed to increase the risk of colorectal adenomas, in contrast to results from another 
study, in which low SULT1A1 (STA3) activity in platelets was associated with an 
elevated risk 48. 
To our knowledge, our study is the first study on smoking and colorectal neoplasm in 
which the potential role of SULT1A1 was considered. SULT1A1 allele frequencies were 
comparable to those reported previously 722-49. Our study indicates that SULT1A1 
polymorphism may modify the association between smoking and colorectal adenomas, 
implying that fast sulfation might predispose to smoking-associated adenomas. These 
findings are consistent with those of in vitro studies which indicate that SULT1A1 might 
activate procarcinogens from cigarette smoke 4"6. Moreover, results from a study 
+
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considering the role of SULT1A1 in the association between well-done meat intake and 
postmenopausal breast cancer point in the same direction u. 
Although large differences in risk of smoking-associated adenomas were observed over 
variants of EPHX, there was no clear pattern. Possibly, inappropriate classification due 
to limited knowledge about its functional significance, obscures the effect of EPHX. 
Hassett and colleagues reported a reduction of enzyme activity and/or stability for 
His 113 variants and an increase for Argl39 variants of EPHX 50. The EPHX HH/HH 
variant resulted in the lowest protein half-life, although it was not statistically 
significantly different from half-lives of other variants 51. Confusion about how to 
impute EPHX phenotypes from genetic variants has led to the use of different, partly 
overlapping, classifications. In a previous paper 23, we used a classification that we 
considered most clear and which was also used by Pastorelli and co-workers 52. To 
enable comparison of our results to those of others, we tested all three classifications. 
The results calculated with the classification we previously used 23 and that of Ulrich et 
at. 13 were more similar to each other than to the results produced with the classification 
used by Cortessis and colleagues 14. This was due to the greater similarity between the 
former two classifications than with the latter classification method. Cortessis and 
colleagues reported that predicted high EPHX stability (presence of three or four stable 
(fast) alleles) increased risk of adenomas in combination with current smoking 14. In 
contrast, Ulrich and co-workers reported that smoking increased risk of adenomas 
especially in combination with the EPHX HH/HH genotype, the EPHX exon 3 HH 
(slow) variant being responsible for this finding 13. 
Frequencies of the GSTM1 and GSTTi genotypes were in the same range as those 
reported from other (Western) European studies and were not associated with adenoma 
risk 15. There was no evidence for predisposition to smoking-associated adenomas 
related with genetic variants of GSTM1 and GSTTI, which is in line with other 
studies 45'46'53-54. 
Our finding that NAT1 slow acetylation (*11 allele present) protects against colorectal 
adenomas can not be verified with other studies, since these compared NAT1*10 or rare 
NAT1 alleles leading to absence of the NAT1 enzyme or to low enzyme activity, with all 
other variants. Recently, however, it was found that the more frequently occurring 
NAT1*11 allele leads to reduced enzyme activity 27. However, frequency of this allele 
was still too low to study the potential interaction of NATi polymorphism with 
smoking in our population. 
Irrespective of smoking status, NAT2 variants did not predispose to colorectal 
adenomas, which is in line with almost all of the previous studies 16. However, we found 
that risk of colorectal adenomas was especially high among smokers with the imputed 
slow NAT2 phenotype. Similar findings were reported by Welfare and co-workers 55. 
These findings are in line with metabolic studies. Whereas heterocyclic amines are 
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mainly activated via N-O-acetylation, iV-acetylation executed by NAT2 is a major 
detoxification route for arylamines present in tobacco smoke, such as 
4-aminobiphenyl17. It remains puzzling why such associations as reported here were not 
found in large studies 44,54, of which one considered colorectal adenomas and found 
smoking to be an important risk factor 44. Therefore, more studies are needed to verify 
our results. 
In summary, we found that smoking increased the risk of colorectal adenomas, and that 
this risk was mainly determined by smoking duration. Smoking especially increased risk 
of small and non-villous adenomas. We found indications for genetic polymorphisms of 
SULT1A1 and EPHX exon 3 and NAT2 to influence the association between smoking 
and colorectal adenomas. The finding that smoking increases risk of adenomas most 
importantly in combination with SULT1A1 fast sulfation and NAT2 slow acetylation is 
consistent with results from biochemical studies and indicates that SULT1A1 and 
NAT2 are indeed important in the metabolism of arylamines and/or PAHs from tobacco 
smoke. GSTM1 and GSTT1, however, do not seem to play a role and the potential role 
of EPHX remains to be elucidated. 
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CHAPTER 6 
Among cases, main indications for endoscopy were routine check-up for adenoma 
recurrence (37%), anal bleeding (27%), and large bowel complaints (15%), while 
controls mainly underwent endoscopy because of large bowel complaints (38%), 
defecation problems (21%), or anal bleeding (17%). 
Medical files were checked for additional information on medical history and 
information on polyp recurrence, size, localization, histology, and the number of excised 
polyps. 
In retrospect, based on information from questionnaires and medical files, we excluded 
170 participants who did not meet the eligibility criteria, mainly because of non-
adenomatous or unknown types of polyps (59%). In addition, we used complete 
information of 64 subjects meeting our criteria, recruited between December 1995 and 
June 1997, from a preceding study on somatic mutations in colorectal adenomas 
conducted in one of the eight hospitals 22. This increased the study population from 861 
to 925 subjects. 
Q U E S T I O N N A I R E S 
All invited subjects received a short questionnaire inquiring about important 
characteristics such as age, gender, alcohol consumption, education level, and smoking. 
About one third of subjects who did not want to participate in the study completed this 
short questionnaire. Although they were older, they did not differ from participants with 
respect to gender, education level, smoking, and alcohol consumption. 
Participants further received dietary and lifestyle questionnaires and were requested to 
complete these according to habits in the year previous to their last endoscopy or 
complaints. 
To assess dietary habits, we used a standardized and validated semi-quantitative food 
frequency questionnaire described in detail by Ocke and colleagues 23. By means of this 
questionnaire, consumption of alcoholic beverages was assessed for beer, white wine, 
red wine, ports, and liquors separately. Subjects could choose to report average 
consumption in glasses per day, week, month or year. Reproducibility of alcohol 
consumption as assessed by this questionnaire was high for both males and females (r= 
0.91) as was its relative validity (r=0.74 for males, r=0.87 for females compared with the 
means of twelve 24-h recalls) 23. Intakes of total energy and of various nutrients and 
ethanol were calculated by use of a computerized version of the Dutch food 
composition table. A Dutch alcoholic consumption contains approximately 10 g of 
ethanol. Nutrients, except ethanol, were adjusted for total energy intake using the 
residual regression method 24. 
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L A B O R A T O R Y ANALYSES 
Blood samples were stored at -20°C. D N A was isolated from 200 |0.1 frozen whole blood, 
using the QIAamp blood kit (Qiagen Inc., U.S.A.), diluted to a concentration of 
approximately 20 ng/|J.l, and stored at 4 °C until analyzed. 
We used a PCR-RFLP method for determination of ADH3 genotype. A 145-basepair 
(bp) fragment of exon 8 of the ADH3 gene was amplified using primers described 
by Groppi and colleagues (5'-GCTTTAAGAGTAAATATTCTGTCCCC-3' and 
5'-AATCTACCTCTTTCCAGAGC-3') 25. To check for DNA cross-contamination, 
one in eight samples contained no D N A but water instead. 
For RFLP analysis, S<rf>I digested the ADH3*1 allele into fragments of 67, 63 and 15 bp, 
and the ADH3*2 allele into fragments of 130 and 15 bp. D N A fragments were separated 
on an ethidium bromide stained agarose gel (4%) and visualized under UV light. 
To control the specificity of ADH3 genotyping, a random sample of primary PCR 
products was digested by Nlalll, cleaving the closely to ADH3 related ADH1 and ADH2 
genes, but leaving ADH3 intact 25. Laboratory personnel was blinded to case-control 
status. DNA was not available of ten participants and it was not possible to genotype 
another eight samples (< 1%) for ADH3. 
D A T A ANALYSIS 
Subjects with incomplete dietary data (n=38) were excluded, as were the 18 subjects of 
whom ADH3 genotype was not assessed. The analyses thus included 869 subjects: 433 
cases and 436 controls. We studied total alcohol consumption in glasses per week, 
calculated by summing the separately reported intakes of beer, wines, ports and spirits, 
as well as total ethanol intake in grams per day from all dietary sources, including small 
amounts from sauces, puddings, chocolates, and low-alcohol beer. Alcohol consumption 
was divided in tertiles based on the distribution in the total study population. To 
additionally evaluate the effect of a combination of ADH3 polymorphism with high 
alcohol consumption, we defined high alcohol consumption as the consumption of 
more than three drinks daily because this amount exceeds the recommended daily 
maximum for both men and women. ADH3*1/*1 was considered as the high-risk 
genotype and compared with the combination of ADH3*l/*2 and ADH3*2/*2 
genotypes. 
The analyses were conducted using Statistical Analysis Software (SAS version 6.12, SAS 
Institute, Cary, NC) . All tests of statistical significance were two-sided. To test for linear 
trend, we modeled the tertile of alcohol intake as a continuous variable in the logistic 
regression model, in which each tertile was assigned its median value. Logistic regression 
models were used to calculate odds ratios (ORs) and 95% confidence intervals (95% 
CIs). Factors selected as possible confounders were age, gender, body mass index, 
indication for endoscopy, center, cigarette smoking, physical activity, family history of 
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colorectal cancer, education level, use of nonsteroidal anti-inflammatory drugs, total 
energy intake, consumption of vegetables, fruit, total and red meat, and nutrients related 
to these food groups. Variables related to colorectal adenomatous polyps as well as to 
exposure at p < 0.5 26 were separately entered as covariates in the regression models. 
None of these changed the odds ratio for alcohol consumption by more than 10%. 
However, we included age and indication for endoscopy (complaints-related, screening, 
and other/unknown) in the multivariate models to control for potential confounding. 
Analyses on the total population were additionally adjusted for gender. Gender-stratified 
analyses were conducted because of 1) different male-female ratios between cases and 
controls, 2) gender-specific patterns of alcohol consumption, and 3) gender-specific 
differences in alcohol vulnerability 27. 
To evaluate the possible interplay between ADH3 genotype and alcohol consumption, 
the group with ADH3*?/*2 or ADH3*2/*2 genotypes in combination with and low 
alcohol consumption (lowest tertile) served as the reference category. 
As in different stages of carcinogenesis different risk factors may operate, we conducted 
case-case analyses for adenoma recurrence (primary vs. recurrent), size (< 1 cm vs. > 1 
cm), localization (proximal vs. distal) and number (multiple vs. single) of polyps. 
To check whether former adenomas among cases or undetected right sided polyps in 
controls could have biased our results, we repeated all analyses after restriction of our 
study population to cases with first diagnosis of adenomas not longer than one year ago 
(n=299) and controls with complete visualization of the colon (n=334). 
Results 
The case group contained more men than the control group (55 vs. 37%). Table 6.1 
shows characteristics of the study population for cases and controls stratified by gender. 
Among women and men, cases were significantly older than controls and less often 
underwent endoscopy because of bowel complaints. Among women, cases had a higher 
intake of alcohol (especially of spirits and fortified wines), vegetables, fruits, and folic 
acid, and had less frequently changed their diet because of bowel complaints compared 
to controls. Among men, cases more frequently (had) smoked and consumed less energy 
and folic acid than controls. There were no differences with respect to ADH3 genotype. 
The distribution of ADH3 was in Hardy-Weinberg equilibrium. 
Alcohol intake from all sources ranged from zero to ten glasses per day. In the control 
group, the median alcohol consumption among men was nine consumptions per week, 
while the median consumption of alcohol among women was only one glass per week. 
Among cases, median alcohol intake was ten drinks per week among men and 2.5 drinks 
per week among women. 
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Alcohol intake correlated positively with energy intake, and education level. Also, 
alcohol consumption was related to (history of) cigarette smoking and family history of 
colorectal cancer (data not shown). 
In Table 6.2, risk estimates for the association between the number of drinks per week 
(in tertiles) and colorectal adenomas are shown. Overall, alcohol intake was weakly but 
not with statistical significance related to colorectal adenomas. Among women, alcohol 
consumption significantly increased risk of colorectal adenomas. When consumers of 
more than 21 alcoholic consumptions per week were compared to consumers of less 
than one glass weekly, alcohol appeared to be a risk factor also for men (OR 1.8, 95% CI 
0.9-3.8). We did not find increased risks for women consuming more than 21 glasses per 
week, probably because this category only contained ten cases and twelve controls (data 
not shown). 
Tab le 6.2. Association between alcohol consumption and risk of adenomatous colorectal 
polyps. 
Alcohol consumption (drinks/week)a 
< 1 1-10 >10 P-
trend 
All 
N (cases/controls) 
Gender and age adjusted OR (95% CI) 
Multivariate OR (95% CI)b 
122/163 139/153 
1 (REF) 1.22 (0.81-1.83) 
l(REF) 0.93(0.59-1.49) 
172/120 
1.44 (0.95-2.17) 
1.10 (0.69-1.73) 
0.06 
0.17 
Women 
N (cases/controls) 
Age adjusted OR (95% CI) 
Multivariate OR (95% CI)b 
76/135 69/99 
1 (REF) 1.17(0.75-1.82) 
1 (REF) 0.99 (0.61-1.60) 
51/41 
2.19(1.30-3.68) 
1.81 (1.02-3.21) 
0.003 
0.04 
Men 
N (cases/controls) 
Age adjusted OR (95% CI) 
Multivariate OR (95% CI)b 
46/28 70/54 
1 (REF) 0.93 (0.50-1.73) 
1 (REF) 0.96 (0.50-1.85) 
121/79 
1.07 (0.60-1.91) 
1.12(0.61-2.05) 
0.63 
0.57 
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The analysis of alcohol intake from all sources in grams per day, which was slightly 
different from the daily alcohol intake in grams imputed from alcoholic beverages only, 
yielded odds ratios comparable to those presented in Table 6.2. N o specific type of 
beverage was responsible for the increased risk of colorectal adenomas (data not shown). 
Case-case analyses did not indicate that alcohol consumption was related to specific 
adenoma characteristics such as location, size, type, and number of adenomas (data not 
shown). 
After exclusion of cases who had previously been diagnosed with adenomas and of 
controls whose proximal colon was not examined, results remained similar (OR and 
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95% CI for women in the highest tertile of alcohol consumption 2.2, 1.1-4.2; and for 
men 1.0, 0.5-2.0). After exclusion of those who underwent endoscopy because of large 
bowel complaints, gender- and age adjusted odds ratio inflated moderately among 
women (OR 1.9, 95% CI 1.0-3.4), but not among men (OR 1.1, 95% CI 0.5-2.1). 
Table 6.3. Risk ' of adenomatous colorectal polyps by alcohol consumption and AD113 
genotype. 
Alcohol consumption (drinks/week)b 
< 1 1-10 >10 
AH 
ADH3*l/*2, 
*2/*2 
ADH3*1/*1 
Women 
ADH3*l/*2, 
*2/*2 
ADH3*1/*1 
Men 
ADH3*l/*2, 
*2/*2 
ADH3*1/*1 
' Adjusted 
othcr/unktio' 
N cases/controls 72/96 99/105 107/79 
OR (95% CI) 1 (REF) 0.97 (0.60-1.56) 1.15 (0.70-1.90) 
N cases/controls 50/67 40/48 65/41 
OR (95% CI) 0.94(0.53-1.64) 0.99(0.54-1.79) 1.76(1.00-3.11) 
N cases/controls 41/77 51/68 35/29 
OR (95% CI) l(REF) 0.94(0.51-1.74) 1.38(0.66-2.87) 
N cases/controls 35/58 18/31 16/12 
OR (95% CI) 0.90 (0.46-1.73) 0.92 (0.42-2.05) 2.61 (1.05-6.50) 
N cases/controls 31/19 48/37 72/50 
OR (95% CI) 1 (REF) 1.03(0.47-2.27) 1.05(0.50-2.20) 
N cases/controls 15/9 22/17 49/29 
OR (95% CI) 1.31(0.41-4.16) 1.06(0.42-2.69) 1.50(0.67-3.34) 
or iscK;, af.ie, an 
viii; '' one alcoholic 
I indication for endoscopy (complaints-related. >crcenm!.£, 
'onsumptioH contains approximately 10 si ol etlianol 
In Table 6.3, we show risk estimates for the combined associations of alcohol 
consumption and ADH3 genotype with colorectal adenomas. The association between 
alcohol and adenomas was not markedly influenced by ADH3 polymorphism, though 
the risk of adenomas was highest among subjects who had the ADH3*1/*1 genotype and 
were in the upper tertile of alcohol consumption (Table 6.3). When comparing 
consumers of more than 21 alcoholic drinks weekly to those consuming less than one 
drink weekly, risk increased most markedly for men with the ADH3*1/*1 genotype (OR 
2.8, 95% CI 1.0-8.3) and less so for men with other genotypes (OR 1.6, 95% 0.7-4.1). 
However, the interaction term did not reach statistical significance. 
D i s c u s s i o n 
In this first study on alcohol consumption and ADH3 genotype in the epidemiology of 
colorectal adenomas, we observed that alcohol consumption increased risk of colorectal 
and that this association may be influenced by 
•st study on alcohol consu ption and A 3 genotype in the epide iology or 
I adeno as, e observed that alcohol consu ption increased risk of colorectal 
polyps most markedly among women /3nr ' +l™t tUie iccr./-iit-ir.  i-ir KF> i flii^ni-^i-l U\r 
ADH3 genotype. 
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We recruited both cases and controls among those undergoing endoscopy. In the 
Netherlands, endoscopies are not routinely conducted for screening purposes like in the 
United States. Consequently, endoscopies were mostly conducted for bowel pain, anal 
bleeding, or defecation problems (64%) in our study. These complaints may influence 
dietary patterns. Our study population might also be more health conscious than the 
general population. This implies that our findings are not easily extrapolated to the 
general population. However, alcohol consumption in our control group was similar to 
the habitual alcohol consumption we assessed using the same questionnaire in a random 
sample (n=1935) from the general population inhabiting the same regions as the 
controls (unpublished data). 
Of those invited, about 54% were willing to participate. Selection bias might have 
occurred if habitual alcohol consumption influenced the probabilities of being invited or 
of participating. It is not likely that alcohol consumption influenced the chance of being 
invited since habitual alcohol consumption was unknown at selection for almost all 
subjects (>95%). Moreover, participants did not differ in alcohol consumption from 
those who refused participation but completed the short questionnaire. 
The control group consisted of significantly more women, possibly because women 
were more likely than men to undergo endoscopy for major bowel complaints such as 
irritable bowel syndrome (IBS) which was found to be more prevalent in Dutch women 
than in men 28. Also, cases were older than controls. Gender and age differences between 
cases and controls were also observed in other case-control studies on colorectal 
adenomas 29~31. Cases with history of adenomas might be over-represented in our study 
population since these had a higher probability of being invited and this might have 
introduced bias. We therefore included indication for endoscopy in our multivariate 
model. Exclusion of those with a history of adenomas yielded essentially the same 
results. 
Inclusion of controls with bowel complaints did probably not lead to important 
overestimation of the true associations between alcohol and adenomas, though bowel 
complaints occurred more often in the control group and were associated to lower 
alcohol consumption in women. Odds ratios only marginally inflated after exclusion of 
those undergoing endoscopy because of bowel complaints. We expect no 
misclassifkation by inclusion of controls with incomplete visualization of the colon 
(22%). In theory, these could have proximal adenomas, leading to bias toward the null. 
However, exclusion of controls with incomplete colonoscopy did not change our 
results. 
Recall bias might have occurred since most cases and controls were aware of their status 
at time of completion of the questionnaires. If alcohol would have been known as a risk 
factor for polyps, cases might have reported lower or higher intake than their true intake 
of alcohol. However, alcohol consumption is generally believed to increase risk of 
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several cancers, but probably not of colorectal adenomas. Indeed, none of those 
previously being diagnosed with adenomas indicated to have changed alcohol 
consumption because of colorectal adenomas. 
We assessed alcohol consumption by use of a food-frequency questionnaire. Although a 
validation study of our questionnaire showed that habitual alcohol intake might be 
systematically underestimated, especially by men, subjects were appropriately ranked on 
alcohol consumption a . Ideally, per beverage type, both frequency and the number of 
drinks per occasion should be inquired 32. We had no information on drinking patterns 
or on drinking habits over the years. Recent drinking habits might well reflect those in 
the past, as in a Dutch cohort, alcohol consumption patterns were found to be relatively 
stable, especially among men 33. The same was concluded from a follow-up study among 
British male doctors 34. 
Allele frequencies of ADH3*1 and ADH3*2 among controls were 59% and 41%, 
respectively, which is similar to frequencies reported from other Caucasian 
populations 10111619. We correctly amplified ADH3 and not ADH1 or ADH2 in all 
samples (as checked by digestion of a random sample of PCR products with the 
restriction enzyme Nlalll). Use of an internal control in RFLP analysis proved that all 
digestions were successful. 
Our finding that alcohol consumption increases the risk of adenomatous colorectal 
polyps corresponds with the results of most previously conducted studies 2931'3540. 
Among women, risk of adenomas already increased at consumption of ten or more 
beverages per week, whereas among men, risk was increased only at consumption of 
more than 21 beverages per week. It is difficult to compare these results with those 
obtained in other studies, since different cut-off points are used and gender-specific 
results are not always presented. In general, like in our study population, men consume 
more alcohol and the range of alcohol consumption is wider in men than in women 33'41. 
A possible explanation for our results is that the threshold for an effect of alcohol on 
adenomas could be higher in men than in women. Women are more vulnerable to 
alcohol than men mainly because of a lower rate of first-pass ethanol metabolism in the 
stomach 27'42. Since blood ethanol levels are higher in women than in men at equal 
consumption and ethanol reaches the colonic epithelium via the blood circulation, this 
might imply that at equal intake of alcohol, the colonic epithelium of women is exposed 
to higher levels of ethanol and acetaldehyde than that of men. 
Alcohol did not specifically increase adenoma recurrence and other adenoma 
characteristics. To our knowledge, only Boutron and colleagues found that alcohol 
consumption specifically increased risk of large adenomas 43. 
We did not find specific types of beverages to be responsible for the observed increase in 
risk, which is in line with the conclusion of the World Cancer Research Fund expert 
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committee stating that 'the effect generally seems to be related to total ethanol intake, irrespective of 
the type of drink' 44. 
The effect of ethanol is probably co-carcinogenic rather than carcinogenic 4'45. In 
contrast, its major metabolite acetaldehyde is a probable carcinogen and was found to 
form adducts, induce D N A cross-links, chromosomal aberrations, and sister chromatid 
exchanges in vitro, and inhibit D N A repair enzymes 5. Therefore, we hypothesized that 
polymorphism of the ADH3 gene, encoding the principal enzyme oxidizing ethanol to 
acetaldehyde, would play a role in the association between alcohol and adenomas. We 
found stronger associations between alcohol consumption and colorectal adenomas in 
carriers of the ADH3*1/*1 genotype than in those with other ADH3 genotypes. 
However, interaction terms for ADH3 genotype and alcohol consumption were not 
statistically significant, possibly because modest gene-environment interactions can only 
be studied in populations with several thousands of subjects 4*. An alternative 
explanation is that the role of ADH3 genetic polymorphism might be obscured by 
production of ADH 47 and/or acetaldehyde production by intestinal microflora 21. 
Because of these effects, ADH3 genotype might be especially important among heavy 
drinkers. In contradiction to our expectations, the potential role of ADH3 
polymorphism did not become more pronounced with high alcohol consumption, i.e., 
more than 21 drinks per week. However, our study population only included very few 
heavy drinkers or alcoholics and this may have influenced our results. Alternatively, 
ADH-catalyzed oxidation of ethanol might be less important because other enzymatic 
systems are upregulated in heavy drinkers 48. 
ADH3 polymorphism has not been considered in studies on colorectal adenomas so far. 
Other studies on the role of ADH3 polymorphism in the association between alcohol 
and neoplasm were on oropharyngeal, laryngeal, head and neck, and breast cancer 14"20. 
Three of these seven studies indicated that drinkers with the ADH3*1/*1 genotype are 
at higher risk of neoplasm than those carrying ADH3*l/*2 and ADH3*2/*2 
genotypes 14"16. 
We conclude that alcohol consumption elevates the risk of adenomatous colorectal 
polyps. ADH3 genotype may be a modest effect modifier of the association between 
alcohol consumption and colorectal adenomas. These findings need further 
confirmation. Our hypothesis that the influence o£ADH3 genotype becomes relevant at 
high ethanol concentrations should preferably be tested in a large population with 
higher alcohol consumption. Moreover, exposure of the human colon to ethanol and 
acetaldehyde and effects of this, and the role and impact of alcohol dehydrogenase 
synthesis by gastrointestinal bacteria need to be studied in more detail. 
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CHAPTER 7 
Abstract 
We evaluated the effect of meat consumption and cigarette smoking in combination with N-
acetyltransferases 1 and 2 (NAT1 and NAT2), and glutathione S-transferase Ml (GSTM1) 
genotypes on risk of colorectal cancer. From a Dutch prospective study, after 8.5 years of follow-
up, data of 102 incident colorectal cancer cases and a random sample of 537 controls frequency-
matched for gender and age were analyzed. Baseline information on dietary and smoking habits, 
as well as blood samples for DNA isolation and genotyping were available. Red meat intake 
increased colorectal cancer risk among men (OR 2.7, 95% CI 1.1-6.7 highest vs. lowest intake), 
whereas poultry and fish decreased risk among women (OR 0.5, 95% CI 0.2-1.07). Cigarette 
smoking for at least 16 years increased colorectal cancer risk among former smokers only (OR 
2.7, 95% CI 1.0-7.4), compared to those having smoked for 15 years or less. NAT1 and NAT2 
polymorphisms did not significantly modify these associations. High consumption of poultry 
and fish was inversely associated with colorectal cancer only in presence of GSTMi. In this 
study, meat consumption and former long-term smoking were associated with colorectal cancer. 
Associations of colorectal cancer with different types of meat were modified by gender and 
GSTMi genotype. 
I n t r o d u c t i o n 
Incidence of colorectal cancer is high and increasing in developed countries. In 1995, the 
incidence rate of colorectal cancer in the Netherlands was about 95 per 100 000 persons 
per year (European Standardized Rate) '. High consumption of red meat and long-term 
cigarette smoking are among its potential risk factors 2"3. 
Although risk estimates are above one in most studies, in individual studies, they range 
from 0.8 to 2.5 2. A recent meta-analysis of 13 studies showed that meat significantly 
increased risk of colorectal cancer by 12-17% per 100 g increase in total and red meat 
consumption. Daily increase in intake of processed meat by 25 g led to an increase in 
risk of 49% 4. As was recently reviewed by Giovannucci5, smoking and specifically long-
term cigarette smoking, was associated with a 1.5-2 times increased risk of colorectal 
cancer in most of the recent studies. These associations were more consistent in US 
than in European populations 5. 
Inconsistencies could of course result from methodological differences (e.g., study 
design, study size, measurement of exposure), but also from differences between study 
populations (e.g., sex and age distribution, lifestyle, and genetic susceptibility). Indeed, 
preferences for meat types, meat preparation methods, and smoking habits differ 
between countries and populations 6. 
Differences in genetic susceptibility to xenobiotics may result from genetic 
polymorphisms leading to differences in gene expression or to different stability or 
activity of the encoded metabolic enzymes. Examples of polymorphic genes are N-
acetyltransferases 1 and 2 (NAT1 and NAT2), involved in metabolism of heterocyclic 
aromatic amines (HCAs) from heavily cooked meat and tobacco smoke, and glutathione 
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S-transferases (GST's), involved in metabolism of polycyclic aromatic hydrocarbons 
(PAHs) from tobacco smoke and barbecued meat. To date, 26 alleles for NAT1 and 29 
NAT2 alleles have been identified f, resulting in fast or slow acetylation. Depending on 
the substrate, fast or slow acetylation of aromatic amines might result in prolonged 
exposure to potential carcinogens and increased formation of DNA-adducts 7. GSTM1 
is important in the detoxification of various xenobiotics. The GSTM1 null genotype 
results in absence of the corresponding enzyme and occurs in 39-62% of Caucasians 8. 
Overall, results regarding a possible role for genetic susceptibility in the associations of 
meat consumption and smoking with colorectal cancer are inconsistent 9"14. NAT1 and 
NAT2 fast acetylators consuming relatively large amounts of meat may be at increased 
risk of colorectal cancer 91°. However, no important roles for NAT2 and GSTM1 
polymorphisms in the association between meat consumption and colon cancer were 
found in a large study n . Similarly, although one study reported an increased risk of 
colorectal cancer for NAT2 slow acetylators having smoked in the past 5 years ,2, the role 
of genetic polymorphisms in smoking-associated colorectal cancer is unclear 1314. 
Although allele frequencies of NAT1, NAT2 and GSTM1 are thought to be constant 
over Caucasian populations, exposure to potential carcinogenic substances is more 
variable. The influence of metabolic genotype on the effect of exposure on disease might 
be most relevant in those being exposed to relatively high or low levels of potential 
carcinogens 15. This variation in exposure and potential variation of its effect warrants 
analysis of gene-environment interactions in different populations. In this first Dutch 
study on gene-environment interactions in colorectal cancer, we investigate the possible 
interplay between meat consumption or tobacco smoking, and genetic susceptibility as 
represented by NAT1, NAT2 and GSTM1 genotypes. 
Materials and Methods 
S T U DY P O P U L A T I O N 
We conducted a nested case-control study using data from the prospective Monitoring 
Project on Cardiovascular Disease Risk Factors which was conducted in three Dutch 
towns, i.e. Amsterdam, Maastricht and Doetinchem between January 1987 and 
December 1991. More than 36,000 men and women were enrolled. A detailed 
description of this project was previously published 16. In brief, each year, a random 
sample of men and women, aged 20-59 years, was selected from the municipal registries 
of the three towns and invited to participate. The overall response rate was 50% for men 
and 57% for women. The study protocol was approved by the Medical Ethical 
Committee of the University of Leiden, The Netherlands in 1987. 
See internet site http:Wwww.louisville.edu/medschool/pharmacology/NAT.html, last revision 
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In Doetinchem, some subjects participated more than once and duplicate observations 
from these participants (n= 1,097; first record was used) were excluded. We further 
excluded subjects who could not be identified in the National Population Database 
(n=24), whose vital status by 31 December 1997 was unknown (n=343), who disagreed 
with release of their medical records from the general practitioner and therefore could 
not be linked to the cancer registry (n=597), who did not provide a blood sample 
(n=705), who were of presumed non-Caucasian nationality (n=1402), or who had 
cancer previous to their inclusion into the cohort (except non-melanoma skin cancer 
and cervix cancer in situ, n=542). From the resulting database, we included all incident 
colorectal cancer cases and a random sample of controls as described below. 
Follow-up for incident cancer for the period 1987 to end of 1998 was achieved via 
computerized record linkage with the Netherlands Cancer Registry (NCR) and with the 
three regional cancer registries (IKA, IKL, and IKO) serving the areas of Amsterdam, 
Maastricht and Doetinchem, respectively. N C R is a national registry of all malignant 
tumors diagnosed from 1989 onwards in people living in the Netherlands. 
Completeness, data consistency and the possibility of duplicate records are extensively 
checked ". Because data from the N C R were complete only for the period 1989 to the 
end of 1996, additional information from the regional cancer registries was used. For 
1987 and 1988, completeness of data from these registries varied between 60% and 100% 
depending on registry and year. For 1997, data from all three regional registries were 
100% complete and for 1998, data were 100% complete for IKL only. Records from the 
cohort were linked using a method based on the two-stage process developed by Van 
den Brandt and colleagues 18. 
In total, 108 incident colorectal cancer cases could be identified. A random sample of 
controls with the same distribution of gender, age (5-year intervals), and center as the 
cases was drawn. As the success rate of D N A isolation was expected to be low, we 
sampled six controls for every case to obtain a final case-control ratio of at least five-to-
one. After exclusion of one case of whom no exposure data was available, our study 
population consisted of 107 cases and 600 controls. About 38% of these originated from 
the Western part (Amsterdam), 23% from the Eastern part (Doetinchem), and 39% from 
the South-Eastern part of the Netherlands (Maastricht). 
Meat consumption and smoking habits were estimated by use of a self-administered 
questionnaire. Dietary habits were estimated using a short semi-quantitative food 
frequency method, validated by the use of a dietary history method '9. Spearman rank 
correlation coefficients for the reproducibility of meat intake as estimated by the 
questionnaire were r=0.59 for men and r=0.56 for women; coefficients for relative 
December 12, 2000 (NAT1) and April 6, 2001 (NAT2) 
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validity were r=0.49 for men and r=0.40 for women 19. As the questionnaire was 
designed to estimate exposure to risk factors of cardiovascular diseases, emphasis was on 
foods supposed to increase this risk (e.g., meat snacks, fats); the questionnaire was 
designed to rank subjects on their usual intake. Frequency of meat consumption was 
inquired separately for beef, pork, poultry, and fish. Consumption was assessed in six 
categories: never, less than once per month, one to three times monthly, once per week, 
two to four times weekly, and more than four times per week. In addition, frequency of 
consumption of four typically Dutch meat snacks, among which sausage slices, was 
asked in categories of never, less than once weekly, once weekly, two to six times a week, 
and daily. Participants were also asked how many sandwiches with meat filling they 
commonly consumed daily. 
Assuming the median frequency per category (i.e., for the category 'two to four times 
weekly' we assumed a consumption of three times per week), total meat consumption 
was calculated by adding up the frequencies of all meat types consumed. Frequency of 
consumption of fresh red meat was estimated by summation of reported beef and pork 
intake. Consumption of other foods (e.g., vegetables, fruit) and energy intake were 
calculated using data from the computerized version of the Dutch food composition 
table 1993, to estimate portion sizes 20. 
Exposure to tobacco smoke was assessed for cigarettes, cigars, and pipe separately. For 
each type, current smoking status, age at start of smoking, total number of years smoked, 
and the amounts smoked usually and currently per day were inquired. 
G E N E T I C SUSCEPTIBILITY 
All participants provided a blood sample that was separated into plasma, erythrocytes, 
and buffycoats, and was subsequently stored at -20°C. Mean storage time until D N A 
isolation was 11.5 years. Of one case and 19 controls respectively, no samples could be 
retrieved. 
DNA was isolated from buffycoats. If DNA isolation failed, the procedure was repeated 
for cases but not for controls, since controls were over-sampled by 20%. DNA could be 
isolated for 102 cases and 540 controls (success rate of 96% for cases and 93% for 
controls). DNA was diluted to a concentration of 20 ng/u.1 and stored at +4°C in deep-
well microtiterplates. 
We determined the presence or absence of GSTM1 with a multiplex PCR procedure, 
developed by Arand and co-workers 21, which simultaneously determines GSTM1 and 
GSTT1 genes. As a positive PCR control, however, we used primers derived from 
(3-globin 22 instead of albumin. The fragments of GSTM1, GSTT1, and P-globin were 
respectively 215, 480, and 350 bp in size. 
Allelic variants of NATi and NAT2 were determined by an allele specific oligo 
hybridization assay described by Bunschoten and colleagues 23. In short, allele specific 
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oligonucleotide probes were covalently applied to a membrane in lines, followed by 
hybridization with PCR products comprising the allelic variants of NAT1 and NAT2, 
perpendicular to the oligonucleotide lines. Using these oligonucleotide probes, we could 
identify NAT1 alleles *4, *3, *10 and *11, and NAT2 alleles +4, *5, *6, *7, *12 (see 23, 
for details). 
We checked for cross-contamination between samples prior to PCR by inclusion of one 
sample without DNA after every seven DNA samples. All these controls were negative. 
Validity and reproducibility of the allele specific oligo hybridization assay were 
extensively tested and proved to be 100% 23. To test reproducibility of the GSTM1 
genotype determination, a number of samples (approximately 10%) were genotyped in 
duplicate; no differences were observed. 
D A T A ANALYSIS 
All subjects of whom at least one genotype (i.e., GSTM1 or NAT1 or NAT2) could be 
determined were included (102 cases and 539 controls). Two controls had missing 
values on important energy sources resulting in an extremely low calculated energy 
intake (1890 and 2270 kj/d) and thus, these were excluded from the analyses, yielding a 
final data set of 102 cases and 537 controls. 
Categorical variables had a separate category for missing information. Data on non-
categorical exposure variables on smoking and meat consumption was divided in 
categories each containing approximately equal numbers of controls, taking the lowest 
categories of exposure as the reference. 
Because there has been debate about the NAT1 genotype-phenotype correlation 24, we 
composed the following categories: slow acetylators were those carrying at least one 
NAT1*11 allele, fast acetylators had at least one NATl*iO allele, and all others were 
classified as normal acetylators. For NAT2, we used the generally accepted 
imputation724 which classifies carriers of NAT2M/M, NAT2*4/*12, and NAT2*i2/*12 
genotypes as fast, carriers of only one NAT2*4 or NAT2*i2 allele as intermediate, and 
all others as slow acetylators. 
All analyses were conducted using Statistical Analysis Software (SAS version 6.12, SAS 
Institute, Cary, NC) . Statistical significance (p<0.05) was tested using two-sided 
Wilcoxon, Kruskal-Wallis, or Fisher's exact test. Odds ratios (OR) and 95% confidence 
intervals (95% CI) were calculated. Factors considered for confounding were history of 
gallstones, diabetes and adenomatous polyps, education level, total energy intake, intake 
of coffee, alcohol, vegetables, and fruit, body mass index, physical activity, use of aspirin, 
smoking (when modeling meat consumption), and meat consumption (for the smoking 
model). These were separately included in the model containing the matching factors 
(i.e., age, sex, and center) and the exposure variables (i.e., meat consumption and 
smoking). Those factors changing the odds ratios for the exposure variables by more 
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than 10% without importantly increasing the associated standard errors were included in 
the model. This resulted in the following multivariate models: the meat consumption 
models contained total energy intake, alcohol consumption and body height, and the 
smoking models contained body mass index (BMI), alcohol intake, and coffee 
consumption. 
To study the interplay between genetic susceptibility and meat consumption or 
smoking, we composed six categories originating from three categories of exposure and 
two categories of imputed phenotype. The combination of the assumed low-risk 
imputed phenotype (i.e., NAT1 slow/normal acetylation (i.e., no NAT1*10 allele 
present), NAT2 slow acetylation, and GSTM1 present) and the lowest exposure category 
served as the reference category. 
We repeated our analyses after exclusion of those for whom follow-up ended within the 
first two years after inclusion (13 cases and one control excluded). Similarly, analyses 
were repeated after exclusion of those with incident colorectal cancer after 31 December 
1997 (nine cases), and after exclusion of those below age 50 at the end of follow-up. 
R e s u l t s 
Table 7.1 shows the baseline characteristics of the study population. Cases had a higher 
BMI and more often reported diabetes. Also, cases were taller, more frequently reported 
a history of gallstones, and were less physically active than controls, but these latter 
differences were not statistically significant. Cases consumed slightly, but not 
significantly, more red meat and less poultry and fish than controls. Although there were 
no apparent differences between the cases and controls with respect to cigarette 
smoking, relatively more cases than controls had recently given up smoking (Table 7.1). 
Results on cigar and pipe smoking are not included in this paper because only 12% of 
cases and 14% of controls reported to have ever smoked cigars and/or pipe regularly, 
90% of them in combination with cigarettes (data not shown). Of the 102 cancers, 63 
were located in the colon and 39 in the rectum or rectosigmoid. 
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Table 7.1. General characteristics of die study population at baseline. 
Characteristic 
Demographic 
Female, % 
Age at baseline, mean (SD) 
Height, cm, mean (SD) 
BMI, kg/m2, mean (SD) 
Caucasian, % 
Medical history, % 
Colorectal polyps 
Gallstones 
Diabetes 
Lifestyle 
Meat, mean intake (SD) 
Total meat, g/day 
Red meat, g/day 
White meat, g/day 
Processed meat, g/day 
Beef, frequency per month 
Pork, frequency per month 
Poultry, frequency per month 
Fish, frequency per month 
Meat snacks, frequency per month 
Other dietary characteristics, mean intake (SD) 
Total energy, kj/day 
Total vegetables, g/day 
Cabbage and Brussels sprouts, g/day 
Fruit, pieces/day 
Coffee, cups/day 
Alcohol, glasses/day 
Cigarette smoking 
Smoking status,%b never 
ex 
current 
Total duration of smoking, years, mean (SD) 
Number of cigarettes per day, mean (SD) 
Age at start of smoking, years, mean (SD) 
Time since quit smoking, years, mean (SD)c 
Other lifestyle characteristics, % 
Regular physical activity in leisure time 
Occasional use of vitamin supplements 
Regular use of aspirin 
Cases 
N = 102 
45.1 
51.3 (7.8) 
171.5 (9.4) 
26.9 (3.9) 
97.1 
2.9 
7.8 
4.9 
83.2 (42.9) 
45.5 (21.2) 
21.7 (18.8) 
27.4 (27.7) 
8.1 (6.0) 
9.4 (5.9) 
3.7 (4.1) 
2.3 (2.2) 
5.9 (6.5) 
6,895 (2,229) 
131.0 (61.8) 
31.4 (22.2) 
1.0 (0.7) 
4.1 (2.6) 
1.5 (1.9) 
29.4 
42.2 
28.4 
18.4 (15.5) 
12.0(11.2) 
17.9 (4.1) 
11.4(8.3) 
63.7 
39.2 
29.7 
Controls 
N=537 
46.0 
51.4 (7.8) 
169.9 (9.3) 
25.9 (3.4) a 
97.0 
1.7 
3.9 
0.9 * 
80.4 (35.3) 
42.8 (21.3) 
25.2 (22.7) 
26.9 (21.5) 
7.8 (6.0) 
8.6 (6.0) 
4.0 (4.4) 
2.9 (3.4) 
6.0 (6.7) 
6,773 (1,871) 
128.9(62.1) 
27.6 (18.7) 
1.0(0.7) 
4.6 (2.9) 
1.2 (1.6) 
29.8 
33.3 
36.5 
18.0 (15.5) 
11.1 (10.5) 
18.2 (5.2) 
15.0 (9.5)a 
72.4 
37.2 
23.8 
" p < 0.05. estimated by Wilcoxon rank test (continuous vari 
(categorical variables); h percentages do not count up to 11)0% as 
two controls:l' ex-smokers only. 
ables) or Fishers' exact test 
information was missing for 
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Table 7.2 shows the associations of meat consumption with colorectal cancer. Frequent 
consumption of fresh red meat increased the risk of colorectal cancer in men only, 
whereas among women, frequent consumption of poultry and fish tended to decrease 
this risk. Consumption of sausages or meat as sandwich filling (both important sources 
of processed meat) were both not associated with colorectal cancer (Table 7.2). After 
exclusion of those who were under age 50 at the end of follow-up (n=13 cases and 62 
l a D i e /.<£. lviciir consumpt ion 
populat ion and by 
Meat consumption 
characteristics 
Total meat (times per 
0-3.9 
4-5.9 
6+ 
p-value for trend 
Fresh red meat (times 
0 - 3 
3.1-4.5 
5 + 
p-value for trend 
gender: odds-
Total 
N 
ca/cob 
week) 
30/183 
33/163 
39/191 
per week) 
22/157 
35/186 
45/194 
Poultry (times per month) 
0 - < 1 
1-4 
4+ 
p-value for trend 
27/116 
32/166 
43/255 
Fish (times per month) 
0 - < 1 
1-4 
4+ 
p-value for trend 
Sausage as a snack 
No 
Yes 
p-value for trend 
Sandwiches with mea 
0 - 1 
2+ 
p-value for trend 
36/177 
34/150 
32/210 
51/253 
51/284 
characteristics 
ratios and 95° 
copulation 
OR (95% CI) 
1 (REF) 
0.7 (0.4-1.2) 
1.1 (0.6-1.9) 
0.48 
l(REF) 
1.3 (0.7-2.3) 
1.6 (0.9-2.9) 
0.10 
l(REF) 
0.8(0.5-1.5) 
0.7 (0.4-1.3) 
0.30 
1 (REF) 
1.1 (0.7-1.9) 
0.7 (0.4-1.3) 
0.23 
l(REF) 
0.9 (0.6-1.3) 
0.50 
filling (number/day) 
60/274 
42/263 
l(REF) 
0.7 (0.4-1.1) 
0.15 
j confidence intervals" 
Stratification 
Women 
N 
ca/co 
20/86 
17/87 
11/72 
15/72 
18/102 
15/71 
15/50 
16/70 
17/125 
21/83 
16/60 
11/102 
27/121 
21/124 
38/159 
10/86 
OR (95% CI) 
l(REF) 
0.7 (0.3-1.4) 
0.5 (0.2-1.4) 
0.50 
l(REF) 
0.8(0.4-1.8) 
1.2(0.5-2.8) 
0.64 
l(REF) 
0.8 (0.3-1.7) 
0.5 (0.2-1.1) 
0.07 
1 (REF) 
1.1 (0.5-2.4) 
0.5 (0.2-1.0) 
0.05 
1 (REF) 
0.8(0.4-1.4) 
0.39 
l(REF) 
0.5 (0.2-1.2) 
0.13 
cancer tor trie total 
by gender 
Men 
N 
ca/co 
10/97 
16/76 
28/119 
7/85 
17/84 
30/123 
12/66 
16/96 
26/130 
15/94 
18/90 
21/108 
24/132 
30/160 
22/115 
32/177 
OR (95% CI) 
1 (REF) 
0.9 (0.4-2.4) 
1.9 (0.9-4.3) 
0.10 
1 (REF) 
2.7 (1.1-6.9) 
2.7 (1.1-6.7) 
0.06 
l(REF) 
0.9 (0.4-2.2) 
1.1 (0.5-2.4) 
0.68 
1 (REF) 
1.3 (0.6-2.8) 
1.2(0.6-2.4) 
0.29 
1 (REF) 
1.0(0.5-1.9) 
1.0 
l(REF) 
0.8 (0.4-1.6) 
0.58 
* Adjusted for age. sex. center, total energy intake, alcohol consumption, and 
ca/co. number of cases over number of controls. 
body licight: N 
controls), the association between red meat consumption frequency and colorectal 
cancer became statistically significant for the total population (OR 2.0, 95% CI 1.1-3.8 
highest vs. lowest consumption group). Sub-site analyses showed that frequent 
consumption of fish protected against colon, but not against rectal cancer (highest vs. 
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lowest category OR 0.5, 95% CI 0.3-0.9 for colon, and OR 1.6, 95% CI 0.7-3.6 for 
rectum tumors). The reduction in risk of colon cancer was largest and statistically 
significant among women (OR 0.4, 95% CI 0.1-0.9). N o other differences were 
observed. 
T a b l e 7.3. Cigaret te smoking characteristics and risk of colorectal cancer for the total 
populat ion and stratified by smoking status: odds ratios and 9 5 % confidence intervals' ' . 
Total population Stratification by smoking status 
Smoking characteristics Former Current 
Cigarette 
Never 
Former 
Current 
Smoking 
all 
0 
1-25 
>25 
smoking 
p-value for trend 
duration (years) 
former/current 
1-15 
16-30 
>30 
p-value for trend 
Cigarettes per day 
all 
0 
1-14 
>14 
former/current 
1-10 
11-20 
. >20 
p-value for trend 
Time since quit smoking 
all formerc 
never smoked 
> 15 years > 18 years 
0-15 years 9-18 years 
still smokes 0-8 years 
p-value for trend 
N 
ca/coc 
30/160 
43/179 
29/196 
30/160 
36/178 
36/197 
30/160 
26/174 
46/201 
30/160 
15/81 
28/97 
29/196 
OR (95% CI) 
l(REF) 
1.4 (0.8-2.5) 
0.9 (0.5-1.7) 
0.27 
1 (REF) 
1.2 (0.7-2.1) 
1.2(0.7-2.1) 
0.99 
l(REF) 
0.9 (0.5-1.7) 
1.5 (0.9-2.6) 
0.32 
1 (REF) 
1.1 (0.5-2.3) 
1.7 (0.9-3.1) 
0.9 (0.5-1.7) 
0.24 
N 
ca/co 
13/77 
23/71 
7/31 
12/75 
21/69 
10/35 
18/53 
16/65 
9/60 
OR (95% CI) 
n.a.d 
1 (REF) 
2.7 (1.03-7.4) 
3.2 (1.04-9.8) 
0.04 
l(REF) 
2.1 (0.9-5.0) 
1.7 (0.6-4.6) 
0.15 
l(REF) 
2.6(1.0-6.5) 
2.2 (0.8-5.5) 
0.10 
N 
ca/co 
3/18 
7/60 
19/118 
10/71 
14/88 
5/37 
OR (95% CI) 
n.a. 
1 (REF) 
0.4 (0.1-1.9) 
1.9(0.5-8.2) 
0.28 
1 (REF) 
1.1 (0.4-2.8) 
1.2(0.3-4.0) 
0.75 
n.a. 
" Adjusted for age. sex, center, coffee and alcohol consumption, an 
'information on smoking characteristics was missing for two controls; ' 
cases over number of controls: '' n.a.. not applicable: '' former smokers on 
was unknown for one former smoker. 
d body mass index: 
:
 N ca/co. number of 
ly. time since quitting 
Associations between cigarette smoking and colorectal cancer are shown in Table 7.3. 
There were no differences between men and women (data not shown). Among former 
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smokers, smoking for more than 30 years was associated with a three times increased 
risk of colorectal cancer, but was not associated with a significantly increased colorectal 
cancer risk among current smokers (Table 7.3). Exclusion of the first two years of 
follow-up led to an even stronger association between smoking duration and colorectal 
cancer among former smokers (OR 5.4, 95% CI 1.5-19.6), but remained insignificant in 
current smokers (data not shown). The increased risk of colorectal cancer among former 
smokers was strongest among those who had quit smoking 9-18 years before inclusion 
and was due to an increased risk of rectum cancer (OR 6.4, 95% CI 1.3-32.1). Although 
the number of cigarettes smoked daily was also related to increased risk of colorectal 
cancer, this association did not reach statistical significance (Table 7.3). 
Table 7.4. Allele frequencies of NAT 1 and NAT2, prevalence of imputed plienotypes 
of NATL NAT2, and GSTM1 and association of these imputed plienotypes with 
colorectal cancer. 
Gene 
Cases 
N Proportion 
Controls 
N Proportion OR (95% CI) 
NAT1 alleles 
*4 
*3 
*10 
*11 
NAT1 imputed phenotype ' 
Slow 
Normal 
Fast 
NAT2 alleles 
*4 
*5A 
*5B/C 
*6 
*7 
*12 
*14 
NAT2 imputed phenotype b 
Slow 
Intermediate 
Fast 
204 
102 
204 
102 
0.760 
0.025 
0.196 
0.020 
0.04 
0.62 
0.34 
0.245 
0.044 
0.397 
0.275 
0.039 
0.00 
0.00 
0.57 
0.36 
0.08 
1074 
536 
0.713 
0.034 
0.227 
0.026 
0.05 
0.55 
0.40 
0.252 
0.031 
0.371 
0.307 
0.035 
0.005 
0.00 
0.56 
0.37 
0.07 
1 (REF) 
1.4(0.5-4.2) 
1.1 (0.4-3.3) 
l(REF) 
0.9 (0.6-1.5) 
0.9 (0.4-2.0) 
1074 
536 
GSTM1 
Present 
Null 
102 
0.43 
0.57 
537 
0.47 
0.53 
1 (REF) 
1.2(0.8-1.8) 
'' S'A'I'I imputed plienotypes; 
allele, slow: at least one *l'l al 
NAT2* 12, or SAT2*4f*12: m 
present. 
fast: at least one *10 
lele. b NA'12 imputed 
termediate: one *4 or 
allele, no * / / allele, norm; 
plienotypes; fast: hormvv 
*12 allele present: slow: ni 
)l: no *1() or *'// 
gotis NAT2*4 or 
> *4 or */_> alleles 
117 
VjjTiXA.1" H JC.JK / 
m 
r-* 
Or 
JD 
K3 
H 
?> 
*v 
~s 
o 
•£* 
J C 
U 
& _ 
CO 
3 
K 
I 
-a 
.0 O 
* « (S 
* t ifi i i i 
r-~ t-~ ov 
2-2-2-
r-~ r- CN 
•A A CN 
vu 
r^  o 
cn in 
• i 
\o oo 
o © 
in o 
CN 
•* m CN 
CN i-< C N 
i i i 
t m in 
2-2-2-
O VO T-H 
^ O ^< 
CN O 
^ - v < ' 
(JL, in CM 
-H A O 
o o •>*• r-~ 
^ CN ^ 
i i i 
"* vo TJ-
2-2-2-
Ov CN Ov 
© A O 
O *-> 
CN T-! 
p_P m CN 
§ ^ 
C- o\ in 
•^  o © 
P-, 
CN 
CN 
i n 
o 
o 
*-* 
o\ 
<N 
r--
o 
•"t-
• ^ H 
u* 
s 
T-H 
00 
^ H 
• * 
o 
00 
o 
• * 
CN 
VO 
<"> 
^ 
^ H 
• * 
CN 
VO 
© ^ 
CN 
• ^ H 
00 
^ H 
i n 
o . 
Ov 
o 
• * Ov 
CN CN 
(R
EF
) 
2 
(0.
6-
4 
(0.
7-
r H r H r H 
<r> IT) 
t-H T—1 
(R
EF
) 
6 
(0.
3-
7 
(0.
4-
H^ o o 
Ov CM 
T-H T-H 
(R
EF
) 
0 
(0.
5-
6 
(0.
3-
^H ^H O 
U E m 
a 
o 
E 
vO T-H © vO vo vO 
CN CO CO CN CN c n 
I I I I I I 
i n vo vo i n i n oo 
2-2-2- 2 - 2 - 2 
M •+ t CN *-> t~~ 
PH 
o 
E 
t-~ 
CN 
m 
o 
CN 
f -
00 
CN 
i n 
© 
*—-CN 
T H 
T ^ 
CN 
£T ^ 
O ON 
1-H O 
r^  
CO 
r^  
o s
—' \o 
•<-H 
n 
•~ 
. w 
„r* 
. ™ 
^ 
Ov 
•<-H 
cn 
o 
r-
o 
• * 
CN 
i n 
o 
T H 
T~< 
cn 
VO 
O 
• * 
r - H 
• * 
cn 
vO 
O 
^1-
T-H 
Ov 
CN 
VO 
O 
cn 
T H 
Tf 
^ H 
cn 
o 
vO 
o 
•* 
CN 
vo 
O 
CN 
T H 
VO 
CN 
VO 
o 
CN 
T ^ 
• * 
- H 
cn 
o 
r-
o 
CN 
•* O 
o 
T H 
VO 
CN 
m 
o 
CN 
T—t 
CN 
CN 
• * 
O 
o 
• ^ H 
CN 
•*f 
O 
© 
T - H 
CN 
• < * -
O 
Ov 
O 
r-~ 
CN 
vO 
O 
cn 
^ 
-* CN 
i n 
© , 
1-H 
T - -
[ - -
CN 
vO 
© 
cn 
T-H 
P* 
s 
^ H 
o 
CN 
• * 
© _ 
Ov 
O 
• * 
cn 
00 
© 
vO 
^ H 
£ o 
c 
OJ 
a-
u 
3 
ex 
E 
^ 
w 
<ii 
Ov 
<-^  
cn 
© 
r~ 
o 
o 
CN 
^J-
o 
Ov 
© 
o 
cn 
vO 
O 
^r 
^ 
VO 
T-H 
cn 
o 
r--
o 
© 
CN 
• * 
o 
Ov 
O 
© 
T ^ 
CN 
o 
i n 
© 
• * 
r - H 
cn 
o 
r^  
o 
Ov 
• ^ H 
•<t 
o 
Ov 
© 
cn 
*^ 
cn 
© 
VO 
o 
i n 
*-* 
cn 
© 
vO 
O 
00 
r-^ 
^ f 
o 
00 
© 
cn 
CN 
m 
o 
© 
" 
m 
• ^ 
cn 
© 
vO 
© 
CN 
'-' CN 
© 
•<t 
© 
cn 
t-~ 
© 
i n 
" 
P H 
s 
T - < 
CN ON 
CN ^ 
vo m 
2- 2-
^H ov 
^H O 
^ H 
CN 
iu "1 
s° 
C> O 
^ H ^ H 
cn 
CN 
VO 
© , 
v—1 
• ^ H 
<u 
o m 
r 
E 
3 
0 
+ J o ^ t 
* M 
" so 
bo a 
•J2 o 
E 00 
00 
rt n , 
i n +3 
CN S 
, o - A 
U 
118 
. MEAT, SMOKING, GENETIC POLYMORPHISM, AND CANCER 
Since our study is the first to report allele frequencies ofNATl, NAT2, and GSTM1 in 
a Dutch population, these are included in Table 7.4. NAT1, NAT2, and GSTM1 
genotypes were not associated with colorectal cancer (Table 7.4). 
To illustrate the possible interplay of meat consumption and smoking with genotype in 
colorectal cancer etiology, risk ratios for the combinations of NAT1, NAT2 and GSTM1 
genotypes and different levels of exposure are shown in Table 7.5. We found no 
indications for important roles of NAT polymorphisms in the associations of meat 
consumption and smoking with colorectal cancer. GSTM1 appeared to influence the 
associations of poultry and fish consumption with colorectal cancer. In presence of 
GSTM1, the associations of poultry and fish with colorectal cancer were inverse, 
whereas no decreased risk was found for the combination of high consumption of 
poultry and fish and the GSTM1 null genotype (Table 7.5). The interaction between 
GSTM1 genotype and poultry reached statistically significance (p=0.01). 
Exclusion of subjects who were diagnosed with incident colorectal cancer (n=13 cases) 
or died for unknown reason ( n = l control) within the first two years of follow up only 
marginally changed our p-estimates and did not change our conclusions. Also, exclusion 
of cases who got incident cancer in 1998 (n=9) did not change the results importantly 
(data not shown). 
D i s c u s s i o n 
Red meat consumption was associated with increased risk of colorectal cancer in men, 
whereas consumption of poultry and fish tended to decrease this risk in women. 
Frequent consumption of fish decreased colon cancer risk. Former smoking tended to 
increase the risk of rectal cancer and long-term smoking tended to increase risk of 
colorectal cancer among former smokers only. Polymorphisms in NAT1, NAT2, and 
GSTM1 genes were not related to colorectal cancer and did in general not influence the 
associations of meat consumption and smoking with colorectal cancer. Frequent 
consumption of poultry and fish decreased colorectal cancer risk only in presence of the 
GSTM1 gene. 
We conducted a nested case-control study with prospective data on exposure. A great 
advantage of this design is that no information or selection bias is to be expected. 
Information of exposure was probably not biased by latent disease since exclusion of the 
first two years of follow-up did not change the results of this study. Since exposure in 
the past is at least equally (and probably more) relevant to cancer etiology as recent 
exposure, we do not consider it a major disadvantage of our study that the information 
on dietary and smoking habits was collected at baseline (almost ten years before most 
cases occurred). 
It is unlikely that one or more controls were misclassified as cases since the linkage 
method used for identification of cases had a sensitivity of 98% and a specificity of 
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100% 18. For the years 1987, 1988, 1997, and 1998, identification of cases had to be based 
on information of regional cancer registries only. Although this might have led to 
underestimation of the actual number of cases, this proportion was estimated to be less 
than 0.3% 17. Exclusion of cases with incident cancer in 1987 and 1988 or 1998 did not 
change our results. 
Our questionnaire was primarily designed to estimate the cohort members' exposure to 
risk factors of cardiovascular diseases. As a consequence, no data on family history of 
cancer was collected. Although only about 5% of cancers are thought to be strictly 
hereditary 3, family history could have confounded our results since it might both be 
related to exposure and to the disease. 
For estimation of meat consumption, a short semi-quantitative food frequency method 
developed and validated by Bloemberg and colleagues was used 19. Since meat 
consumption was estimated by frequencies of consumption of beef, pork, poultry, and 
fish, a major source of meat intake in the Dutch population was possibly missed; i.e., 
minced meat being composed of a mix of pork and beef. Validation by a dietary history 
method showed, however, that meat consumption was estimated with acceptable 
reproducibility and validity (see Methods section) 19. Because only consumption of 
selected foods was inquired, our questionnaire underestimated energy intake, but 
accurately ranked energy intake as estimated by twelve 24-hour recalls (r=0.71, Ocke et 
at, unpublished data). 
Smoking habits were assessed by detailed questions and almost no data on smoking were 
missing. In contrast to Giovannucci and colleagues 25,26, we had no information on 
smoking habits in the distant past, nor did we record the number of cigarettes smoked 
daily at different ages. Although the questionnaire included questions on the number of 
cigarettes smoked daily at present and in the past, the year in which smoking habits were 
changed was not recorded. Hence, we considered past smoking habits to be most 
accurate in estimating ones' exposure to cigarette smoke. This might have caused some 
misclassification and attenuation of the effect of smoking dose among current smokers, 
since 10% indicated to have increased their daily cigarette consumption. 
Red meat consumption -was positively associated with colorectal cancer while the 
association between poultry and fish consumption and colorectal cancer (specifically the 
association between fish consumption and colon cancer) was negative. These findings 
correspond with those of two large US prospective studies 27,28, but not with results of 
European studies 29~31. These opposite associations are not the result of substitution of 
red meat by poultry and fish as was suggested earlier 27: consumption of poultry and fish 
was not correlated with red meat and those in the highest category of red meat 
consumption had almost equal probability to be in the lowest or highest of category of 
poultry and fish consumption. Consequently, adjustment of our analyses on the 
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association of red meat with colorectal cancer for poultry and fish and vice versa did not 
influence our results. 
The observation that red meat intake and colorectal cancer were only related among 
men could be the result of the higher intake or the greater diversity in beef and pork 
intake among males (median intake 4 times a week, interquartile range 2 - 6 times 
weekly) than in females (3.5, 2 - 4 , respectively). The inverse association between 
poultry and fish consumption and colorectal cancer among women was, however, not a 
result of higher (range of) intake by women. Although red meat was associated with 
unhealthy behavior (e.g., smoking, high coffee consumption), whereas poultry and fish 
consumption correlated with healthy habits (e.g., high consumption of vegetables), 
adjustment in the analyses for these factors did not change our results. However, 
residual confounding can remain even after adjustment. Our results could also be due to 
differences in food preparation (leading to differences in HCA concentration), food 
processing, fat or heme content 3'32. In contrast to other studies 4-2730) we found no 
association between sausage consumption and colorectal cancer, possibly because we had 
no information about other commonly consumed processed meats, such as smoked 
ham. Our null findings for consumption of meat on sandwiches could partly be due to 
the fact that this category comprised processed as well as fresh meats. 
We found that duration of cigarette smoking was positively associated with colorectal 
cancer, which is in accordance with most recently conducted studies 5. This effect was 
strongest for rectum cancer and among those who quit smoking 9 - 1 8 years ago. It is 
not clear why former smokers had an increased risk of cancer while current smokers had 
not, as both were of the same age and smoked the same amount of cigarettes daily. 
Moreover, current smokers had smoked for a longer period than former smokers had. 
Our findings can not be attributed to a latency effect causing latent cases to quit 
smoking, because exclusion of the first two years of follow-up strengthened the 
association between smoking duration and colorectal cancer among former smokers, but 
did not change the association in current smokers. Finally, our results can not be 
explained by unbalanced numbers in the different categories of smoking duration, 
because changing these categories to improve balance did not change our conclusions. 
We did not observe an increased risk of (colo)rectal cancer for those who quit smoking 
more than 15 years ago, possibly because the total duration of smoking did, in general, 
not exceed three or four decades 5. 
Despite the large base population and the relatively long follow-up period, we could 
only include 102 colorectal cancer cases in this study. With a sample of about 100 cases 
and 500 controls, we estimated the power to be about 90% for a true relative risk of 2.0 
for one factor at a time. Thus, the power to study the combined effect of genotype and 
exposure was low. 
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DNA isolation was not successful for 7% of samples, possibly because problems with 
collection of buffycoats at the start of the study. However, D N A isolation success rate 
was not different between samples collected at the start (1987) and at the end of the 
study (1991). 
The allele frequencies of NAT1, NAT2 and GSTM1 were similar to frequencies in 
other studies among European Caucasians 7'8'23. Consistently with most other studies, 
NAT1, NAT2 and GSTM1 genotype did not increase risk of colorectal cancer8,33. In 
contrast to Chen and colleagues 10, we found no indication that NAT1 genotype 
modulates the associations of meat consumption and smoking with colorectal cancer. 
Like these authors 10, we classified those carrying at least one NAT1*10 allele as fast and 
all others as normal acetylators. This may be incorrect since recent studies indicate that 
NAT1*11, *14, and *15 lead to low enzyme activity, whereas activity associated with 
NAT1*10 is similar to activity of the wildtype enzyme 24. Unfortunately, the infrequent 
presence of these slow alleles did not allow us to study the effect of slow versus normal 
NAT1 acetylation (see Table 7.4). 
There was no indication for interplay between NAT2 polymorphism and meat 
consumption or smoking in colorectal cancer, which is in accordance with a large US 
case-control study ,1, but contradicts two other studies 910. However, when we 
alternatively chose low meat consumption as the reference category in both groups of 
acetylators, both the positive association of red meat consumption and the inverse 
association of poultry and fish consumption with colorectal cancer were strongest 
among those carrying the NAT2 fast acetylation genotype (as can be concluded from 
Table 7.5). This effect might be the result of differences in concentrations of specific 
HCAs between fresh red meat and poultry 34~36, or of differences in metabolism of the 
different HCAs by NAT2 37. However, it is also possible that poultry and fish generally 
contain less HCAs than red meat in the Netherlands, due to differences in preparation 
methods. HCAs formed during meat preparation were not considered as a risk factor for 
colorectal cancer at the time the cohort was enrolled (January 1987 until December 
1991). Therefore, we had no information on meat preparation habits and this could have 
flawed our results on the interactions between genetic susceptibility and meat 
consumption. Our results on smoking and NAT2 polymorphism are in accordance with 
the results of the large US case-control study 13, although another study showed that 
colorectal cancer risk was confined to current smokers with the slow NAT2 
phenotype 12. 
The inverse associations of consumption of fish and poultry with colorectal cancer were 
strongest in presence of the GSTM1 gene. The association of poultry with cancer was 
significantly modified by GSTM1 genotype, which is not in accordance with the US 
case-control study ". Consistent with other studies ,3M, no indications for a role of 
GSTMi genotype in smoking-associated colorectal cancer was found. The nature of the 
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observed effect modification is not clear, since the GSTM1 genotype is thought to be 
more important in the associations of smoking characteristics with colorectal cancer, as 
the GST-u. enzyme is probably more involved in detoxification of PAHs than in HCA 
detoxification 38. Exposure to PAHs through intake of meat is presumably very low, 
since this occurs when meat is cooked over an open flame as in barbecuing which is 
rarely practiced by the Dutch population. Since the GST-u. enzyme itself is highly 
inducible by a range of substances from food and cigarette smoke, and GSTM1 
genotype influences inducibility of cytochrome P 450 enzymes (CYP1A1 and 1A2) 
which also play a major role in the metabolism of xenobiotics 38, other mechanisms 
might be more important. However, adjustment of our analyses on GSTM1 for possible 
inducers, such as cruciferous vegetables and coffee, did not change our results 
importantly. Alternatively, the protective effect of the GST-U, enzyme with high poultry 
and fish consumption could be associated with the protective effect of the more healthy 
lifestyle associated with consumption of these meats, such as a relatively high 
consumption of vegetables and fruit. Apart from GST-u,, other GST enzymes, such as 
GST-6, may play a role in the detoxification of carcinogens 39. Although we had 
information about GSTT1 genotype in this study, we did not consider the effect of the 
polymorphism. The GSTT1 null genotype occurs in 10 - 20% of Caucasians 8, and in 
16.5% of the subjects in our study. Considering the relatively low number of cases, there 
were too few cases with the null genotype to enable subgroup analyses. 
In this relatively young population, red meat consumption and former long-term 
smoking modestly increased risk, whereas poultry and fish tended to decrease risk of 
colorectal cancer in subgroups only. GSTM1 genotype altered the inverse associations of 
poultry and fish with colorectal cancer. In general, modification by genotype appears to 
be small and less important than the effect of gender, smoking status, and location of the 
tumor. However, as mentioned, our study is small and our results need confirmation in 
other (European) study populations. 
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CHAPTER 8 
In the studies described in this thesis, we investigated the potential influence of genetic 
susceptibility on the associations of high meat consumption, alcohol intake, and cigarette 
smoking with colorectal tumor risk. As the strengths and limitations of cohort and case-
control studies have been addressed in detail elsewhere and many papers have 
summarized possible associations between diet and colorectal neoplasm (see e.g., 1 6 ) , 
these issues will not be discussed here. Instead, in this Chapter, emphasis will be on 
issues related to studies investigating the influence of genetic susceptibility (through 
metabolic polymorphisms) on the association between specific exposures and colorectal 
tumors. Although specifically addressing colorectal cancer, many of the issues discussed 
here will also apply to other diseases in which low-penetrance genetic susceptibility 
plays a role. 
First, the main results of the studies described in this thesis will be summarized and 
compared to results reported by others. Next, the strengths and limitations of 
epidemiological studies incorporating metabolic polymorphisms and finally, the 
potential for this type of studies in the future and other possibilities for future research 
will be discussed. 
M a i n findings 
The studies described in this thesis aimed to evaluate the potential interplay between 
common genetic polymorphisms encoding metabolic enzymes, and the risk of colorectal 
tumors associated with meat consumption and preparation (Chapters 4 and 7), cigarette 
smoking (Chapters 5 and 7), and alcohol intake (Chapter 6). Methodological issues 
related to these studies were addressed in Chapters 2 and 3. 
The environmental exposures studied were found to be probable risk factors of 
colorectal tumors 7'8, possibly through the action of potential carcinogens, which are 
metabolized by enzymes encoded by polymorphic genes. Genetic polymorphisms may 
thus influence the risk of neoplasm. The main results of the studies described in 
Chapters 4 through 7 are depicted in Table 8.1. 
As shown in Table 8.1, meat consumption did not increase risk of colorectal adenomas. 
We also did not find that unfavorable meat preparation methods increased adenoma risk. 
Frequent red meat consumption was weakly positively associated with increased risk of 
colorectal cancer. We found no strong indications for genetic polymorphisms to modify 
the association of meat consumption with colorectal neoplasm (Table 8.1). 
Cigarette smoking was a relatively strong risk factor of colorectal adenomas, mainly 
through smoking duration (Table 8.1). This association was most pronounced in those 
with inherited variants of SULT1A1 leading to fast sulfation (OR 4.3, 95% CI 1.6-11.8), 
and of NAT2 encoding slow acetylation (OR 3.5, 95% CI 1.9-6.4). Smoking-associated 
adenoma risk also varied over categories of EPHX, but not in a clear pattern. The risk of 
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colorectal cancer was also increased with smoking duration, although only among 
former smokers (OR 2.7, 95% CI 1.0-7.4, for those who had smoked for more than 16 
years compared to those who had smoked for less than 16 years). We found no 
indications for any of the studied genotypes to modify this association. 
Table 8.1. Summary of main results described in thesis regarding the potential influence 
of genetic susceptibility on the associations of meat consumption and preparation, 
cigarette smoking, and alcohol consumption, with colorectal tumor risk. 
Genetic susceptibility" 
a: a -
Environmental exposure Endpoint Overall OR ^ ^ (95% CI) 8 * b 2 co co 3; •* ^ „ 
tq O U 2 £ £ U 
o. 
Total meat intake 7 vs. < 5 times 
per week 
Meat preparation all vs. < 1 meat 
types dark 
Red meat intake 5+ vs. < 3 times 
per week 
White meat intaked 4+ vs. < once 
per month 
Cigarette smoking > 25 yr. vs. 
never smoking 
Cigarette smoking > 25 yr. vs. 
never smoking 
adenomas 1.2(0.8-1.9) * 
adenomas 1.0(0.6-1.5) * 
cancer 1.6 (0.9-2.9) * _ * 
cancer 0.7(0.4-1.3) * * 
adenomas 2.4 (1.4-4.1) * 
cancer 1.2(0.7-2.1) * * 
Alcohol intake 
women 
10+ drinks vs. 
< 1 drink 
weekly 
adenomas 1.8 (1.0-3.2) 
1.1 (0.6-2.1) 
, i t b 
! M i 1 ie 
observed. 
• - • 
M i I * . l i 
'l ! I ti 1 I,I | 
i i l i n k , 1 i ' i ipr 
| I > I I I I 
i l >l ' < 1 
i1 f I I • | * M1 
• in \ 
Il , t l ,1 
High alcohol consumption was a risk factor for colorectal adenomas especially among 
women (Table 8.1). Risk of adenomas among men was increased only with the 
consumption of more than 21 drinks per week (OR 1.8, 95% CI 0.9-3.8). Although the 
risk of adenomas was higher among alcohol drinkers with the imputed ADH3 fast than 
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with the slow phenotype, we found no strong indications that ADH3 polymorphism 
modifies the association between alcohol drinking and colorectal adenomas. 
Overall, our results show, at best, modest influence of the metabolic polymorphisms 
studied, with odds ratios for interaction between metabolic polymorphisms and 
environmental exposures ranging from 1.3 to 1.8 (see Table 2.3, Chapter 2). Our results 
are in accordance with those of other studies, some of which included large populations 
(i.e. more than 2,000 cases and controls 9,1°). Like in our studies, in these studies odds 
ratios for the exposed genetically susceptible group generally ranged from 1.5 to 3.5 and 
were rarely higher than 5 (see Table 1.1, Chapter 1) 11,12. There are a number of potential 
reasons why the studies conducted thus far have produced inconsistent results. These 
issues will be discussed below. 
S t u d i e s i n c o r p o r a t i n g g e n e t i c suscep t ib i l i t y : s t r e n g t h s a n d s h o r t c o m i n g s 
Until recently, in epidemiological studies the association between environmental 
exposure factors and colorectal neoplasm was analyzed without consideration of genetic 
susceptibility. Most of these studies found weak and inconsistent associations between 
exposure and disease 613 possibly because the assessment of environmental exposure is 
prone to errors ' and genetic susceptibility was not assessed. 
A S S E S S M E N T OF G E N E T I C SUSCEPTIBILITY 
With the development of methods to detect DNA polymorphisms, the incorporation of 
genetic susceptibility to common environmental exposures into epidemiological studies 
evolved. Since the early 1990s, an increasing number of epidemiological studies 
incorporated data on genetic polymorphisms. This was considered an important 
improvement, as the incorporation of metabolic polymorphisms may increase our 
knowledge on which carcinogens potentially increase cancer risk 14. As genetic 
polymorphisms, unlike e.g. mutations in tumor suppressor genes, do not directly affect 
carcinogenesis, their overall effect is expected to be small 15'16. However, in the presence 
of exposure to a relevant carcinogen, these polymorphisms might be potent effect 
modifiers of cancer risk, as susceptible subjects may respond differently to specific 
carcinogenic substances compared to non-susceptible persons M. Moreover, the impact 
of genetic susceptibility may be small at individual level but may nevertheless be 
important in terms of population attributable risk, as this type of genetic susceptibility is 
highly frequent in the general population and determines the effective dose of 
commonly occurring carcinogens 1718. In comparison with environmental exposure 
assessment, the assessment of genetic susceptibility is considered to be highly sensitive 
and precise. However, the assessment of genetic susceptibility has several limitations 11, 
as will be discussed below. 
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Dete rmina t ion of genet ic po lymorphisms 
Errors in the determination of genotypes or in the subsequent imputation of phenotypes 
may result in misclassification. Misclassification due to measurement errors is thought 
to be of minor importance for the assessment of genotypes. In our study, validity and 
reproducibility of newly developed methods for NAT1 and NAT2 were extensively 
tested (see Chapter 3). Reproducibility of other methods was also tested by 
determination in duplicate for about 10% of the samples. Reproducibility and validity 
were close to 100% for all genotypes. Nonetheless, misclassification of imputed 
phenotypes could have occurred because not all known alleles were included in the 
analyses 19. However, this type of misclassification is thought to have only a minor effect 
for most of the genotypes described in this thesis, since we determined all alleles 
frequently occurring in Caucasian populations. For example, for NATi, we were not 
able to distinguish between NAT1*10 (normal acetylation) and NAT1*14 and NAT1*15 
(slow, respectively no NATI acetylation 20). However, NAT1*14 and NAT1*15 allele 
frequencies are very low in Caucasian populations 20'21. 
In our studies, all genotypes were determined by standardized methods. To control for 
cross-contamination, we included negative controls in all tests. Where needed, positive 
controls were also included to test for PCR-performance (as in the case of GSTM1 and 
GSTT1, where no PCR product is formed in the absence of these genes, i.e., in samples 
from subjects with homozygous null genotypes). Laboratory personnel was blinded to 
case-control status. Differential misclassification did probably not occur in our studies, 
as the genotypes were, in almost all investigated situations, not dependent on other 
variables under study (see Chapters 4-7). 
Genotype-phenotype correlat ion 
For some genes, such as EPHX and to a lesser extent NATi, phenotype-genotype 
correlation is not yet clear 22,23, and it is therefore difficult to impute phenotypes based 
on the determined genotypes. The use of imputed phenotypes for these genes might 
introduce phenotype misclassification and might also provide an explanation why we did 
not observe any effect of these imputed phenotypes on exposure-related neoplasm. 
Gene expression is influenced by genetic and environmental factors (see under 'Effective 
dose of carcinogens'). Genes may contain several polymorphic sites in coding and non-
coding regions, which may be present on the same or on the complementary D N A 
strand. The exact location of these polymorphic sites may determine the nature of the 
gene product. Often, this location can not be determined by genotyping but haplotype 
analysis is required instead 24. Genotype-phenotype correlation may vary over tissues, as 
expression of many genes is tissue-specific. For example, NAT2 is mainly expressed in 
the liver, whereas NATI is expressed in most tissues, including colorectal epithelium 25. 
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Assumpt ion of independence 
One assumption frequently made when studying potential interaction between exposure 
and genotype is that the occurrence of genotype and exposure are independent of each 
other 26. It is questionable whether this assumption always applies, as we found that 
GSTM1 and GSTT1 genotype frequencies differed with smoking status (Chapter 5). 
However, such dependence has never been published before. Violation is nevertheless 
possible for ADH3 and alcohol consumption (Chapter 6). The ADH3*1 allele was 
found to be in linkage disequilibrium with ADH2*2, which decreases the risk of 
alcoholism, although ADH3 itself was not associated with drinking behavior within 
strata of ADH2 27~29. Probably, such dependence does not influence the analyses 
described in Chapter 6, as we analyzed the combined effect of ADH3 genotype and 
alcohol consumption against other combinations o£ADH3 and alcohol intake. 
Involvement of mul t ip le polymorphic genes 
If one metabolic enzyme is not expressed or has a reduced substrate affinity or a lower 
stability due to an underlying genetic polymorphism, other metabolic enzymes might 
take over its function. This was indeed found for the GST superfamily, which consists 
of four closely related enzymes with broad substrate specificity30. It may be important to 
consider all the principal genetically polymorphic enzymes possibly involved in the 
metabolism of the carcinogen under study. Methods to genotype many polymorphisms 
at once are rapidly evolving 31, but most epidemiological studies so far do not have 
enough power to include many polymorphic genes (see under 'Sample size requirements'). 
In spite of the availability of these methods, we might not be able to study all genes in a 
single pathway, simply because for most metabolic routes, not all the genes involved will 
be known. Moreover, it is not exactly known which are the interactions between the 
different enzymes involved in the same metabolic route. Some researchers, when 
including several polymorphisms in one epidemiological study, found indicative gene-
gene interactions (e.g., between GSTs 32 and between NAT1 and NAT2 33,34), whereas 
others did not find evidence for such associations 35. Whether such interactions are 
important remains unclear. On the one hand, studies that failed to detect such 
interactions may have had insufficient power, but on the other hand, the comparison of 
multiple combinations may have led to the finding and publication of some spurious 
associations. 
A S S E S S M E N T OF E N V I R O N M E N T A L EXPOSURE 
Obviously, the assessment of exposure to environmental risk factors may be prone to 
errors and does not directly reflect the amount of the ultimate carcinogen (effective 
dose) to which the target tissue becomes exposed. The events leading from 
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environmental exposure, measurable in traditional epidemiological studies, to the 
ultimate effective dose of the corresponding carcinogen are shown in Figure 8.1. 
With respect to assessment of exposure, three issues are important, namely correct 
assessment of certain sources of potential carcinogens (i.e., diet, smoking), assessment of 
exposure to specific carcinogens, and assessment of the effective dose of a carcinogen, 
which is determined by a cascade of events starting with absorption (Figure 8.1). 
Exposure to environmental (and especially dietary) factors is difficult to assess 1'3M8. 
Here, the assessment of exposure to the specific factors studied in this thesis will be 
discussed briefly. Also, problems will be discussed that may occur with assessment of 
exposure to potential carcinogens in relation to the effective dose of the ultimate 
carcinogen, which may initiate DNA mutations and ultimate tumor formation (Figure 
8.1). 
carcinogen 
source A 
carcinogen 
source B 
other substances 
carcinogens 
anti-carcinogens 
Figure 8.1. Relation of measured exposure (carcinogen of source A) to the ultimate 
carcinogen and neoplasm risk. 
De te rmina t ion of exposure 
The quality of the assessment of environmental exposure in our studies is comparable to 
that applied in other studies. For the assessment of dietary habits in the adenoma case-
control study (Chapters 4-6), we used a validated self-administered semi-quantitative 
food frequency questionnaire 39, of which reproducibility and validity were judged 
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sufficiently high (i.e., median correlation coefficients for relative validity 0.6), although 
the relative validity for some food groups, such as vegetables and fish, was low (i.e., 
r<0.4) 39,4°. Correlation coefficients for the reproducibility and relative validity of alcohol 
consumption were high (r>0.8 and r>0.7, respectively) 39. Meat consumption was 
assessed by a questionnaire that has not yet been validated but that yielded estimates 
correlating well with meat consumption assessed from the food frequency questionnaire 
(c=0.7 - 0.9), which was reported to have a reproducibility of about 0.7 and a relative 
validity of about 0.5 39. The individual reproducibility of preparation habits assessed for 
beef patties was high (Cohen's K=0.8, see Chapter 4), 
In the prospective nested case-control study on colorectal cancer, dietary habits were 
estimated by a short semi-quantitative food frequency method validated using a dietary 
history method (Chapter 7) 41. Spearman rank correlation coefficients for the 
reproducibility of meat intake were about 0.6, and between 0.4 and 0.5 for relative 
validity. 
Current smoking rates might have been underreported to a small extent 42. 
Underreporting of current smoking in our studies was not considered important, as 
smoking rates within the adenoma study population did not differ from rates observed 
in a random sample of the general population and were also similar to rates reported by 
non-participants (see Chapter 2). The frequency of cigarette smoking among controls of 
the nested case-control study was equal to that in the general Dutch population by 1989, 
when the cohort was enrolled *. 
Differential misclassification can result from under- or over-reporting of certain 
exposures or to differential recall, as has been discussed in detail elsewhere \ In this 
respect, alcohol consumption may be underestimated especially by heavy drinkers. If 
heavy drinking increases the risk of colorectal adenomas, than this risk might be 
underestimated if heavy drinkers underestimate the number of drinks they consume. 
Thus, misclassification of exposure (especially to dietary factors) may have attenuated 
the effects of exposure on disease in our studies. 
Actual intake of relevant carcinogens 
For many carcinogens, it is difficult to estimate the actual intake of the specific 
carcinogen of interest correctly. One example is the estimation of HCA concentrations 
in well-done meat. Preparation of meat at high temperatures was consistently found to 
increase HCA concentrations in laboratory studies 4346, but HCA concentrations in beef 
patties prepared as habitual at home by volunteers did not clearly correlate with height 
of the heat source (used as proxy for cooking temperature, Chapter 4). Thus, estimation 
of exposure to HCAs by use of databases in which this exposure is imputed from 
* See http:Wwww.cbs.nl; Centraal Bureau voor de Statistiek, 2001. 
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laboratory assessments 475n has its limitation as it may not correctly reflect the true 
exposure. 
Large variations in the intake of HCAs and PAHs from meat can be expected, as these 
are the result of varying preparation methods 5I. If the concentration of carcinogens is 
considered to be relatively constant, like in manufactured cigarettes, it may still vary over 
time and over different brands 52. Besides, several measurable exposures, such as 
cigarette smoke, may contain many more carcinogens than just the carcinogen of 
interest 52. Also, not all the potential sources of exposure may be known, and not all 
known sources of a certain exposure might have been assessed. For example, PAH can 
originate from cigarette smoke and from barbecued meat, but also from many other 
sources, such as occupational exposure, or through contamination of dietary 
components (especially grains) 53. However, in most situations, the main source of 
exposure will be evaluated. For instance, in our study population, PAH exposure 
probably mainly originated from cigarette smoke, as occupational exposure will have 
occurred in only a few subjects, and contamination of dietary components was probably 
less important (see the Appendix to this thesis). 
Absorption of carcinogens 
The absorption of carcinogens may depend on the matrix in which they are ingested. 
For example, when consumed with dietary fiber that may bind carcinogens or decrease 
bowel transit time, exposure of the colon epithelium to potential carcinogens may be 
decreased 5. Carcinogens may also interact with anti-carcinogens leading to 
inactivation 54 or may be bound by human colon microflora 55. Furthermore, genetic 
control of absorption may occur through control of membrane-bound proteins 
facilitating the absorption of complex substances 56. 
Effective dose of carcinogens 
To damage D N A of colon epithelial cells, the absorbed carcinogens need metabolic 
activation and subsequent transportation to the tissue where the D N A damage is 
induced. Potential carcinogens can be transported directly to the target tissue where 
metabolic activation takes place, but mainly, they undergo metabolism in the liver, after 
which carcinogenic metabolites may be transported to the target tissue. Here, further 
metabolic activation can occur depending on the expression of specific metabolic genes 
in that tissue, as was proposed for HCAs 57. During transport, carcinogens may be bound 
to proteins and this process may also be under genetic control56. 
Metabolism of potential carcinogens occurs via complex pathways involving many 
enzymes of which a large proportion is encoded by polymorphic genes. These metabolic 
pathways are under complex control of many genetic and environmental factors 58'5961. 
This especially applies to phase I cytochrome P450 enzymes 61'62, but, more recently, it 
was discovered that induction and inhibition of several phase II enzymes also occurs M. 
135 
CHAPTER 8 
A specific carcinogen may also be metabolized via alternative pathways, as was found for 
many potential carcinogens such as benzo[a]pyrene M and ethanol65. The complexity of 
carcinogen metabolism was clearly illustrated with a figure of the breakdown of 
arylamines by Grant and colleagues 66 (see Figure 1.2, Chapter 1, for a simplified 
reproduction of the metabolism). 
If one of the metabolic enzymes is not or less functional due to a genetic polymorphism, 
other enzymes may compensate for this particular enzyme, as discussed before (see 
under 'Involvement of multiple polymorphic genes'). Further, metabolic enzymes, such as 
mEH, have broad substrate specificity and may therefore be involved in the metabolism 
of many potential carcinogens 67. Besides, some enzymes (e.g., mEH and NATs) may be 
involved both in carcinogen detoxification and in activation, the process being 
dependent on the chemical properties of the intermediary metabolites formed 67. 
Thus, the sum of all these processes determines the nature and concentration of the 
final metabolites of a specific carcinogen and thus, the effective dose. In fact, the final 
effective dose of the ultimate carcinogen may be too low to result in increased risk of 
neoplasm 14. 
Ini t ia t ion of t u m o r formation 
If the ultimate carcinogen reaches the target tissue and indeed induces DNA damage, an 
effect on neoplasm risk is only expected when the damage (such as D N A adducts) is not 
repaired. It is possible that the ultimate carcinogen mainly forms 'benign' adducts (such 
as protein adducts), of which the relation to cancer is unknown 68. The repair of such 
adducts is under the genetic control of polymorphic genes 69,7°. Multiple genetic 
alterations are required before cells will convert to malignant cells. Probably, the cells 
that have accumulated DNA damage will be most sensitive to the effects of further 
exposure to carcinogenic factors 15. Once a cell has become malignant, it might undergo 
multiple cell divisions to form a tumor, or the damaged cell undergoes programmed cell 
death. Alternatively, mutated cells may be scavenged by cells of the immune system. 
Recent findings indicate that all these processes are also dependent on genetic 
polymorphisms 70. 
Thus, the formation of tumors depends on multiple processes in which environmental 
and genetic factors interact at many levels. More knowledge on these processes is needed 
to investigate the relation of environmental exposure to ultimate tumor formation in 
more detail. 
SAMPLE SIZE R E Q U I R E M E N T S T O STUDY G E N E - E N V I R O N M E N T I N T E R A C T I O N S 
As illustrated above, studies incorporating metabolic polymorphisms might suffer from 
various biases that may attenuate risk estimates. Especially when evaluating potential 
interaction between the genetic polymorphism and exposure under study, important 
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attenuation of risk estimates may occur especially when relatively modest effects are to 
be expected 71, underlining the need for sufficiently large sample sizes. 
For our adenoma case-control study, we calculated sample sizes according to 
Schlesselman 2. With 435 cases and an equal number of controls, we were able to detect 
an odds ratio of about two with a power of 90% for the exposed, genetically susceptible 
group, provided that the frequency of the high-risk genotype is about 40%, and the 
exposure is analyzed in tertiles (see Chapter 2). For the nested case-control study on 
colorectal cancer, with the inclusion of 100 cases and of 500 controls, we calculated that 
the power would be sufficient (i.e. >80%) to detect odds ratios of two given an exposure 
prevalence of minimum 20% 2. Thus, our sample of 102 cases and 537 controls was large 
enough to detect odds ratios of around 2 for single exposures such as meat consumption, 
smoking, or genetic susceptibility as predicted from imputed phenotypes 72,73. 
With these calculations of required sample sizes, we did not aim to evaluate interactions, 
but rather we wanted to evaluate the combined effect of exposure and genetic 
susceptibility, although we had sufficiently large sample sizes to detect interaction odds 
ratios of 3 to 4 with a power of 80% (one-sided oc=0.05, see Table 2.3, Chapter 2), 
which were expected beforehand. However, we only found indications for weak 
interactions (i.e., O R < 2 ; see Table 2.3, Chapter 2). To detect relatively weak 
interactions, large sample sizes are needed 26,74. 
As has been illustrated by Garcia-Closas and Rothman and colleagues 71'7576; 
misclassification can severely bias odds ratios for relatively weak gene-environment 
interactions. The bias will tend to weaken multiplicative interaction terms, resulting in a 
large decrease of study power, but can lead to bias away from the null for additive 
interaction terms while still decreasing study power 71. As misclassification of dietary 
factors 39,41 is considered inevitable whereas minor misclassification may occur in the 
classification of genetic susceptibility, this implies that, in order to detect truly present 
but rather weak gene-environment interactions, very large study populations are needed, 
including several thousands of subjects 71,75. 
The application of large sample sizes, however, has consequences for the quality of the 
data collected and for monitoring of data collection 12. This, in turn, will decrease study 
power and increase the minimum sample size required 75 and might be one explanation 
why no effect of NAT2 and GSTM1 was found in some large studies 9,,°. This example 
illustrates that, although study samples can be expanded to several thousands of subjects, 
sample sizes that can be enrolled feasibly are still limited and adaptations to designs are 
thus needed. 
Future studies 
In the last years, our knowledge about cancer etiology and epidemiology has evolved 
rapidly. A decade ago much less was known about metabolic polymorphisms. For 
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example, NAT1 was thought to be monomorphic, whereas over 20 polymorphic sites 
have been detected to date 7?. Also, it was relatively unknown that, like phase I enzymes, 
many phase II enzymes, such as GSTs, can be induced by a variety of environmental 
factors 63. This has complicated the overall picture of the potential role of metabolic 
polymorphisms in cancer etiology. Nevertheless, epidemiological studies integrating 
data on exposure and genetic susceptibility may be useful to indicate candidate genes 
that may increase individual susceptibility to cancer. It is still possible that these 
metabolic polymorphisms do modify cancer risk, but that we were not able to prove this 
because of lack of biological knowledge, of appropriate study populations, and of 
methodological constraints. 
IMPROVE BIOLOGICAL K N O W L E D G E 
In this paragraph, several possibilities to improve our biological knowledge on the 
potential relation between genetic susceptibility to environmental exposure and 
colorectal cancer will be discussed. Apart from the advantages, potential disadvantages 
will also be discussed. 
Genotypc-phenotype correlat ion 
Although importantly determined by the underlying genotype, it is the enzyme activity 
(phenotype) that determines the potential of formation of ultimate carcinogens. Thus, it 
is important to understand the correlation between genotypes (which can be easily 
incorporated in large epidemiological studies) and the resulting phenotypes. This may 
need a multidisciplinary approach, integrating biochemical studies using recombinant 
D N A techniques, studies investigating enzyme expression and enzyme extracts, and 
studies on the level of metabolites formed by different polymorphic variants 16. The 
results produced by such studies should still be verified in animal and human 
experiments, as the situation in vitro might be quite different from the in vivo situation 
and might also differ between animals and humans '6. 
Inclusion of more metabol ic po lymorphisms 
To study a specific metabolic route of a potential carcinogen in more detail, all the 
known polymorphisms of important enzymes in this route might be considered at once. 
This can be achieved using one of the rapidly evolving high-throughput methods, 
and/or by screening of relevant DNA sequences for new mutations 31. While offering 
many new and exciting opportunities, the use of these techniques may also introduce 
problems. The problem of multiple comparisons is aggravated, and at least some 
spurious associations will be found if the Bonferroni correction for multiple 
comparisons is not applied ". Further, such data might be difficult to interpret, as the 
function of newly detected polymorphisms will not yet be clear. As the groups sharing 
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the same polymorphisms will be relatively small, very large sample sizes are required, 
and the total costs of such a study will be high ". 
An efficient approach to explore differences between cases and control with respect to 
known and new potentially interesting polymorphisms is to pool small aliquots of 
samples from cases and to compare this pooled sample with a pooled sample of all 
controls. This approach may be applied at the level of gene polymorphisms, gene 
expression (by investigating expression profiles), and protein concentrations. The 
subsets that differ most between cases and controls can subsequently be identified, and 
can than be used to evaluate the presence of interaction with environmental risk 
factors n . 
Identif ication of highly susceptible and highly exposed subgroups 
It is possible that the effect of genetic susceptibility is greater for certain subgroups, but 
that this effect is attenuated by the inclusion of many less susceptible groups within the 
group assumed to be 'genetically susceptible' 12. Garte 12 proposed the conduct of 
subgroup analyses comparing the highly susceptible and highly exposed subgroup with 
all other subjects in the study population. However, sound knowledge about metabolic 
routes, exposures, and polymorphisms is needed to identify who are susceptible 12, 
which is not always available. Besides, there should be an identifiable group being highly 
susceptible, and the formation of an ultimate carcinogen should occur at clearly higher 
rate in this group compared to the total population. Moreover, if the susceptible group 
has very specific characteristics and if many factors are known to influence the 
metabolism, then the number of susceptibles might be too small to detect any 
potentially present but still relatively small effect. So far, analyses in subgroups defined 
by multiple genetic susceptibility and exposure factors have indeed resulted in somewhat 
higher odds ratios 12'78, although this increase could also be the result of the fact that risk 
estimates based on small groups tend to be higher '. 
Deve lopment of b iomarkers that can be applied in large popula t ions 
Biomarkers may increase our understanding of the many processes that take place 
between the environmental exposure and ultimate tumor formation 79. The metabolic 
polymorphisms described in this thesis may be considered biomarkers of suscepti-
bility 79, and the incorporation of other biomarkers may be useful. To date, few reliable 
and easily applicable biomarkers are available 80. The measurement of biomarkers is 
often complicated and requires large amounts of biological samples, which may lead to 
decreased participation rates. Most markers reflect recent exposure only and 
concentrations may be modified in the presence of disease 80. Moreover, biomarkers do 
not necessarily reflect the actual exposure or the risk of ultimate disease. Markers of 
absorption do not include information about metabolism. The concentrations of 
markers including this information (e.g., urinary or fecal metabolites or mutagenicity, 
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and protein or DNA adducts in blood) do not necessarily correlate with concentrations 
in the target tissue. DNA adducts measured in the target tissue may be considered as 
markers of disease, although these do not necessarily predict risk of ultimate cancer, as 
most adducts will be repaired 81'82. Similarly, markers that occur after the induction of 
D N A damage, such as aberrant crypt foci, probably do not always develop into tumors. 
Application in epidemiological studies requires biomarkers that can be collected and 
assessed easily, reliably, and at low cost. These biomarkers need to have a proven 
connection with either the (long-term) exposure or the disease, and should, after 
thorough validation, ideally be tested in prospective studies to establish the exact role of 
the marker in carcinogenesis 79. This way, valid biomarkers may help to better 
understand the many processes that take place between the environmental exposure and 
ultimate tumor formation. 
A L T E R N A T I V E S T U D Y DESIGNS 
Adapta t ion of epidemiological study designs 
Very large numbers of cases and controls are needed to study the interplay between 
environmental exposure and genetic susceptibility in neoplasm 75. The enrollment of 
thousands of study subjects may not be feasible, especially if the disease under study is 
rare. Moreover, the application of very large samples may result in weak and biologically 
meaningless associations, which are nevertheless significant. Bayesian statistics, in which 
background knowledge about the associations under study is incorporated in the 
analyses, may help to overcome this problem 83. 
Several alternative study designs by which the potential effects of genetic susceptibility 
to environmental carcinogens can be studied more efficiently have been proposed. 
Assuming that the genetic polymorphism and the exposure under study occur 
independently, Piegorsch and colleagues proposed the case-only design 84. Case-only 
studies include the same cases as would be enrolled for normal case-control studies, but 
no controls. The non-exposed cases are then considered as the pseudo-control group, 
whereas the exposed cases form the pseudo-case group. Odds ratios calculated for the 
effect of genetic susceptibility represent the gene-environment interaction effect 84,85. 
Case-only studies offer better precision than traditional case-control studies, as the 
variability of the control group is excluded, and the power to detect gene-environment 
interaction is comparable to the power calculated for assessment of a single main effect 
in a case-control study 86. However, this design has several disadvantages. First, it is 
questionable whether the assumption of independence between genotype and exposure 
is correct 87. Second, main effects of the exposure and of the genotype cannot be 
considered. Third, these studies would miss gene-environment effects that do not 
depart from multiplicativity, but do nevertheless depart from additivity 86. To be able to 
study main effects in case-only studies, adaptations of this design have been proposed. 
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One of these is the 'incomplete-data' case-control design, in which both genotype and 
exposure are assessed among cases, but only one of these among the controls, so that 
main effects can be studied as well, whereas required sample sizes are half of those 
needed for traditional case-control studies 88. However, this design also requires 
independence between genotype and exposure. To test whether this assumption is valid, 
genotype and exposure data should be collected in a random sample of controls 88. 
Genetic polymorphisms that occur at lower frequencies than those studied in this thesis 
(e.g., lower than 10%) may be studied more efficiently using study designs in which 
susceptible subjects are over-sampled, such as two-stage case-control studies and case-
family studies 86. 
The advantages and disadvantages of these alternative designs should be studied in more 
detail 86. It has to be emphasized that case-control studies are generally conducted with 
multiple purposes, some of which are not attainable using the designs described above. 
In tervent ion studies 
To study the potential influence of genetic susceptibility toward a specific 
environmental exposure factor in more detail, one might conduct a controlled 
intervention study in which intermediate endpoints are used, such as adenoma 
recurrence 89,9°, DNA-adduct formation 91"94, or colon epithelial proliferation 95,96. To 
more efficiently study the effect of genetic susceptibility, susceptible subjects can be 
over-sampled 97. The great advantage of such a design is that a generally occurring 
environmental exposure can be carefully controlled and that the inclusion of several 
biomarkers of exposure or of early effect may increase our knowledge on different 
processes occurring between exposure and cancer. However, intervention studies 
require specific and relatively simple hypotheses 59, as only one exposure and a limited 
number of susceptibility markers can be studied. Moreover, the choice of a suitable 
endpoint is difficult. The association with ultimate cancer is only weak for early 
endpoints such as D N A adducts (and these might even be considered as late markers of 
exposure), and the inclusion of late endpoints, such as recurrence of colorectal 
adenomas 89,9°, might not be feasible as it requires long intervention periods. 
Shifting hypotheses: who did Mg£ get the disease? 
Alternatively, instead of investigating what factors increase colorectal cancer risk, one 
might also investigate which factors protect subjects who are highly susceptible to 
colorectal cancer (such as persons harboring a rare mutation that increases risk of a 
certain cancer dramatically) 98. For example, about 30% of the women carrying BRCA1 
or BRCA2 mutations reaches the age of 70 without diagnosis of breast cancer, and it is 
not known what protects these women. Studies among carriers of highly penetrant 
mutations in mismatch repair genes (leading to hereditary nonpolyposis colorectal 
cancer) or the APC gene (causing familial adenomatous polyposis coli) might increase 
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evidence on protective colorectal cancer factors. The discovery that at least some of the 
mutations found in hereditary and sporadic colorectal tumors are identical suggests 
similar mechanisms of carcinogenesis " . The disadvantage of such studies is that it may 
be difficult to disentangle genetic and exposure effects, as these hereditary disorders are, 
by definition, clustered within families. Moreover, recruitment of study populations 
may be difficult, as the diseases studied are rare, although participation rates may be 
higher. 
Concluding remarks 
Thus far, epidemiological studies have only found weak indications that metabolic 
polymorphisms modify colorectal cancer risk. In the future however, with increasing 
knowledge of the underlying biological processes, we might be able to elucidate the 
influence of metabolic polymorphisms in cancer etiology 10°. At present, the application 
of alternative study designs may help uncovering the role of specific genetic 
polymorphisms. In this respect, the application of intervention studies over-sampling 
genetically susceptible subjects may be promising. Also, epidemiological studies 
including individuals with inherited genetic defects that greatly increase colorectal 
cancer risk may be used. Both these designs are applied in projects currently conducted 
at our division. Certainly, the investigation of the potential influence of metabolic 
polymorphisms on cancer susceptibility needs an integrative approach in which many 
types of studies should be conducted. 
If, in the future, genetic susceptibility to xenobiotics from environmental sources will be 
found to increase colorectal neoplasm risk, this will strengthen the hitherto weak 
evidence that environmental risk factors for colorectal cancer may increase cancer risk 
through their potentially carcinogenic constituents. The frequencies of metabolic 
polymorphisms are high in the general population (generally, between 20 and 60%) and 
the effect of these is expected to be small on an individual level but, because of their 
high frequency, high in terms of population attributable risks 17,18. Future screening of 
the total population for such highly frequent low-penetrance polymorphisms is not 
expected 18. The general population will only be served with genetic screening if the risk 
of developing the disease if susceptible (positive predictive value) is relatively high 
(greater than 50%), which is not to be expected for most metabolic polymorphisms 18. In 
the light of ethical constraints, the relevance of genetic screening should thus be 
thoroughly considered, even if certain subgroups will be found to be highly susceptible 
toward several carcinogens. More gain for cancer prevention is to be expected from 
reduction of potential exposure to carcinogens, e.g. by the application of low-risk meat 
cooking methods, quitting smoking, or reduction of alcohol intake. 
As explained in this Chapter, molecular epidemiological studies alone will not solve the 
issue of genetic susceptibility to carcinogens. The many studies conducted during the 
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last decade have shown that genetic susceptibility is complex and may be important at all 
stages between environmental exposure and the formation of a malignant tumor. 
Cancer, and surely colorectal cancer, is a complex disease evolving via many different 
routes and involving many factors. The exact cascade of processes leading to colorectal 
cancer will be different for each and every individual. For researchers, it remains 
however important to detect common patterns in this complex variety of processes. 
Thus, to study just one or a few metabolic polymorphisms in this cascade is probably 
too simplistic and integrated approaches are needed, requiring new study designs and 
methods for analysis, and involving biochemical and molecular studies, animal 
experiments, and controlled intervention trials, together with studies like the ones 
described in this thesis. 
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Colorectal cancer is the second most common cancer in the Western world, whereas it 
rarely occurs in non-Western, developing countries. Colorectal cancer is thought to arise 
almost uniquely from colorectal adenomas and has been estimated to be attributable to 
environmental exposure (mainly diet) for about 90%. The factors that probably increase 
colorectal cancer risk are (red) meat and alcohol intake, and (long-term) smoking, 
possibly through their potentially (co-)carcinogenic constituents. However, their effects 
were found to be relatively small. Certain subgroups may be more susceptible to specific 
carcinogens than the general population on average, and the risk of colorectal cancer 
resulting from exposure to these substances may be higher in these subgroups. This 
increased susceptibility is thought to arise via polymorphisms in genes that code for 
enzymes metabolizing potential carcinogens. 
Genet ic susceptibility to env i ronmenta l carcinogens 
Most carcinogens need metabolic activation in the human body before they can cause 
DNA damage, and thus, possibly increase cancer risk. This implicates that the 
metabolism of these potential carcinogens is crucial with respect to cancer risk. The 
extent to which potential carcinogens become activated or detoxified depends on the 
(genetically determined) properties of metabolic enzymes and determines the 
individuals' genetic susceptibility to environmentally induced cancer. These properties 
are importantly determined by genetic polymorphisms resulting in differences in 
enzyme activity by alteration of gene expression or differences in enzyme activity, 
stability or substrate affinity. Polymorphisms are associated with a low individual cancer 
risk, but because they occur at high frequency (generally, between 20% and 60%) in 
populations, they could importantly influence population attributable risk. 
Aim o f studies 
In this thesis, we studied the potential influence of genetic susceptibility to carcinogens 
determined by genetic polymorphisms, on associations of meat consumption, (long-
term) cigarette smoking, and alcohol intake with colorectal tumor risk. 
Methods and popula t ion 
For this purpose, efficient and reliable techniques for the detection of genetic 
polymorphisms are needed. In Charjtcr_3, we described the development of such a 
method, the reverse line blot method. The method was tested for N-acetyltransferases 
(NAT) 1 and 2. We demonstrated that our method was reliable (sensitivity and 
specificity, as compared to commonly used methods for NAT1 and NAT2 genotype 
determination, were both 100%), quick, and relatively cheap. Moreover, expansion of 
the method with other allelic variants is achieved relatively easy. Our method is thus 
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useful for the analyses of multiple polymorphisms in relatively large epidemiological 
studies. 
The impact of genetic susceptibility was studied in two populations. The first was a case-
control population recruited among those undergoing endoscopy at the outpatient 
clinics of eight hospitals in the central region of the Netherlands, between June 1997 
and June 2000. The recruitment procedures and the main characteristics of the study 
population were described in Chapter 2. In this chapter, methodological strengths and 
weaknesses of our population were also discussed. After three years of recruitment, 887 
subjects were included, 440 cases and 447 controls. We concluded that the results 
produced from our study population were internally valid, although they should not be 
extrapolated inconsiderately to the general population. The second population 
originated from the prospective cohort recruited within the Monitoring Project on 
Cardiovascular Disease Risk factors, including more than 36,000 men and women 
recruited in three Dutch towns between January 1987 and December 1991. After about 
8.5 years of follow-up, we analyzed data of all cases of colorectal cancer (n=102) that 
had arisen in the cohort and of a random sample of 537 controls frequency-matched 
with cases on age, sex and town. 
Meat 
The association between meat consumption (and preparation) and colorectal neoplasm 
was described in Chapters 4 and 7. At present, it is not known how high meat 
consumption increases the risk of colorectal neoplasm. Possibly, heterocyclic aromatic 
amines (HCAs) which are formed in meat cooked at high temperature may be 
responsible for this increase in risk. We therefore first investigated if HCA exposure 
occurs in the general Dutch population and found that HCAs were indeed present in 
beef patties habitually prepared at home by 63 apparently healthy volunteers. Next, we 
investigated if commonly occurring polymorphisms in genes that encode enzymes 
involved in HCA metabolism modified the associations of meat consumption and 
preparation with colorectal neoplasm. In our adenoma case-control study, we collected 
detailed data on meat consumption and meat preparation. We also determined the 
genotypes of the polymorphic NAT1, NAT2, sulfotransferase (SULT) 1A1, and 
glutathione S-transferase (GST) Ml and Tl genes (see CJiarxCT^I). From the nested 
case-control study on colorectal cancer, we used data on meat consumption and we 
determined genetic polymorphisms ofNATl, NAT2 and GSTM1 (Chapter 7). Meat 
consumption did not increase risk of colorectal adenomas (OR 1.2, 95% CI 0.8-1.9), nor 
did meat preparation methods assumed to be associated with HCA formation increase 
risk, possibly because the preparation methods inquired do not clearly reflect HCA 
concentrations (Chanter_4). Frequent red meat consumption was weakly positively 
associated with increased risk of colorectal cancer (OR 1.6, 95% CI 0.9-2.9, highest vs. 
lowest intake, Ouj) ter7) . We found no strong indications for genetic polymorphisms to 
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modify the association of meat consumption with colorectal neoplasm (Chaj2tci^_4_and 
7). 
Cigare t te smoking 
To investigate the potential association between (long-term) cigarette smoking and 
colorectal neoplasm in more detail, we incorporated data on genetic polymorphisms 
encoding enzymes that metabolize cigarette smoke carcinogens, such as arylamines and 
polycyclic aromatic hydrocarbons. Results for colorectal adenomas were presented in 
Oiaj?terJ}, whereas results for colorectal cancer were described in Chapter 7. We found 
that cigarette smoking was a relatively strong risk factor of colorectal adenomas and that 
this risk was mainly determined by smoking duration. Smoking for more than 25 years 
more than doubled adenoma risk (OR 2.4, 95% CI 1.4-4.1). Cigarette smoking was 
most strongly associated with adenomas less than 1 cm in size and of tubular histology. 
The association between long-term cigarette smoking and adenomas was most 
pronounced in those with inherited variants of SULT1A1 leading to fast sulfation (OR 
4.3, 95% CI 1.6-11.8), and of NAT2 encoding slow acetylation (OR 3.5, 95% CI 1.9-
6.4), although we found no indications for statistically significant interactions (i.e., more 
than multiplicative). We found no indications of effect modification by genetic 
polymorphisms of epoxide hydrolase (EPHX) at exons 3 and 4, GSTM1 and GSTT1. 
The frequency of the imputed NAT1 slow phenotype was too low to allow evaluation of 
potential effects (Chapter 5). Similar to colorectal adenomas, risk of colorectal cancer 
was also increased with smoking duration, although this association was found among 
former smokers only (OR 2.7, 95% CI 1.0-7.4, for 16-30 years of past smoking and OR 
3.2, 95% CI 1.0-9.8, for more than 30 years of past smoking, compared to former 
smokers having smoked for less than 16 years). In this nested case-control study, we 
found no indications for any of the studied genotypes to modify this association 
(Chapter 7). 
Alcohol 
Finally, we studied modification of the association between alcohol consumption and 
colorectal adenomas by the alcohol dehydrogenase (ADH) 3 genetic polymorphism. The 
results are described in Chapter 6. Alcohol consumption in itself was a risk factor for 
colorectal adenomas, especially among women drinking ten or more beverages weekly 
(OR 1.8, 95% CI 1.0-3.2) in comparison with women drinking less than one 
consumption per week. Risk of adenomas among men was increased only 'with 
consumption of more than 21 drinks per week (OR 1.8, 95% CI 0.9-3.8). Although the 
risk of adenomas was highest among those with the ADH3 fast imputed phenotype, we 
found no strong indications that the ADH3 polymorphism indeed modifies the 
association between alcohol drinking and colorectal adenomas. 
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Discussion and concluding remarks 
In summary, the results of our studies do not point toward strong modifying effects of 
genetic polymorphisms of enzymes involved in carcinogen metabolism, although weak 
indications were found that some genetic polymorphisms might indeed cause subjects to 
be more susceptible toward environmental carcinogens. These findings are in 
accordance with the growing amount of epidemiological studies incorporating data on 
metabolic polymorphisms (see Chapters 1 and 8). The modifying effects of genetic 
polymorphisms may be diluted in several ways, of which one is carcinogen metabolism. 
Most carcinogens are metabolized via various complex metabolic routes, involving 
numerous genetically polymorphic metabolic enzymes, which are under the complex 
control of many other genes and environmental substances. The sum of all these 
processes determines the nature and concentration of the final metabolites and thus, the 
effective dose of the carcinogen, thereby influencing ultimate tumor risk. It is also 
possible that the statistical power to detect relatively weak interactions between 
environmental exposures and genetic susceptibility was insufficient because it rapidly 
decreases in the presence of misclassification. Misclassification of environmental and 
especially dietary exposure assessed via self-administered questionnaires is considered 
inevitable, but misclassification may also occur in the determination of genetic 
polymorphisms and subsequent imputation of phenotypes, as phenotype-genotype 
correlations are not always clear. 
Apart from the fact that more knowledge is needed on the diverse factors involved in 
carcinogenesis, to study the impact of genetic susceptibility on colorectal tumor risk, 
alternative methods are needed using an integrated approach. Intervention studies 
among genetically susceptible subjects, in which the environmental exposure factor of 
interest is carefully monitored and several markers of exposure and disease are 
incorporated, might be most promising. Further, epidemiological studies may include 
individuals with inherited genetic defects that greatly increase colorectal cancer risk to 
investigate why some subjects are not affected with cancer. Both these designs are 
applied in projects currently conducted at our division. 
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- voor iedereen die meer over het onderzoek wit weten-
De titel van het proefschrift in het Nederlands luidt: 
Vlees, roken, alcohol en dikke darm tumoren: 
de rol van aangeboren gevoeligheid 
D a r m k a n k e r : voo rkomen en onts taan 
In landen met een hoge levensstandaard is dikke darmkanker een van de belangrijkste 
vormen van kanker. In Nederland worden er elkjaar ongeveer 6000 nieuwe gevallen van 
dikke darmkanker geconstateerd. Darmkanker komt even vaak voor bij mannen als bij 
vrouwen. Bij mannen komt het na longkanker en prostaatkanker het meeste voor, 
terwijl het bij vrouwen na borstkanker de meest voorkomende kankersoort is. In Figuur 
1 is geillustreerd hoe darmkanker waarschijnlijk ontstaat. 
normaal 
weefsel 
poliep kanker 
dikke 
darmwand 
spierlaag 
ontaarde eel 
uitzaaiingen naar andere 
weefsels 
t i jd 
(5 a 10 jaar) 
Figuur 1. Van normaa] dikke darmwccfsel naar kanker. 
Dikke darmkanker ontstaat voornamelijk uit zogenaamde adenomateuze dikke 
darmpoliepen (Figuur 2), goedaardige gezwellen in de dikke darm. Lang niet alle 
poliepen ontaarden uiteindelijk in kanker. Uit voorzorg worden echter alle poliepen die 
worden gevonden tijdens een kijkonderzoek van de dikke darm (endoscopic) 
verwijderd. Zowel poliepen als kankergezwellen noemen we tumoren, hoewel de eerste 
(nog) goedaardig zijn. 
153 
SAMENVATTING 
Risicofactoren en aangeboren gevoeligheid 
Het is nog lang niet duidelijk hoe dikke • B P I H ^ ^ ^ I F ieuur 2 
darmkanker precies ontstaat. Wei lijken het eten ' . ^ ^ ^ ^ ^ ^ l Voorbedden 
van veel vlees, het bereiden van vlees bij hoge \£> « J ^ ^ ^ | van dikke 
temperaturen, het drinken van alcohol en het i s Z l ^ E B ^ B H darmpolicpen. 
langdurig roken de kans op dikke darmkanker te 
verhogen. Hoe dat precies gebeurt, is niet 
duidelijk. Wei weten we dat vlees, alcohol en 
sigaretten kankerverwekkende stoffen kunnen 
bevatten. De resultaten van onderzoek naar de 
risicofactoren voor dikke darmkanker en 
-poliepen zijn echter niet eenduidig. Soms, maar lang niet altijd, blijkt uit onderzoek dat 
deze factoren de kans op kanker licht kunnen verhogen. Een mogelijke verklaring 
hiervoor is dat vlees, alcohol en sigarettenrook niet voor iedereen even schadelijk zijn, 
omdat de gevoeligheid van mensen voor kankerverwekkende stoffen gedeeltelijk is 
aangeboren. Op deze manier kan erfelijkheid dus een rol spelen bij de manier waarop 
het lichaam met schadelijke stoffen uit onze omgeving en uit onze voeding omgaat. 
E E N V O O R B E E L D 
Een goed voorbeeld van aangeboren gevoeligheid is de relatie tussen de kleur van de 
huid (erfelijk) en blootstelling aan zonlicht. Mensen met een lichte huid verbranden 
sneller dan mensen met een donkere huid en hebben bovendien een hogere kans op het 
krijgen van huidkanker door zonlicht. We kunnen in dit geval niet spreken van een 
erfelijke ziekte, omdat lang niet alle mensen met een lichte huid huidkanker krijgen -
zelfs niet als ze veel en lang in de zon zitten. Bovendien gaat het om een veel 
voorkomende variatie in het DNA: er zijn immers heel veel mensen die een lichte 
huidkleur hebben. Wei zeggen we dat mensen met een lichte huid een aangeboren 
gevoeligheid hebben voor het krijgen van huidkanker door zonlicht. Zo is het ook met 
de vormen van darmkanker waarnaar wij onderzoek hebben gedaan. Wij onderzochten 
bepaalde veel voorkomende variaties in het erfelijke materiaal die ervoor kunnen zorgen 
dat iemand gevoeliger is voor bepaalde mogelijk kankerverwekkende stoffen. Benadrukt 
dient te worden dat we geen zeldzame erfelijke afwijkingen onderzochten die in bijna 
alle mensen met die afwijking tot dikke darmkanker leiden. 
Activering van mogelijk kankerverwekkende stoffen 
Kankerverwekkende stoffen zijn meestal pas echt schadelijk na activering in het lichaam. 
Na opname door de darmen worden deze stoffen naar de lever getransporteerd, waar ze 
worden omgezet in andere stoffen. Voordat ze onschadelijk kunnen worden gemaakt, 
moeten deze stoffen eerst worden geactiveerd. De geactiveerde stoffen zijn het meest 
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schadelijk. Aan deze geactiveerde stof (ook wel de schadelijke metaboliet genoemd) kan 
een zogenaamde ontgiftende groep worden gekoppeld, waardoor de stof onschadelijk 
wordt (Figuur 3). Enzymen kunnen deze omzettingen vergemakkelijken. Door variaties 
in deze enzymen varieert de snelheid van de omzettingen. 
1 
deze stof komt 
het lichaam binne 
fase I: 
activatering 
» < \-
. I r 
11
 t 
enzym A 
fase I I : 
ontgifting 
enzym B 
deze stof i i i i j r 
n (de schadelijke metaboliet) ^ • • i r 
kan DNA schade * 
veroorzaken 
ontgiftende 
groep 
y J 
A 
deze stof is onschadelijk 
en kan na eventuele 
verdere bewerkingen 
het lichaam verlaten 
Figuur 3, Schema van de ornzctdng (het metabolisme) van mogelijk kankcr-
verwekkende stoffen in het menselijk lichaam. 
Uit Figuur 3 kunnen we afleiden dat de eerste fase (activatering door enzym A) snel 
gevolgd wordt door de tweede fase (ontgifting door enzym B). Als op de een of andere 
manier het proces na de eerste fase stagneert (bijvoorbeeld doordat enzym A zeer snel 
werkt, of doordat enzym B niet goed werkt), kan er stapeling van de geactiveerde stof 
(de schadelijke metaboliet) ontstaan. Deze schadelijk metaboliet kan binden aan het 
D N A en dit kan tot gevolg hebben dat de eel niet meer normaal zal functioneren en een 
tumorcel wordt. N u komt de aangeboren gevoeligheid die wij hebben bestudeerd in 
beeld. In veel gevallen is het namelijk erfelijk bepaald hoe goed enzym A en B 
functioneren. Daarom is het mogelijk dat de ene mens bij een zelfde dosis van een 
mogelijk schadelijke stof (bijvoorbeeld door dezelfde hoeveelheid sigaretten per dag te 
roken), toch veel meer aan de schadelijke metabolieten van deze stof is blootgesteld dan 
de andere mens. 
Doe! van ons onde rzoek 
Toen we met het onderzoek dat in dit proefschrift is beschreven begonnen, wisten we 
nog maar weinig over deze vorm van aangeboren gevoeligheid voor dikke darmkanker. 
Het enige dat we wisten was dat vlees, alcohol en sigarettenrook de kans op darmkanker 
kunnen verhogen, maar hoe precies wisten we niet. We dachten dat dat wel eens aan de 
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eventuele schadelijke stoffen in deze producten zou kunnen liggen. Als deze schadelijke 
stoflfen hiervoor inderdaad verantwoordelijk zijn, dan zouden mensen die gevoelig zijn 
voor die stof (die dus veel van de schadelijke metaboliet aanmaken), een hogere kans op 
darmkanker moeten hebben dan mensen die hiervoor niet of minder gevoelig zijn. 
We vroegen ons het volgendc al: 
- Verhoogt het eten van vlees, het bereiden van vlees bij hoge temperaturen, het 
drinken van alcohol en het roken van sigaretten de kans op dikke darmtumoren? 
- Speelt aangeboren gevoeligheid voor kankerverwekkende stoffen uit deze producten 
hierbij een rol? 
Dit werd apart onderzocht voor darmpoliepen (zie Hoofdstuk 4 tot en met 6) en voor 
dikke darmkanker (zie Hoofdstuk 7). 
O p z e t van het, onderzock 
Het onderzoek naar dikke darmpoliepen, de POLIEP-
studie (Figuur 4), werd uitgevoerd in acht ziekenhuizen 
in Nederland tussen juni 1997 en juni 2000. Voor dit 
onderzoek vroegen we alle mensen bij wie tijdens een 
kijkonderzoek in de dikke darm adenomateuze poliepen 
waren gevonden om deel te nemen (patienten). Ook 
vroegen we mensen bij wie juist geen poliepen waren 
Figuur 4. Logo van de gevonden om mee te doen (controles). Al deze mensen 
POZJiiP-studie. kregen een aantal vragenlijsten waarmee we hun 
voedingspatroon, medicijngebruik, en overige leef-
gewoonten probeerden te achterhalen. Ook stonden alle mensen wat bloed af waaruit 
wij DNA isoleerden om er erfelijke variaties in te bepalen. Er deden uiteindelijk 440 
mensen met poliepen en 447 mensen zonder poliepen mee aan het onderzoek. Details 
over deze onderzoekspopulatie zijn beschreven in Hoofdstuk 2. 
De invloed van erfelijke gevoeligheid bij dikke darmkanker werd onderzocht in een 
groot onderzoek, uitgevoerd door het Rijksinstituut voor Volksgezondheid en Milieu 
(RIVM). Voor dit onderzoek werden in Amsterdam, Doetinchem en Maastricht 
gedurende vijf jaar (januari 1987 tot en met december 1991) alle personen tussen de 20 
en de 59 jaar oud benaderd. Deze mensen werd gevraagd of ze vragenlijsten wilden 
invullen en een beetje bloed wilden afstaan. In totaal deden er meer dan 36.000 mensen 
aan dit onderzoek mee. Ruim acht jaar na aanvang van het onderzoek bleek dat in deze 
groep 102 mensen dikke darmkanker hadden gekregen. Deze groep van 102 mensen (de 
patienten) werd vergeleken met een groep van 537 mensen zonder kanker (de controles) 
die aan hetzelfde onderzoek meededen. Uit het bloed dat bij deze mensen was 
verzameld werd D N A gei'soleerd, zodat we de aangeboren gevoeligheid voor mogelijk 
kankerverwekkende stoffen uit vlees en sigarettenrook konden bepalen. 
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In beide onderzoeken vergeleken we de eet- en rookgewoonten van de mensen met 
darmpoliepen of darmkanker (de patienten) met die van de controlegroep. Zo konden 
we zien of mensen met darmpoliepen bijvoorbeeld over het algemeen meer vlees aten of 
meer rookten dan mensen zonder darmpoliepen. Uit deze vergelijkingen konden we 
vervolgens de kans op darmpoliepen of darmkanker afleiden, onder andere voor het eten 
van veel ten opzichte van weinig vlees. 
Rcsultaten: Vlees 
Als vlees bereid wordt bij zeer hoge temperaturen kunnen er kankerverwekkende 
stoffen in ontstaan. Deze stoffen worden omgezet door enzymen die erfelijke variaties 
vertonen. We konden deze schadelijke stoffen aantonen in vlees bereid door 
Nederlanders, maar mensen die vaak vlees aten hadden niet meer kans op poliepen dan 
mensen die weinig vlees aten. Wei leek het erop dat mensen die elke dag varkens-, 
rund-, of ander 'rood' vlees aten ongeveer anderhalf keer zoveel kans hadden op het 
krijgen van dikke darmkanker dan mensen die dit minder dan vijf keer per week aten. 
We konden echter niet vaststellen dat dit verschil in risico niet op toeval berustte. We 
vonden geen aanwijzingen dat aangeboren gevoeligheid voor kankerverwekkende 
stoffen hierbij een rol speelde. 
Resul taten: Roken 
Het is algemeen bekend dat roken schadelijk is voor de gezondheid. Roken wordt vooral 
in verband gebracht met hart- en vaatziekten en longkanker. Het wordt steeds 
duidelijker dat het ook de kans op andere vormen van kanker, zoals dikke darmkanker, 
kan verhogen. We konden aantonen dat mensen die gedurende lange tijd (meer dan 25 
jaar) sigaretten rookten of hadden gerookt, bijna tweeeneenhalf keer zoveel kans hadden 
op het krijgen van dikke darmpoliepen als mensen die nooit gerookt hebben. Ditzelfde 
gold ook voor darmkanker: mensen die langer dan 16 jaar hadden gerookt, hadden 
ongeveer drie keer zoveel kans darmkanker te krijgen dan mensen die nooit hadden 
gerookt. De schadelijke stoffen in sigarettenrook kunnen door verschillende enzymen 
worden geactiveerd, waarvan sommige in verschillende varianten voorkomen. Er waren 
inderdaad verschillen tussen mensen met snelwerkende en langzame varianten van 
enkele van deze enzymen, maar die verschillen waren erg klein. Zo bleek dat de kans op 
dikke darmpoliepen groter is bij rokers die de 'snelle' variant van het enzym 
sulfotransferase (vergelijkbaar met enzym A in Figuur 3) hadden, dan onder rokers die 
een 'langzame' variant hadden. Verder verhoogden 'langzame' varianten van N-
acetyltransferase (vergelijkbaar met enzym B in Figuur 3) de kans op dikke 
darmpoliepen onder rokers. 
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Resul ta ten: Alcohol 
Wij vonden in ons onderzoek een verband tussen het drinken van alcohol en het 
v66rkomen van dikke darmpoliepen. Dit verband was sterker voor vrouwen dan voor 
mannen. Vrouwen die meer dan tien glazen alcohol per week dronken hadden een bijna 
twee keer zo hoge kans op poliepen dan vrouwen die minder dan een glas per week 
dronken. Een zelfde risicoverhoging werd bij mannen pas gevonden als ze meer dan 21 
glazen per week dronken. Uit onderzoek is bekend dat een afbraakproduct van alcohol, 
aceetaldehyde, veel schadelijker is dan alcohol zelf. Het enzym alcoholdehydrogenase zet 
alcohol om in aceetaldehyde. Dit enzym heeft enkele erfelijk bepaalde varianten. De 
'snelle' variant verhoogt mogelijk de kans op dikke darmpoliepen omdat er stapeling van 
het schadelijke aceetaldehyde kan plaatsvinden. In ons onderzoek vonden we echter 
geen sterke aanwijzingen hiervoor. 
blootstelling 
aangeboren 
gevoeligheid 
4 
7 kanker 
Figuur 5. Dikke darmkanker: een zwarte doos? 
Diseussie en conclusie 
Ons onderzoek bevestigde dat het eten van vlees, het drinken van alcohol en het 
langdurig roken van sigaretten de kans op dikke darmtumoren kunnen verhogen. We 
vonden echter geen aanwijzingen voor een belangrijke rol van aangeboren gevoeligheid 
voor mogelijk kankerverwekkende stoflfen afkomstig uit deze producten. Onze 
resultaten kwamen goed overeen met die van andere onderzoekers. Dit wil echter niet 
zeggen dat aangeboren gevoeligheid niet belangrijk is. Het is goed mogelijk dat 
aangeboren gevoeligheid wel een rol speelt, maar dat we deze rol niet zichtbaar konden 
maken. Kanker kan worden gezien als een 'zwarte doos'. We weten immers maar weinig 
over het ontstaan ervan en vaak hebben we alleen informatie over de blootstelling aan 
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een bepaalde risicofactor (bijvoorbeeld roken) en de uiteindelijke 'ziekte' (darmkanker 
of darmpoliepen). Door het bestuderen van aangeboren gevoeligheid hoopten we meer 
informatie te krijgen over het belang van blootstelling aan kankerverwekkende stoffen 
bij het ontstaan van darmkanker. Echter, we tasten nog steeds in het duister over wat er 
nu precies gebeurt. De 'zwarte doos' van kanker is eigenlijk niet veel kleiner geworden 
(Figuur 5). Dat komt misschien omdat het ontstaan van tumoren een complex en 
langdurig proces is, waarbij veel verschillende factoren van binnen en buiten het lichaam 
een rol spelen. Vaak is het al moeilijk om de blootstelling aan een bepaalde 
kankerverwekkende stof te meten, bijvoorbeeld omdat deze afkomstig kan zijn van 
verschillende bronnen en ook nog varieert in de tijd (sigaretten zijn in de loop van de 
jaren bijvoorbeeld minder giftige stoffen gaan bevatten). Daarnaast is het afhankelijk van 
bijvoorbeeld de voeding hoeveel het lichaam van de stof opneemt. Bij activering van de 
stof in de lever speelt vervolgens aangeboren gevoeligheid een rol. Na activering wordt 
een deel van de stof naar de dikke darm getransporteerd en kan daar DNA-schade 
veroorzaken. Gelukkig kan DNA-schade in veel gevallen worden gerepareerd. Pas als er 
ernstige schade aan het D N A is ontstaan die niet wordt gerepareerd, dan kan de eel 
ontaarden en kwaardaardig worden. Sommige cellen zijn echter zo ernstig beschadigd, 
dat ze dood gaan en niet kwaardaardig worden. Uit het bovenstaande blijkt dat kanker 
een proces is waar vele stappen aan vooraf gaan (Figuur 6). Pas als het bij al die stappen 
'fout' gaat, zal een tumor ontstaan. 
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blootstelling uit 
andere bronnen 
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opname in lichaam, 
transport naar lever 
n 
werkelijke 
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geactiveerde 
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— » | DNA-s :hade |—*\ tumor | 
Figuur 6. Kanker ontstaat na vele stappen, Deze Figuur geeft een vcrsimpelde 
weergave van dit complexc proces. NB: tusscn DNA-schade en de vorming van een 
tumor zircen ook nog vele stappen die hier niet zijn weergegeven. 
O m dikke darmkanker beter te kunnen bestrijden is meer inzicht over het ontstaan 
ervan nodig. Meer inzicht kunnen we waarschijnlijk alleen krijgen door op veel vlakken 
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meer onderzoek te doen. Zo moeten we bijvoorbeeld te weten komen welke enzymen 
nog meer belangrijk zijn bij de omzetting van mogelijk kankerverwekkende stofFen, 
welke aangeboren varianten er van deze enzymen bestaan en wat het effect is van deze 
varianten op de omzetting van de kankerverwekkende stofFen. Daarnaast moeten we ook 
meer weten over de blootstelling aan mogelijk kankerverwekkende stoffen en over de 
gevolgen van deze blootstelling. Onderzoek naar het effect van aangeboren gevoeligheid 
op het ontstaan van dikke darmkanker vereist dus onderzoek vanuit verschillende 
wetenschapsgebieden. Hierbij zal epidemiologisch onderzoek zoals beschreven in dit 
proefschrift, zeker een belangrijke rol blijven spelen. 
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Role of EPHX in the associations of smoking and diet with 
colorectal adenomas 
E.W. Tiemersma, J. Kloosterman, A. Bunschoten, F.J. Kok, and E. Kampman 
Abstract; IARC Scientific Publications, in press 
Introduction 
Humans can be exposed to polycyclic aromatic hydrocarbons (PAH) via cigarette smoke and 
possibly, via intake of foods containing PAH residues formed during production, packaging, or 
preparation of food. PAH are metabolized by the microsomal epoxide hydrolase enzyme, 
encoded by the polymorphic EPHX gene. Polymorphisms occur in the third and fourth exon. 
The exon 3 polymorphism leads to a tyrosine (Y) 113 —> histidine (H) substitution in 30-35% of 
Caucasians, resulting in a markedly lower enzyme activity in HH homozygotes. A histidine (H) 
139 —> arginine (R) substitution in exon 4 leads to a higher enzyme activity and is found in 15-
20% of Caucasians. As EPHX is involved in both activation and detoxification of PAH, genetic 
variation in the underlying gene may influence the rate of PAH metabolism, and through that, 
the effect of smoking and intake of foods potentially containing PAH residues on the risk of 
colorectal adenomas. 
Methods 
Cases (n=385) and polyp-free controls (n=396) were recruited from an ongoing study between 
1997 and 2000 among those undergoing endoscopy at the outpatient clinics of eight Dutch 
hospitals. Eligible subjects were Dutch speaking, of European origin, aged 18 to 75 years at time 
of endoscopy, had no hereditary colorectal cancer syndromes, chronic inflammatory bowel 
disease, history of colorectal cancer, or previous bowel resection. We also excluded subjects with 
only hyperplastic or unknown types of polyps. 
Smoking and habitual consumption of foods known to be possibly containing PAH residues 
(e.g., (barbecued) meat, green leafy vegetables, and fat and oil) were assessed through self-
administered questionnaires, one of which was a validated semi-quantitative food frequency 
questionnaire described in detail elsewhere '. Information on histology of excised polyps was 
obtained through medical files. Blood samples were drawn from all participants for DNA 
extraction. EPHX polymorphisms in exon 3 and 4 were determined as we described previously2. 
Exposure variables describing smoking habits and consumption of relevant foods were divided 
in quartiles based on the distribution in the control group. We considered the highest exposure 
category and the slow genotypes of EPHX, i.e. YH and HH for exon 3 and HH for exon 4, as 
high-risk categories. We calculated odds ratios adjusted for age, gender, and constipation history, 
and several other potential confounders, depending of the variable under study. 
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Resul ts 
Selected characteristics of the study population are summarized in Table A.l . Exposure to 
cigarette smoke was higher among cases than among controls. Also, cases consumed more fat 
and oil and green leafy vegetables than controls. The distributions of EPHX exon 3 and 4 
polymorphisms did not differ between cases and controls. 
Table A.2 shows risk estimates for colorectal adenomas for the total population and for EPHX-
defined subgroups. Smoking increased risk of colorectal adenomas. For exon 3, this risk was 
confined to those with the fast (YY, YH) genotype. There was no difference in risk between 
carriers of fast or slow variants of exon 4. Intake of fat and oil was also positively associated with 
adenomas, but there were no differences between the EPHX variants. Total meat intake, green 
leafy vegetables consumption, and barbecue frequency were not associated with adenomas, and 
EPHX genotype did not influence these associations (data not shown). 
T a b l e A. l . (iuieral chaiuctcristics of the study population. 
Sex, % male 
Age, years 
BMI, kg/m2 
History of constipation in last three years, % 
Ever smoked cigarettes, % 
Cigarette smoking, pack-yearsb 
Total energy, kj/day 
Fat and oils, g/day 
Vegetables, g/day 
Green leafy vegetables, g/day 
Total meat, g/day 
Barbecue, frequency/year 
EPHX exon 3 genotype, % fast (YY) 
EPHX exon 4 genotype, % fast (HR or RR) 
Cases 
n=385 
54.0 * 
59.5 ± 10.5' 
26.1 ±3.8" 
26.2* 
62.4" 
25.0 ± 20.7 * 
8725 ± 2594 
27.5 ± 14.7 * 
127.9 ± 52.3 
23.8 ± 17.8a 
109.4 ± 54.2 
3.1 ± 8.0a 
49.4 
34.8 
Controls 
n=396 
37.6 
51.2 ± 13.7 
25.5 ± 4.2 
42.9 
53.3 
18.8 ± 18.9 
8652 ± 2629 
23.8 ± 15.3 
124.2 ± 45.5 
21.1 ± 15.7 
104.6 ± 54.7 
3.0 ± 5.7 
48.2 
37.2 
'Significantly different from control-; fp<0.0i?) 
Di sctission 
In this study, we found indications for interplay between EPHX genotype and smoking in the 
etiology of colorectal adenomas. Of two recently published studies, one provided results similar 
to those of our study \ but the other presented opposite findings 4. These conflicting results can 
partly be due to differences between the three studies with respect to classification of EPHX 
polymorphisms. Data on genotype-phenotype correlation in vitro and in vivo are limited, 
especially for the different combinations of exon 3 and 4 polymorphisms, and we therefore did 
not combine both. Cortessis and Ulrich both used different classifications of EPHX imputed 
phenotypes (from fast to very slow) based on the combinations of exon 3 and 4 polymorphisms. 
Whereas the role of epoxide hydrolase in PAH metabolism is well-established 3, more research 
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on the enzyme activity of combinations of exon 3 and 4 variants and on its effect on PAH-
associated neoplasm is needed. 
From our study, we conclude that EPHX genotype at exon 3 possibly modulates the association 
between smoking and colorectal adenomas, the fast variant being related to highest risk. 
T a b l e A.2, Smoking, intake of fat and oil, IU'lIX imputed phenotvpes, and risk of colorectal 
adenomas: odds ratios (95% contklen.ee intervals). 
Total 
population 
Smoking status ' 
Never 
Former 
Current 
Pack-years * 
None 
<10 
10-20 
>20 
1.0 (REF) 
1.2(0.8-1.7) 
1.7(1.1-2.5) 
1.0 (REF) 
1.1 (0.7-1.7) 
1.2(0.8-2.0) 
1.9 (1.2-2.9) 
Intake of fat and oil (g/day)h 
< 15 
15-25 
25-35 
>35 
1.0 (REF) 
1.5(0.96-2.4) 
1.5 (0.9-2.4) 
1.8(1.0-3.1) 
Exon 3 
Fast 
(YY) 
1.0 (REF) 
1.1 (0.6-1.8) 
2.0 (1.1-3.5) 
1.0 (REF) 
0.8 (0.4-1.6) 
1.5 (0.8-2.8) 
2.5 (1.3-4.6) 
1.0 (REF) 
2.7 (1.4-5.2) 
2.5(1.2-5.0) 
2.2 (1.1-4.7) 
Slow 
(YH or HH) 
0.9 (0.6-1.5) 
1.2 (0.7-2.1) 
1.3 (0.7-2.2) 
0.9 (0.6-1.5) 
1.3 (0.7-2.3) 
0.9 (0.4-1.9) 
1.4 (0.8-2.6) 
1.8 (0.9-3.4) 
1.6 (0.9-3.1) 
1.5 (0.7-3.1) 
2.5(1.2-5.2) 
EPHX 
Exon 4 
Fast 
(HR or RR) 
1.0 (REF) 
1.7(0.9-3.2) 
2.6 (1.3-5.0) 
1.0 (REF) 
2.5(1.2-5.1) 
1.5(0.7-3.4) 
2.3 (1.1-4.7) 
1.0 (REF) 
2.1 (0.96-4.6) 
1.6 (0.7-3.7) 
2.2 (0.95-5.3) 
Slow 
(HH) 
1.6(0.98-2.8) 
1.6 (0.9-2.7) 
2.1 (1.2-3.7) 
1.7(1.0-2.8) 
1.1 (0.6-2.1) 
1.8 (0.9-3.6) 
2.8 (1.5-5.2) 
1.6(0.8-3.3) 
2.0 (0.99-4.2) 
2.3 (1.1-5.0) 
2.5 (1.1-5.4) 
'" Adjusted tor age, gender, constipation history, and alcohol consumption; h adjusted tor age, 
gender, constipation history, total energy intake, intake of cereals, and duration of .smoking. 
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